Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
CFH	ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS	ENSG00000000971	Complement factor H	P08603	1	196651878-196747504	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity		Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 295.2	Cell type enriched	Detected in many	4	Hepatocytes: 1052.9	Cancer enriched	Detected in all	9	liver cancer: 151.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		MAIT T-cell: 16.5	Lineage enriched	Detected in single	27	T-cells: 16.5	Cell line enhanced	Detected in many		HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7									CAB016385, CAB016769, HPA038922, HPA049176, HPA053326	Supported		Approved	Vesicles	Secreted to blood			396000000000	110000000000	Vesicles		CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113	unprognostic (2.40e-1)	unprognostic (9.86e-2)	unprognostic (1.22e-1)	unprognostic (8.39e-2)	unprognostic (5.40e-3)	unprognostic (1.80e-1)	unprognostic (3.75e-3)	unprognostic (7.40e-2)	unprognostic (1.06e-1)	unprognostic (1.04e-1)	unprognostic (9.08e-2)	unprognostic (2.08e-1)	prognostic unfavorable (1.92e-6)	unprognostic (6.50e-3)	unprognostic (4.49e-3)	unprognostic (1.73e-1)	unprognostic (1.37e-1)	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1	3.9	3.7	2.5	8.7	15.2	3.4	17	47.3	2	1.2	7	295.2	11	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19	3.3	10	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22	22.8	5.8	17.2	16.8	0	0.1	0.6	0.1	0	16.5	1	0	13.6	0	0	21.4	12.1	0	5.5	13.5	0.7	2.9	0	2.5	0	2	0	0	0.4	0	5	0.5	0.2	0	4.1	16.2	0	26.9	0.1	0	26.3	0	4	1.7	81	16.8	0	15.3	0.5	19.1	0	0.1	0	0	0	0	0	19.6	4.3	0	47.7	0	0	0	0	0	0.1	0	0	1.2	16.2	0.2	0.1	0.1	0.1	0	0	2.9	0	1.2	0	0.1	0	1.8	0	16.5	0	6	3.5	0.1	0	0.4	1.4	0.6	0	0	0	0	1	1.6	3.8	2.6	2.7	2	1.2	5.3	1.7	5.3	2.9	8.9	14.5	21	47.7	39.3	0.4	6.2	30.6	119.1	131.9	5.2	0	0	0	1.9	1.5	55	0	0	0.7	0	200.9	8.6	3.5	1052.9	0.9	0	0	57.1	34.9	3.6	262.9	6	42.2	0	0	0.3	6.4	0	130.4	0	1.4	6.5	36.8	0.7	0.6	33.4	0.1	10.2	0	49.2	Hepatocytes
PON1	ESA, PON	ENSG00000005421	Paraoxonase 1	P27169	7	95297676-95324707	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters		Hydrolase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	liver: 144.1	Cell type enriched	Detected in some	47	Hepatocytes: 399.2	Cancer enriched	Detected in some	78	liver cancer: 97.8	Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0	Not detected	Not detected			Low region specificity	Detected in some			HPA001610	Approved				Secreted to blood			96000000000	24000000000			HPA001610: AB_1079656	unprognostic (2.02e-2)	unprognostic (2.41e-2)	unprognostic (3.04e-1)	unprognostic (3.54e-2)	unprognostic (2.70e-1)		prognostic favorable (7.24e-7)	unprognostic (2.24e-1)	unprognostic (1.95e-1)	unprognostic (9.02e-3)	unprognostic (1.76e-3)	unprognostic (3.97e-2)	unprognostic (6.74e-9)	unprognostic (1.09e-3)	unprognostic (2.29e-2)	unprognostic (2.07e-1)	unprognostic (5.54e-3)	0	1.7	0.2	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.1	0.1	0	144.1	0	0	0.1	0	0.2	0	0	0.3	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.1	0	6.1	0	0	0	0	0	0.1	0.5	0.6	0	1	0.1	0	0	1.5	0.1	0	0	0	0.1	0	0	0	0	0	0.6	0.3	0	0	0	0.1	0	0	0.1	0	0	0	1	0.6	0	0.4	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0.4	0.4	0	0.2	0	1	0	0	0.3	0.6	0.1	0	0.3	0	0.2	0.4	0	0.5	0	0.1	0	0.2	1	0.3	0	0	0.2	0.3	0.6	0	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0.3	1	0	0.5	0	0	0.2	0.1	0	0	0.1	0.1	0.1	0	0	0	0	1	0	0	0	0	0.4	7.6	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0.1	0.6	0	399.2	0	0	2.9	8	8.6	0	0.6	0	0	0	0	0.3	0.1	0	0	0	0.3	0	0	0.4	0	0.1	0	0	0	0	Hepatocytes
ABCB4	GBD1, MDR2, MDR3, PFIC-3, PGY3	ENSG00000005471	ATP binding cassette subfamily B member 4	P21439	7	87401697-87480435	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease mutation, Intrahepatic cholestasis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 93.2	Cell type enriched	Detected in some	6	Hepatocytes: 235.3	Cancer enriched	Detected in some	11	liver cancer: 16.3	Low region specificity	Detected in single			Group enriched	Detected in some	6	memory B-cell: 4.9;naive B-cell: 11.4	Lineage enriched	Detected in many	8	B-cells: 11.4	Group enriched	Detected in some	5	SH-SY5Y: 12.0;WM-115: 22.9	Low region specificity	Detected in many			Not detected	Not detected			HPA049395, HPA053288	Enhanced		Approved	Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites						Nucleoplasm, Plasma membrane, Actin filaments	Focal adhesion sites	HPA049395: AB_2680745, HPA053288: AB_2682102	unprognostic (7.92e-2)	unprognostic (8.87e-2)	unprognostic (1.97e-1)	unprognostic (1.90e-1)	unprognostic (8.95e-2)	unprognostic (1.06e-2)	unprognostic (2.35e-3)	unprognostic (9.91e-2)	unprognostic (3.53e-1)	unprognostic (1.19e-1)	unprognostic (2.44e-3)	unprognostic (8.43e-2)	unprognostic (2.83e-2)	unprognostic (8.01e-3)	unprognostic (7.12e-2)	unprognostic (2.11e-2)	unprognostic (2.47e-1)	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0	0	0.1	0.2	0.6	0.1	0.3	4	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0	0.5	0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0	0	0	0.1	0.2	0	0	2.8	0	0	0	0	0.1	2	0	0	0	0	1.8	0	0	0.1	0.1	0	0	0	0	0.5	0.3	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.3	0	0	0	0.3	0	0	0	0.1	12	0	0.6	2.2	0.5	0.2	0.5	0	0.2	1.6	0.1	0	0	0	2.8	0.2	0	22.9	0	0	0	0	0	0.1	4.9	0	0.1	1.4	11.4	0	0	0	0	0	0.4	0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0	0.3	23.1	0	0.9	0	9.3	0	0	0	1.8	0	0.9	0	0.1	0.6	0.8	0.1	0	0	0.2	1.5	0	0	235.3	0.5	36.5	0	5.5	5.4	0.2	0	0	10.1	0	0	0	0.1	0	0.4	0.5	0	0	0.9	0.5	0.1	0.4	0.1	0	0	0	Hepatocytes
FMO3		ENSG00000007933	Flavin containing monooxygenase 3	P31513	1	171090877-171117819	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	liver: 170.2	Cell type enriched	Detected in some	12	Hepatocytes: 378.8	Cancer enriched	Detected in many	13	liver cancer: 94.9	Region enriched	Detected in single	5	pons and medulla: 1.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	ASC diff: 25.4;ASC TERT1: 19.2	Not detected	Not detected			Not detected	Not detected			HPA013750	Enhanced											HPA013750: AB_1848968	unprognostic (1.87e-2)	unprognostic (6.30e-2)	unprognostic (1.00e-1)	unprognostic (6.81e-3)	unprognostic (2.64e-1)	unprognostic (1.31e-3)	prognostic favorable (3.46e-4)	prognostic favorable (5.60e-5)	unprognostic (2.95e-1)	unprognostic (9.34e-2)	unprognostic (3.02e-1)	unprognostic (7.21e-2)	prognostic unfavorable (1.13e-4)	unprognostic (1.84e-1)	unprognostic (2.59e-1)	unprognostic (3.45e-1)	unprognostic (7.27e-2)	9.5	2	0	0.8	0.2	0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0	0.1	6.4	170.2	3.7	1.5	0.2	0	0.9	0.7	0.3	2.7	0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0	0.8	1.2	2.6	0.2	0	0.7	0.2	0	0	0	0	0	0	0	0	0	25.4	19.2	0	0	1	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	1	0.3	0	5.3	0	0	0	0.4	0	0	0	0.8	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.2	0	0	0	0.2	0.1	0.1	0	0.1	0.2	0	1.4	0.1	11.9	0.3	0.9	0.3	0.3	0	0.3	5.1	32.1	27.3	0	0	0	0	0	0.1	1.3	0	0	0	0	0.9	0.1	0	378.8	0	0	0	4.9	6.9	0	0.3	0	1.7	0	0	0.2	0.1	0	0	0	0.1	6.5	3.8	0	0	0.4	0	0	0	0	Hepatocytes
MASP2	MASP1P1	ENSG00000009724	Mannan binding lectin serine peptidase 2	O00187	1	11026523-11047233	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	98	liver: 185.1	Cell type enriched	Detected in some	68	Hepatocytes: 541.9	Cancer enriched	Detected in some	71	liver cancer: 41.9	Region enriched	Detected in single	4	cerebellum: 1.7	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in many	7	Hep G2: 20.5	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA029313, HPA029314	Uncertain		Supported	Golgi apparatus	Secreted to blood			340000000	880000000	Golgi apparatus		HPA029313: AB_10669654, HPA029314: AB_10670029	unprognostic (7.00e-2)	unprognostic (8.37e-2)	unprognostic (2.75e-2)	unprognostic (2.89e-1)	unprognostic (1.86e-1)	unprognostic (3.26e-3)	prognostic favorable (1.60e-4)	unprognostic (2.92e-3)	unprognostic (3.13e-2)	unprognostic (4.04e-2)	unprognostic (6.90e-3)	unprognostic (8.30e-4)	unprognostic (7.14e-2)	unprognostic (3.91e-1)	unprognostic (2.62e-2)	unprognostic (1.05e-1)	unprognostic (1.09e-4)	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0	0.3	0.3	0.3	0.3	0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0	0.5	0.3	2.9	1.6	0	0.1	0.5	0.8	0	0	0	1.3	1.1	2.4	0.7	0	0.6	0.7	0	0	0	0.6	2.3	1.4	2.6	20.5	0	2.2	1.7	0	0	0.1	0	2	0	1.9	0.8	0.5	0	0.6	0.6	1.2	0.4	0.2	0.6	1.8	1	0.5	0	1.4	1.8	0.7	0.9	0.5	0.5	1.8	0.6	1.3	1.2	0.9	0.6	1	0.6	0.8	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0	0	3.4	0.2	0.8	0	0.4	2.5	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.1	541.9	0.1	0	0	8	7	0	0	0	1.7	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0.1	Hepatocytes
CPS1		ENSG00000021826	Carbamoyl-phosphate synthase 1	P31327	2	210477682-210679107	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Urea cycle	Allosteric enzyme, Ligase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	liver: 298.3	Cell type enriched	Detected in many	72	Hepatocytes: 1670.2	Cancer enriched	Detected in many	8	liver cancer: 136.1	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HeLa: 90.5;SK-BR-3: 27.3	Low region specificity	Detected in single			Not detected	Not detected			CAB003781, HPA021400	Enhanced		Supported	Nucleoli,Nucleoli rim					2100000	Nucleoli, Nucleoli rim		CAB003781: , HPA021400: AB_1847197	unprognostic (1.67e-2)	unprognostic (3.72e-2)	unprognostic (4.02e-2)	unprognostic (7.21e-7)	unprognostic (3.81e-2)	unprognostic (2.52e-1)	prognostic favorable (6.93e-5)	unprognostic (1.23e-2)	unprognostic (2.65e-1)	unprognostic (1.35e-2)	unprognostic (5.38e-2)	unprognostic (1.94e-3)	unprognostic (2.38e-4)	unprognostic (5.90e-2)	unprognostic (1.13e-1)	unprognostic (3.14e-2)	unprognostic (3.74e-2)	0.4	0.1	0.5	0.3	1.6	0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0	0.4	1.1	1.4	0.3	0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0	0.4	0.4	0.1	0.2	0.4	0.3	0	0	0	0	0.8	0	0.3	2.4	6.3	4.3	4.2	7.4	6.7	2.3	2.7	2.7	4.2	0.6	0	1	0.1	2.5	3.8	1.1	0.2	3.8	6.8	0	1.9	4	90.5	5.6	1.4	2.1	0	3.8	2.8	5.3	5.4	6.9	0.3	1.7	4	0.3	4.4	1.1	0.1	0.2	2.4	0	0.6	0.2	5.8	0.5	5.7	0	0.1	0.4	15.8	27.3	3	8.5	0	0.7	3	7	2.1	2.1	4.9	0	0.3	0	4.6	4.4	4	0	0	0	0.2	0	0	0	0.3	0	0	0.3	0	0.8	0	0	0	0	0	0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5	11.9	9.6	20.7	0.5	1.9	1.1	0.7	15.3	1.4	6.8	1.8	7.9	0.3	0	0.1	23.2	1.4	0.3	23.3	0.2	0.4	2.5	1.2	3.5	1670.2	0.2	0	0	16.5	22.7	3.6	2.3	1.8	1.7	0	0.1	1.4	0	0	1.1	0.7	2.2	0	2.5	0.3	1.1	1.6	17.4	5	0.1	0.4	Hepatocytes
C8B		ENSG00000021852	Complement C8 beta chain	P07358	1	56929210-56966140	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	52	liver: 240.9	Cell type enriched	Detected in some	11	Hepatocytes: 251.9	Cancer enriched	Detected in some	181	liver cancer: 107.0	Not detected	Not detected			Cell type enriched	Detected in single	47	basophil: 4.6	Lineage enriched	Detected in single	47	granulocytes: 4.6	Cell line enriched	Detected in some	5	Hep G2: 5.8	Not detected	Not detected			Low region specificity	Detected in many			HPA023694	Supported				Secreted to blood				3600000000			HPA023694: AB_1847128				unprognostic (6.65e-2)			prognostic favorable (9.31e-5)	unprognostic (2.37e-1)			unprognostic (2.37e-1)			unprognostic (1.29e-2)	unprognostic (6.57e-2)	unprognostic (5.12e-3)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	240.9	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.1	0.1	0	0.7	0	5.8	0	1.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0.3	0.9	0	0	0	0	0	0.5	0	0	0	0	0	0.3	0	0.1	0	0	0.6	0	0.2	0	0.2	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0.3	17.8	0	0	0	0	0	0	0	4.9	0	0	23.3	0.6	0	0	0	0	251.9	0.1	0	0	6.2	5.3	8.9	0.6	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Hepatocytes
ABCC2	CMOAT, cMRP, DJS, MRP2	ENSG00000023839	ATP binding cassette subfamily C member 2	Q92887	10	99782732-99852192	Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters	Transport	Translocase	Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 28.4;kidney: 25.6;liver: 74.3	Cell type enriched	Detected in some	6	Hepatocytes: 52.9	Cancer enhanced	Detected in many		liver cancer: 24.0	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 4.1	Lineage enriched	Detected in single	6	granulocytes: 4.1	Group enriched	Detected in some	5	A549: 60.2;Hep G2: 60.0	Not detected	Not detected			Not detected	Not detected			HPA071145	Enhanced											HPA071145: 	unprognostic (1.49e-3)	unprognostic (5.92e-2)	unprognostic (1.59e-1)	unprognostic (3.67e-1)	unprognostic (1.93e-2)	unprognostic (2.33e-1)	unprognostic (2.51e-1)	unprognostic (7.15e-3)	unprognostic (5.68e-2)	unprognostic (2.01e-1)	unprognostic (4.30e-1)	unprognostic (1.40e-3)	prognostic unfavorable (1.93e-5)	unprognostic (1.31e-1)	unprognostic (3.22e-2)	unprognostic (2.95e-1)	unprognostic (1.26e-2)	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0	0.1	1.2	0.1	0.3	0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0	0	60.2	0.9	3	4.6	3.5	1	0.1	0.3	0.1	0.2	12.9	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0	0.2	60	0.1	0	0.2	0.6	4.1	0.4	0.4	0.1	0.1	0.1	0	0.1	0	0.2	0	0.4	0.1	11.2	0	0.1	0	0.1	0.4	0	0	0	0.1	0.9	7.4	0.1	0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0	0	4.9	1	0.3	4.1	0.2	0.3	0.3	0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.8	0.1	0	0.2	0.4	2.5	4	0	0	0	0.2	0	0	1.6	0	0	0	0.3	0	0	0.2	1.1	52.9	0.2	0	0	0.6	1.3	0.2	0.3	0	5	0	0	0.2	0.1	0	0	9.1	1.4	0	0.4	0.7	0.3	0	1.4	0	0	0	Hepatocytes
HSD17B6	HSE, RODH, SDR9C6	ENSG00000025423	Hydroxysteroid 17-beta dehydrogenase 6	O14756	12	56752161-56787790	Enzymes, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	liver: 241.2	Cell type enriched	Detected in many	10	Hepatocytes: 1569.2	Cancer enriched	Detected in many	5	liver cancer: 170.3	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Karpas-707: 11.8;U-266/84: 14.6	Not detected	Not detected			Low region specificity	Detected in all			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA059141: AB_2683922	unprognostic (7.70e-2)	unprognostic (8.76e-2)	unprognostic (5.08e-2)	unprognostic (1.92e-2)	unprognostic (2.01e-1)	unprognostic (3.79e-2)	prognostic favorable (6.32e-4)	unprognostic (1.06e-2)	unprognostic (3.21e-1)	unprognostic (1.44e-1)	unprognostic (1.35e-1)	unprognostic (6.74e-2)	unprognostic (2.50e-10)	unprognostic (1.26e-1)	unprognostic (1.79e-1)	unprognostic (1.08e-1)	unprognostic (1.05e-1)	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2	2.6	1.1	0.3	0.2	0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1	6.2	0.8	3.2	0.8	0	13.3	0	0.3	9.9	2.3	2	2	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1	6.5	2	3.2	1	0.5	1.1	1.6	5.3	0.9	0.3	1	0.5	0.5	0	9	0.9	11.8	0.8	2.1	4.6	1	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0	0.2	0.1	3	0.6	3.4	2	2.5	2.4	0.6	1.1	3.3	2.2	0	0.1	1.3	2	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17	0	0	1.3	0	0	2.5	0.4	0	23.3	0	2.4	4.8	9.9	0	1569.2	0.3	0	0	31.3	41.1	1.5	11.5	0.1	0	1.8	0.3	1	0.1	0	1.4	0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9	Hepatocytes
ITIH1	H1P, IATIH, ITIH	ENSG00000055957	Inter-alpha-trypsin inhibitor heavy chain 1	P19827	3	52777592-52792068	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	95	liver: 321.2	Cell type enriched	Detected in some	23	Hepatocytes: 864.9	Cancer enriched	Detected in some	598	liver cancer: 329.1	Not detected	Not detected			Cell type enhanced	Detected in some		classical monocyte: 3.3	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4	Not detected	Not detected			Low region specificity	Detected in all			HPA041639, HPA042049	Approved		Approved	Vesicles	Secreted to blood			4490000	31000000000	Vesicles		HPA041639: AB_10796349, HPA042049: AB_10797379	unprognostic (1.87e-4)	unprognostic (1.31e-3)	unprognostic (2.38e-1)	unprognostic (8.55e-2)	unprognostic (1.03e-1)	unprognostic (2.64e-3)	prognostic favorable (1.89e-5)	unprognostic (2.27e-2)	unprognostic (1.70e-1)	unprognostic (1.30e-1)	unprognostic (2.91e-2)	unprognostic (8.45e-2)	unprognostic (4.53e-4)	unprognostic (4.02e-3)	unprognostic (5.70e-3)	unprognostic (2.08e-1)	unprognostic (2.24e-2)	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0.1	0.2	0	0	0	321.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	1.1	0	3.3	0.8	0	0.9	0	0	0	0	10.9	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0.1	0	0	0	0	0	0.3	0	3.3	0	2.5	0.5	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0.1	0.1	0	0	0.1	1.4	0	0	0	0	0	0.7	0	0	0	0	0	0.2	0	0	0	0	0.3	0.1	0.3	0	0.7	0	0	3.3	0	0	0.9	0	0	0	0	1.1	0	0	0	0	0.8	0.2	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	38.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	864.9	0.1	0	0	18.4	14.8	1	0	0	0	3.6	0	0	0	0	0	0	0	0	1.4	0	0	0.1	0.1	0.5	0	0	Hepatocytes
F7		ENSG00000057593	Coagulation factor VII	P08709	13	113105788-113120681	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	39	liver: 68.0	Cell type enriched	Detected in some	6	Hepatocytes: 131.2	Cancer enriched	Detected in some	17	liver cancer: 41.4	Not detected	Not detected			Group enriched	Detected in some	15	gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6	Lineage enriched	Detected in single	17	T-cells: 1.7	Group enriched	Detected in some	9	CACO-2: 16.6;Hep G2: 10.3	Not detected	Not detected			Not detected	Not detected			HPA004826			Approved	Mitochondria	Secreted to blood			351000000	1500000000	Mitochondria		HPA004826: AB_10602805	unprognostic (2.06e-1)	unprognostic (2.55e-1)	unprognostic (1.03e-1)	unprognostic (1.34e-1)	unprognostic (3.27e-1)	unprognostic (1.91e-1)	unprognostic (1.50e-3)	unprognostic (3.81e-1)	unprognostic (4.36e-3)	unprognostic (1.16e-1)	unprognostic (4.19e-3)	unprognostic (1.15e-1)	unprognostic (1.35e-3)	unprognostic (3.36e-3)	unprognostic (1.09e-1)	unprognostic (2.86e-1)	unprognostic (1.47e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1.7	0.1	0	0.2	0.1	0	0	0	0	0.2	0	0	0	16.6	0	0	0	0.2	0.1	0	0	0	0	0	0	0.1	0	10.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.7	0	0	0.1	0	0	0	0.3	0	0	0.2	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.7	0	1.2	0	0	1.6	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0	0	2.4	0	0	0.6	0.4	2.5	0	0	0	0	0	0	0	0	0	0	23.3	0.2	0	0.5	0	0	131.2	0.1	0	0	3.7	3.1	0	0.9	0	0	0	0	0	0	0	1.8	0.1	0.1	0	0.1	0.1	0.9	0.1	0.1	0.5	0	0	Hepatocytes
CREB3L3	CREB-H	ENSG00000060566	CAMP responsive element binding protein 3 like 3	Q68CJ9	19	4153601-4173054	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Transcription, Transcription regulation, Unfolded protein response	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	95	intestine: 117.4;liver: 179.5	Cell type enriched	Detected in some	9	Hepatocytes: 100.8	Cancer enriched	Detected in many	18	liver cancer: 91.4	Not detected	Not detected			Group enriched	Detected in some	5	eosinophil: 1.0;T-reg: 1.5	Group enriched	Detected in many	13	granulocytes: 1.0;T-cells: 1.5	Cell line enhanced	Detected in some		CACO-2: 4.6;HDLM-2: 31.5;Hep G2: 10.0;HMC-1: 5.8;U-266/70: 6.9	Low region specificity	Detected in some			Not detected	Not detected			HPA040671, HPA056228	Enhanced											HPA040671: AB_2677072, HPA056228: AB_2683072	unprognostic (1.86e-2)	unprognostic (2.13e-1)	unprognostic (2.81e-1)	unprognostic (1.66e-2)	unprognostic (8.41e-4)	unprognostic (1.79e-4)	unprognostic (1.88e-1)	unprognostic (5.28e-4)	unprognostic (3.01e-1)	unprognostic (3.61e-2)	unprognostic (1.55e-2)	unprognostic (1.49e-1)	prognostic unfavorable (3.53e-6)	unprognostic (3.18e-3)	unprognostic (1.48e-1)	unprognostic (3.27e-2)	unprognostic (3.35e-2)	0.1	1.3	0.1	0	0.1	0	0	0	0.2	0	38.6	0	0	61	0	0	0	0	0.1	0	0.1	0.2	0.5	179.5	0	0	0.1	0.2	0.1	0.2	0	0	0	0.1	0	0	0	0	0	0	0	117.4	0	0.1	0.1	0.3	0.1	0	0.8	0	0	0	0	0	0	0	1	0	0	1.5	0	0	0.3	0	0	0	0	2.2	0	0	0	0	4.6	0.1	0	0	0	0.4	0	0	0	0	31.5	0	0	0	10	0	0	5.8	0	0	0	0	0	0	0.1	0	2.3	0	0	2.6	0.3	0	0	0	1.3	0	0.8	0	0	0.1	0.6	0	0	0	0	0	0.2	0	0	0	0.1	0	6.9	2.8	0	0	2.6	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.5	0	0.1	0.1	0	0.2	0.1	0.2	0.1	0.2	0.1	0	0	0	0.8	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	10.7	0	0	0.2	0	0	0	100.8	0	0	0	2.5	3.2	0	0	0	0	0	0.5	0	0.5	8.6	0	0.3	0	0	0	0	0	0	0	0	0.4	0	Hepatocytes
NTHL1	NTH1, OCTS3	ENSG00000065057	Nth like DNA glycosylase 1	P78549	16	2039815-2047866	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	DNA damage, DNA repair	Glycosidase, Hydrolase, Lyase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	12	Hepatocytes: 755.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB025152	Supported											CAB025152: 	unprognostic (1.06e-1)	unprognostic (9.71e-2)	unprognostic (1.23e-1)	unprognostic (2.54e-1)	unprognostic (7.89e-2)	unprognostic (1.77e-1)	unprognostic (2.86e-1)	unprognostic (2.46e-2)	unprognostic (4.98e-2)	unprognostic (1.11e-1)	unprognostic (2.77e-2)	unprognostic (6.78e-2)	unprognostic (6.53e-2)	unprognostic (2.27e-1)	unprognostic (1.34e-1)	unprognostic (5.08e-2)	unprognostic (1.62e-2)	10.5	8.2	13.4	10.5	19.9	6	7.8	15.6	17.9	14.8	12.3	9	15.1	9.7	11.8	6.9	9.4	20.5	14.7	10.6	12.5	12.1	7.4	17.5	11.1	10.4	13.6	15.7	18.8	24.6	5.8	8.7	8.3	13.3	9.8	8.2	9.1	22.2	18.2	12.4	6.3	11.2	7.8	10.4	15.2	11.1	6.4	11.6	9.6	9.5	6.6	8.4	7.8	9.3	21.4	14.7	2.4	14.2	9.7	18.8	8.5	10.8	26.7	7.8	11.8	3.2	6.1	8.7	4.5	4.9	8.7	5.5	19	10.6	23.2	9.6	3.8	5.7	9.8	9.6	10.7	1.5	10.7	23.6	7.2	17	21.1	4.4	8.2	8.5	5.1	5.5	4.6	5	5.8	12.1	14.3	7.8	8.4	3.4	12.1	12.2	30.8	17.3	13.5	17.5	29.4	8.2	37.3	6.2	3.9	16.6	16.5	5	15.3	8.8	3	11	8.1	4.7	7.4	8.2	6.6	8.5	11.5	13.4	9.4	3.3	11.5	9.2	2.4	8.7	2	8.8	14.2	9.8	21.4	10.5	9.8	14.7	17.1	7.8	9.5	0.3	9.7	12.1	14.6	18.8	8.5	13.4	19.9	15.6	17.9	12.5	12.1	13.6	15.7	13.3	11.6	26.8	28	7.5	16.5	7.7	8.8	9.8	48.4	16	15.9	3.5	0	9	14.9	15.3	7.6	35.9	21.6	0	8	14.8	13.9	8.1	5.7	755.9	11.6	6.4	64.8	43	19.9	16.6	31.4	11.7	20.3	6.4	53.2	10.1	11.3	40.7	23.7	22.5	6	12.9	18.9	5.8	30.9	8.8	2.3	9.2	42.8	19.7	Hepatocytes
SPP2	SPP24	ENSG00000072080	Secreted phosphoprotein 2	Q13103	2	234050679-234077134	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	879	liver: 113.0	Cell type enriched	Detected in some	22	Hepatocytes: 258.9	Cancer enriched	Detected in some	112	liver cancer: 65.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.1;RH-30: 3.5;RPTEC TERT1: 1.0;U-698: 1.4	Low region specificity	Detected in some			Not detected	Not detected								Secreted to blood				540000000										prognostic favorable (2.33e-6)	unprognostic (7.02e-3)		unprognostic (9.62e-3)								0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	0	0.6	0.6	0	0	0.9	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	0	3.5	0	1	0.8	0	0	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	1.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.9	3.5	0.9	0	0	0	0.3	7.6	2.7	3.4	0	0	0	0	0	0	0	0	0	0.6	0	0	0	4.7	258.9	0.1	0	0	5.5	3.2	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
AFM	ALB2, ALBA	ENSG00000079557	Afamin	P43652	4	73481683-73504001	Plasma proteins, Predicted secreted proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 169.0	Cell type enriched	Detected in some	8	Hepatocytes: 272.5	Cancer enriched	Detected in single	167	liver cancer: 62.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	CACO-2: 5.9	Not detected	Not detected			Not detected	Not detected			HPA017006, HPA052437	Enhanced				Secreted to blood			54900000000	5000000000			HPA017006: AB_1844635, HPA052437: AB_2732575							prognostic favorable (1.80e-4)				unprognostic (5.73e-2)		unprognostic (4.24e-2)					0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	12.5	169	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0	1.1	0	0.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0	0	0.5	0.6	0	0.6	0	0	0	0	0	0	0	0	0	0	0.4	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	0.7	0	0.2	2.5	0	0	1.8	0	0.7	0	0	0	0	0	0	0.8	0	0	0	0	272.5	0.1	0	0	4.3	1.6	0	0	0	0	0	0	0	0.1	0	0	36.3	0	0	0	0	0	0.1	0.1	0	0	0	Hepatocytes
CPB2	CPU, PCPB, TAFI	ENSG00000080618	Carboxypeptidase B2	Q96IY4	13	46053195-46105033	Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Carboxypeptidase, Hydrolase, Metalloprotease, Protease	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	82	liver: 246.8	Cell type enriched	Detected in some	8	Hepatocytes: 1070.7	Cancer enriched	Detected in some	112	liver cancer: 268.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	76	Hep G2: 62.5	Not detected	Not detected			Not detected	Not detected			HPA004146	Approved				Secreted to blood				14000000000			HPA004146: AB_1078397	unprognostic (3.44e-2)	unprognostic (1.25e-1)	unprognostic (2.94e-2)	unprognostic (1.89e-2)	unprognostic (7.69e-2)	unprognostic (1.17e-2)	prognostic favorable (2.06e-4)	unprognostic (1.89e-1)	unprognostic (2.74e-1)	unprognostic (2.48e-1)	unprognostic (3.17e-2)	unprognostic (4.83e-2)	unprognostic (3.20e-3)	unprognostic (1.34e-1)	unprognostic (7.10e-2)	unprognostic (3.34e-2)	unprognostic (9.61e-2)	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.7	0	0	0.7	0	0	0	0	246.8	3	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0.2	0.5	0.5	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	62.5	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0	0	0.3	0	0.6	0	0	0.4	0.2	0.1	0	0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0	0	0	0	0.1	0	0	0	0	0	0	3	24.8	0	0	0	0	0	127.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	1070.7	0.1	0	0	16	15.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	Hepatocytes
APOB		ENSG00000084674	Apolipoprotein B	P04114	2	21001429-21044073	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport	Heparin-binding	Atherosclerosis, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	145	intestine: 224.8;liver: 442.2	Cell type enriched	Detected in some	10	Hepatocytes: 2874.2	Cancer enriched	Detected in some	99	liver cancer: 295.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	30	Hep G2: 155.4	Not detected	Not detected			Not detected	Not detected			CAB016070, HPA049793	Supported		Supported	Vesicles,Cytosol	Secreted to blood			1490000000000	89000000000	Vesicles, Cytosol		CAB016070: AB_626690, HPA049793: AB_2680885	unprognostic (1.63e-2)	unprognostic (2.71e-2)	unprognostic (1.75e-1)	unprognostic (1.06e-1)	unprognostic (1.04e-2)	unprognostic (7.31e-2)	unprognostic (1.46e-2)	unprognostic (6.53e-3)	unprognostic (4.43e-2)	unprognostic (8.89e-3)	unprognostic (3.01e-1)	unprognostic (4.59e-3)	unprognostic (3.60e-3)	unprognostic (2.89e-2)	unprognostic (2.38e-1)	unprognostic (2.99e-1)	unprognostic (6.23e-2)	0.3	0.1	0.1	0	0.1	0	2.3	0.1	0.1	0.1	68.9	0	0	24.9	0.1	0	0.1	0.1	0	1.2	0.1	0.1	0.1	442.2	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.2	224.8	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	155.4	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0.2	0.2	0	0.2	0.2	0.1	0	0.4	0.2	0.1	0.9	0.3	0	0.3	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	7	0	0	0	14.6	293	0	0	0	0	0	0	0	1	0	0	46.7	0	0	0	0	0	2874.2	0.1	0	0	51.5	53.3	0.7	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.5	0.2	0	0	0	0	0	Hepatocytes
GCKR		ENSG00000084734	Glucokinase regulator		2	27496842-27523684	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in some	16	liver: 60.9	Cell type enriched	Detected in some	7	Hepatocytes: 76.9	Cancer enriched	Detected in some	8	liver cancer: 14.9	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8	Not detected	Not detected			Low region specificity	Detected in all			CAB034098, HPA052227	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		CAB034098: AB_2247323, HPA052227: 	unprognostic (3.31e-1)	unprognostic (2.11e-3)	unprognostic (2.27e-1)	unprognostic (6.97e-2)	unprognostic (1.68e-2)	unprognostic (5.70e-2)	unprognostic (2.31e-1)	unprognostic (1.70e-1)	unprognostic (1.52e-1)	unprognostic (4.12e-1)	unprognostic (2.25e-3)	unprognostic (1.65e-1)	unprognostic (1.02e-7)	unprognostic (6.51e-2)	unprognostic (1.18e-1)	unprognostic (9.27e-3)	unprognostic (1.50e-2)	0.2	2	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.3	0.4	0	3.9	0.5	0.1	0	0.2	60.9	0.1	0.1	0.1	0.1	2	0.9	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.5	3.1	0.9	0.2	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.8	2.6	1.2	1.7	0.9	0.7	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0	0.1	0.3	0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0	0	0.1	0	12.7	0.5	19.4	0.8	0.1	0.4	0.3	1	0.5	0.1	2.2	6.2	0	0	0.2	0.2	0.1	0.1	0.7	0.1	0	0	0.3	0	0.1	0.2	0.2	0	0.1	0.1	0.2	0.1	0.1	0.5	0.1	3.8	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	2.6	1.2	0.3	0.6	1	0.6	0.8	0.4	0.4	0.1	2.4	0.9	0.8	2.1	1.7	0.3	0.8	0.1	0.7	0.1	0.3	0.2	0.1	0.1	0	0.1	0.1	0.2	0.2	0	0	0	0	0.1	0	0.3	5.1	0	0	0	0	0	0	7.6	6.3	0.4	0	0	9	0	0	0.3	0	76.9	0.1	0	0	1.3	1.9	2.8	0.3	0	0	0	0	0	10.7	0	0	0	0	0	0.2	0.1	0.1	0	0	0	0	0	Hepatocytes
FETUB		ENSG00000090512	Fetuin B	Q9UGM5	3	186635969-186653141	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Fertilization	Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 76.1	Cell type enriched	Detected in some	7	Hepatocytes: 37.1	Cancer enriched	Detected in some	12	liver cancer: 44.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7	Not detected	Not detected			Not detected	Not detected			HPA035132, HPA035133	Supported		Approved	Vesicles	Secreted to blood			47500000000	4500000000	Vesicles		HPA035132: AB_10601650, HPA035133: 		unprognostic (9.01e-2)		unprognostic (1.95e-1)	unprognostic (4.62e-1)	unprognostic (8.74e-2)	unprognostic (6.28e-3)	unprognostic (1.24e-2)	unprognostic (7.55e-2)	unprognostic (9.78e-2)	unprognostic (1.73e-2)			unprognostic (9.18e-2)	unprognostic (1.79e-1)	unprognostic (8.39e-2)		0	0	0	0	0	0	0	0	0.1	0.5	0	0.1	0	0	0.1	0.1	2.2	0	0	0	0	0	0	76.1	0	0	0.2	0	0	2.8	0	0	0	0	0	0	0	0.5	0	0	0.6	0	0	0	0	0	0.2	0.1	0.3	0	2.6	11.5	0	0.6	0	0	0	0	0	0.8	0	0	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0.2	0	0	0	0	1.5	0.2	0	0	0	0	4.5	0	0.5	0	1	0.1	0	0.2	0	0	0.1	0.2	0	0.1	0	0	0	1.7	0	0	0.2	0.7	0.4	0.2	0	0.4	0.1	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	5.5	0	0	0	0.2	0	0	0	0	37.1	0	0	0	1.3	2.4	4.2	0.3	0	0	0	0	0	0.1	1.5	0.4	0	0	0	0	0	0.1	0	0.1	0	0	0	Hepatocytes
APOH	B2G1, BG	ENSG00000091583	Apolipoprotein H	P02749	17	66212033-66256525	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Heparin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	550	liver: 823.7	Cell type enriched	Detected in some	37	Hepatocytes: 7635.3	Cancer enriched	Detected in many	232	liver cancer: 2878.9	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	20	Hep G2: 166.9	Low region specificity	Detected in many			Not detected	Not detected			HPA001654, HPA003732, CAB022214	Enhanced		Supported	Golgi apparatus	Secreted to blood			247000000000	44000000000	Golgi apparatus		CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183			unprognostic (2.11e-2)	unprognostic (1.87e-1)	unprognostic (1.28e-1)		prognostic favorable (2.39e-7)	unprognostic (1.26e-1)		unprognostic (5.99e-2)	unprognostic (2.88e-3)		prognostic unfavorable (1.10e-6)	unprognostic (1.26e-2)	unprognostic (5.76e-2)			0	0	0	0.1	0	0	0	0	0.1	0	0.1	0.1	0	0	0	0.2	0	0	0.1	0	0	0	1.1	823.7	0.3	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0.1	0	0	0.3	0.1	0.1	0	0	0.1	0	0	0.1	0.1	1.4	0.7	0.9	1.3	1	1.3	0.2	0	4.5	0	0	0	0	0	0	0	0	0	8.2	0	0.1	0	0	0.2	0.1	0	0	0	0	0	0.3	0.1	166.9	0	0.8	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	4.2	0	0.1	0.9	0	0	0.1	0	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0.5	2.1	0.3	0	0	1.3	0.4	1.3	0.5	1.3	0.8	0.8	0.6	0.7	1.4	0.9	0.8	0.9	1	0.4	0.5	0.7	0.2	0	0	0	0.1	0	0	0	0	0.1	0	0	10.5	46.2	0	0	0	0	206.4	1.4	1.2	0	0	0	3.3	0.3	0.1	0	0	163.5	2	0	0	0	0	7635.3	0.5	0	0	134.4	149.8	0	0	0	0	0	0	0	0.3	0	0	12.9	0	0	0	0	0	0	0.6	0.7	0.8	0	Hepatocytes
SERPIND1	D22S673, HC-II, HC2, HCF2, HLS2	ENSG00000099937	Serpin family D member 1	P05546	22	20773879-20787720	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Chemotaxis, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	47	liver: 170.8	Cell type enriched	Detected in some	10	Hepatocytes: 223.1	Cancer enriched	Detected in many	80	liver cancer: 334.4	Low region specificity	Detected in some			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	10	Hep G2: 64.2	Low region specificity	Detected in all			Not detected	Not detected			CAB008639, HPA055767	Supported		Approved	Vesicles	Secreted to blood				94000000000	Vesicles		CAB008639: AB_1618010, HPA055767: AB_2682912	unprognostic (1.68e-1)	unprognostic (8.27e-2)	unprognostic (4.40e-2)	prognostic favorable (4.09e-4)	unprognostic (5.42e-2)	unprognostic (1.23e-1)	unprognostic (1.12e-3)	unprognostic (1.56e-1)	unprognostic (1.13e-1)	unprognostic (1.74e-1)	unprognostic (1.21e-2)	unprognostic (2.88e-1)	unprognostic (3.94e-9)	unprognostic (2.01e-1)	unprognostic (4.66e-2)	unprognostic (8.36e-3)	unprognostic (1.46e-1)	0	0	0	0	2.3	0	0.2	0.6	0.9	0.3	0	1.4	0	0	0.3	0	0	0.1	0	0.3	0	0	0	170.8	0.3	0	0	0.7	0.3	0	3.6	0.1	0.2	2.6	0	0	0.1	0	0	0	0	0	0.5	0.4	0	0.1	0.1	0.5	0	0.1	0	0	0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	64.2	0	0.2	0.1	0	0	0.5	0	0	6.4	0	0	0	0.1	0	0	0	0	0.7	5.2	0	0.2	0	0	1	0	0	0.1	0	0	0	0	0	0.5	0.1	0	0	0	0	0	0	2.3	0	4.4	0	0.4	0	1	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0	2.3	0.6	0.9	0	0	0	0.7	2.6	0.5	0	13.7	0	0	0	0	0.8	5.1	0	0	0	0	0	0	0	0	0	0	23.3	0	0	0.7	0	1.1	223.1	0.1	0	0	4.9	2.9	0	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
DDT	DDCT	ENSG00000099977	D-dopachrome tautomerase	P30046	22	23971365-23980469	Enzymes, Plasma proteins, Predicted intracellular proteins	Melanin biosynthesis	Lyase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 52.8;liver: 58.4	Cell type enriched	Detected in all	5	Hepatocytes: 4710.9	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HEK 293: 68.5									HPA049871, HPA074115	Enhanced		Approved	Mitochondria						Mitochondria		HPA049871: AB_2680926, HPA074115: 	unprognostic (1.77e-2)	unprognostic (1.13e-1)	unprognostic (1.40e-1)	unprognostic (1.22e-2)	unprognostic (8.09e-2)	unprognostic (4.00e-3)	unprognostic (2.02e-3)	unprognostic (6.58e-2)	unprognostic (4.66e-2)	unprognostic (2.23e-2)	unprognostic (1.96e-1)	unprognostic (6.06e-3)	unprognostic (1.12e-1)	unprognostic (7.34e-2)	unprognostic (3.30e-1)	unprognostic (3.81e-1)	unprognostic (2.61e-3)	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38	23.8	29	28.6	27.1	11.6	4	9.4	7.7	6.8	24.5	7.9	5.3	6.9	7.2	10.2	7.9	26	7.4	4.1	10.2	22.5	10	9.8	4.5	11	68.5	15.6	15.8	22.2	7.8	34.2	15.7	6.8	7.5	6.9	6.1	8	7.4	4.1	14.1	10.5	6.9	13.3	7.5	31	12.1	24	35	16.5	7.5	37.1	12.3	10	13.7	13.2	16.3	30.9	23.2	5.7	7.8	10.8	8.5	7.2	16	7.3	8.2	32.4	10.7	16.3	14.1	12.7	13.8	20.7	38	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29	28.6											77.4	62.3	170.5	177.4	123.4	46.7	20.4	580.9	78.9	76.2	230.3	84.4	209.3	608.5	198.5	156.1	122	650.8	116.8	322.3	247	92.9	222.4	128	4710.9	242.3	41.3	249.4	161.4	217.6	261.8	108.4	147.1	150.1	220	322.2	63.3	238.6	309.5	104	969.7	70.4	77.6	140	72.1	40.3	164.4	250.7	154.1	488.9	247.4	Hepatocytes
CYP2D6	CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D	ENSG00000100197	Cytochrome P450 family 2 subfamily D member 6	P10635	22	42126499-42130906	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 78.0	Cell type enriched	Detected in many	38	Hepatocytes: 435.9	Cancer enriched	Detected in many	35	liver cancer: 90.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3									HPA045223	Enhanced		Approved	Golgi apparatus		No	No			Golgi apparatus		HPA045223: AB_10962927	unprognostic (4.40e-3)	unprognostic (7.68e-3)	unprognostic (5.45e-2)	unprognostic (1.22e-3)	unprognostic (1.24e-1)	unprognostic (1.29e-4)	unprognostic (3.83e-2)	unprognostic (7.27e-3)	unprognostic (1.13e-1)	unprognostic (1.71e-1)	unprognostic (4.03e-4)	unprognostic (2.11e-2)	unprognostic (5.61e-5)	unprognostic (3.01e-1)	unprognostic (2.23e-1)	unprognostic (4.08e-1)	unprognostic (4.82e-5)	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	78	0.1	0.1	0.1	0.1	0.5	0.3	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0.8	0.1	0.5	0	0	0	0	0	1	0	0	0	0	0.1	0.2	0	0	0	0	0.2	0	0.2	0	0	0	0	0.1	4.4	0	0.1	6.2	0	0	0	0	0	0	0.3	0	1.9	0	0.3	0.2	0	0.6	0	0.2	3.6	0	1.1	0	0	0.1	0.3	1.2	0.1	0	0	2.3	0	0	0	1.7	0	0.3	4.3	0	0	0	0.7	0.5	0	0	0	0	0	0.8	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.6	0	0.5	0.5	6.5	0.3	2.5	1.4	0	1.8	2	0.1	1.7	0.6	2.9	0.3	3.9	0	0.5	0.1	0.2	0.5	0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0	0	0	0	1	0.9	0.5	2.9	1.4	0.5	2	0	0.2	0.7	0.3	1	0.3	0.5	0.8	0.2	Hepatocytes
SLC10A1	NTCP	ENSG00000100652	Solute carrier family 10 member 1	Q14973	14	69775417-69797289	Predicted membrane proteins, Transporters	Host-virus interaction, Ion transport, Sodium transport, Symport, Transport	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	44	liver: 121.2	Cell type enriched	Detected in some	13	Hepatocytes: 130.2	Cancer enriched	Detected in some	79	liver cancer: 65.2	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 4.3	Not detected	Not detected			Not detected	Not detected			HPA042727	Approved											HPA042727: AB_10960691	unprognostic (3.42e-1)	unprognostic (9.39e-2)	unprognostic (1.51e-2)	unprognostic (2.11e-2)	unprognostic (1.93e-2)	unprognostic (6.51e-3)	prognostic favorable (9.53e-6)	unprognostic (6.07e-3)	unprognostic (8.95e-2)	unprognostic (2.17e-1)	unprognostic (5.75e-3)	unprognostic (1.22e-1)	unprognostic (1.71e-2)	unprognostic (1.05e-1)	unprognostic (3.21e-1)	unprognostic (2.45e-1)	unprognostic (5.69e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0.3	2.7	0.5	0.1	0.6	0	0.2	0	0.2	0.4	0	0	0.4	0	0	0.1	0	4.3	0.1	0.6	0	0	0.1	0.4	0	0	0	0.2	0.5	0.6	0.3	0.6	0	0.8	0.5	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0.1	0.1	0.1	0.1	0.3	0	0	0.9	0.1	0.1	0.8	0.5	0	0.1	0.4	0.5	1.1	0.1	0.6	0	0.3	0	0.1	0.9	0.1	0.6	0.1	0	0.3	1.7	0.5	0.3	0.4	0.8	0.5	0.2	0.3	1	0.6	0.4	2.7	0.1	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.6	0.4	10.2	0	0	0	0	0.1	0	0	1.2	0	0	0	0	0	0	0.1	0	130.2	0.1	0	0	1.8	2.7	3.6	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Hepatocytes
HAO1	GOX, GOX1	ENSG00000101323	Hydroxyacid oxidase 1	Q9UJM8	20	7882981-7940474	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	594	liver: 121.8	Cell type enriched	Detected in some	44	Hepatocytes: 293.3	Cancer enriched	Detected in some	184	liver cancer: 93.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.7;RH-30: 2.3;U-251 MG: 2.5	Not detected	Not detected			Not detected	Not detected			HPA049552, HPA072442	Enhanced								200000			HPA049552: AB_2680814, HPA072442: 					unprognostic (4.88e-2)		unprognostic (2.87e-3)				unprognostic (1.08e-2)	unprognostic (1.25e-1)						0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	121.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	2.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	2.5	0.1	0	0.8	0	0.4	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	293.3	0	0	0	6.7	6.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
F9	FIX	ENSG00000101981	Coagulation factor IX	P00740	X	139530758-139563458	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2334	liver: 233.6	Cell type enriched	Detected in some	20	Hepatocytes: 475.1	Cancer enriched	Detected in single	1354	liver cancer: 67.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.8;RH-30: 2.0;SiHa: 1.6;U-698: 1.1	Low region specificity	Detected in single			Not detected	Not detected								Secreted to blood				11000000000										prognostic favorable (6.69e-4)											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	233.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0	0	0	1.8	0.2	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0.2	0	0	0	2	0	0	0	0	0	1.6	0.1	0	0	0	0	0.3	0	0	0	0	0.3	0	1.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0.2	17.8	0	0	0	0	0	0	0	0	0	0	23.3	0	0	0	0	0	475.1	0	0	0	15.4	17.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
DHODH		ENSG00000102967	Dihydroorotate dehydrogenase (quinone)	Q02127	16	72008588-72027664	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Pyrimidine biosynthesis	Oxidoreductase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	liver: 72.4	Cell type enriched	Detected in many	5	Hepatocytes: 106.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all							HPA010123, HPA011942	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol						Mitochondria	Nucleoplasm, Cytosol	HPA010123: AB_1847648, HPA011942: AB_1847649	unprognostic (4.88e-2)	unprognostic (1.10e-1)	unprognostic (1.90e-1)	unprognostic (2.12e-2)	unprognostic (1.41e-3)	unprognostic (2.10e-1)	unprognostic (4.27e-2)	unprognostic (1.31e-2)	unprognostic (1.26e-1)	unprognostic (2.68e-1)	unprognostic (2.14e-1)	unprognostic (6.40e-2)	unprognostic (9.26e-3)	unprognostic (1.98e-1)	unprognostic (1.97e-1)	unprognostic (1.14e-1)	unprognostic (1.81e-1)	5.9	4.2	4.7	8.8	5.1	2.9	5	2.7	5	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4	2.6	5.2	3.9	4.8	5.9	6	4.4	11.7	4	3	7.5	4	3.5	3.4	4.3	5.4	4	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7	11.4	14	3.1	5.9	19.8	12	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5	4.3	3	4.8	2.7	5.2	5.4	3	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7	3.9	12	5	6.6	2.1	6.7	0.7	0	4.4	9.6	6	5	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0	9.9	7.9	8	3.3	2.4	5	6.2	4.1	Hepatocytes
AQP9	HsT17287, SSC1	ENSG00000103569	Aquaporin 9	O43315	15	58138169-58185911	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	blood: 127.8;liver: 147.0	Cell type enriched	Detected in some	4	Hepatocytes: 258.5	Cancer enriched	Detected in many	30	liver cancer: 132.4	Low region specificity	Detected in some			Cell type enriched	Detected in some	20	neutrophil: 127.8	Lineage enriched	Detected in many	20	granulocytes: 127.8	Cell line enriched	Detected in single	27	U-87 MG: 25.9	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA074762, CAB075684	Enhanced											CAB075684: , HPA074762: AB_2732267	unprognostic (1.91e-1)	unprognostic (1.92e-1)	unprognostic (7.30e-2)	unprognostic (2.67e-1)	unprognostic (1.24e-2)	unprognostic (4.15e-2)	unprognostic (1.36e-3)	unprognostic (2.28e-2)	unprognostic (3.82e-2)	unprognostic (2.03e-1)	unprognostic (4.80e-3)	unprognostic (6.98e-2)	prognostic unfavorable (5.72e-11)	unprognostic (8.78e-2)	unprognostic (1.13e-2)	unprognostic (1.25e-1)	unprognostic (8.39e-2)	7.8	0.3	0.6	12.9	0.7	9.8	0.6	0.7	1.4	0.2	0.3	0.1	1	0	0.2	7.8	0.7	3	0.8	2	0.4	0.2	0.8	147	8.6	12	2.4	0.4	1.2	0.3	2.8	0.4	1.4	0.6	0.4	0	0.5	0.4	0.8	0.4	6.9	0.3	1	0.5	15.8	0.7	2.5	0.4	0.4	0.5	0.1	0.4	1.3	0.6	0	0.2	127.8	6.2	0	0	1.7	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.9	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	25.9	0.1	0	0	6.2	0.1	0	1.9	0	0	0	0	0.2	0	0	0	127.8	0	2.3	0	0	1.7	0.6	0.7	0.7	1.4	0.4	0.2	2.4	0.4	0.6	0.4	0	19.3	4.3	0.1	0.3	0	1.2	5.1	2.7	5.7	0	0	0.3	0	0.1	1.9	0.1	0	0	0.2	0.5	0.4	0	7	258.5	43.2	0	0	8	34.5	0.8	0.3	57.7	0	2.8	0	0	0.8	0	0	0.3	0	0	0.1	0	0	0.5	0.7	1.3	0	0.1	Hepatocytes
SLC39A14	KIAA0062, NET34, ZIP14	ENSG00000104635	Solute carrier family 39 member 14	Q15043	8	22367249-22434129	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport, Zinc transport		Disease mutation, Dystonia, Neurodegeneration, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 135.5;pancreas: 77.2	Cell type enriched	Detected in many	8	Hepatocytes: 491.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in all		BJ hTERT+: 66.5	Low region specificity	Detected in all							HPA016508, HPA056732	Enhanced		Approved	Endoplasmic reticulum,Golgi apparatus,Plasma membrane					950000	Endoplasmic reticulum, Golgi apparatus, Plasma membrane		HPA016508: AB_1857148, HPA056732: 	unprognostic (1.67e-1)	unprognostic (6.67e-3)	prognostic favorable (5.00e-5)	unprognostic (9.83e-3)	unprognostic (9.21e-3)	unprognostic (8.99e-3)	unprognostic (1.99e-1)	unprognostic (2.91e-2)	unprognostic (4.95e-2)	unprognostic (5.66e-2)	unprognostic (6.64e-2)	unprognostic (1.53e-1)	prognostic unfavorable (3.79e-7)	unprognostic (4.88e-2)	unprognostic (8.73e-2)	unprognostic (1.63e-2)	unprognostic (1.11e-3)	15	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3	6.4	4	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19	5	1.8	2.5	0.5	2.9	8.7	3.9	10.4	13.9	3.9	7.8	14	11.8	8.5	15	66.5	23.5	37.1	46.2	9.9	10.4	8.5	17.6	61.2	11.5	19.2	18.7	38.8	10.8	11	8.3	11.1	46.5	33.3	5.7	9.1	12.5	15.3	41.6	29.1	11.9	10.4	7.5	7.2	10.7	11.9	4.8	8.6	3.6	23.7	16.6	10.7	12.3	7.3	22.2	8.6	4.5	6.6	10.3	15.3	6.6	31	8.7	5.2	8.3	5.7	29.2	14.9	18.4	15.4	6.2	5.6	13.6	41.3	7.6	17	0	0.5	2.5	8.3	0.1	8.7	5	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8	3	4.8	3.7	8.8	29.7	7.1	50.1	50.9	0	3.4	7	2	0.2	1.7	48.7	0.4	31.6	63.6	0	63.9	2.1	30.9	17.2	0	491.4	1.5	46.1	32	31.9	15.9	1.8	22.2	1.6	42.2	4.6	51.4	4.6	55.6	28.8	39.3	21.4	7.4	0	46.7	0	2.4	18.3	0.5	4.9	33.7	9.8	Hepatocytes
FGL1	HFREP-1	ENSG00000104760	Fibrinogen like 1	Q08830	8	17864380-17910365	Plasma proteins, Predicted secreted proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 450.7	Cell type enriched	Detected in many	23	Hepatocytes: 6738.7	Cancer enriched	Detected in some	40	liver cancer: 399.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	15	A549: 22.2;Hep G2: 52.2	Low region specificity	Detected in some			Not detected	Not detected								Secreted to blood				1800000				unprognostic (3.62e-2)	unprognostic (1.14e-2)		unprognostic (1.75e-5)	unprognostic (3.00e-1)	unprognostic (3.54e-2)	unprognostic (7.89e-2)	unprognostic (2.15e-1)	unprognostic (2.62e-1)		unprognostic (2.71e-1)	unprognostic (1.09e-2)	unprognostic (2.86e-7)	prognostic unfavorable (5.38e-4)	unprognostic (3.62e-1)	unprognostic (2.58e-2)	unprognostic (1.35e-1)	0.1	0	0.1	0.2	0.2	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	0.1	0	0.1	450.7	0.2	0.1	0.1	0.1	0.1	71.3	0	0.1	0.6	0.2	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0	0	0	0.4	0	0	0	0	22.2	0	2.4	0	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	52.2	0	0.3	0	1.2	0	0	0	0	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0.2	0	0	0	0	0.5	0.3	0	0	0.1	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	0	3.4	104.9	0.1	0	0	1	298.1	0	0	0	0	0.2	0	4.2	35.8	0	0	140.2	59.6	0.4	0	8.5	0	6738.7	15.3	0	0	190.3	185.3	19	0.6	0	0	2.8	0	0	121.6	0	0.4	0	0	0	0.3	0.7	0.5	0	0.8	0	0	0.1	Hepatocytes
SULT2A1	DHEA-ST, STD	ENSG00000105398	Sulfotransferase family 2A member 1	Q06520	19	47870466-47886397	Enzymes, Predicted intracellular proteins	Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 211.7	Cell type enriched	Detected in some	24	Hepatocytes: 1127.7	Cancer enriched	Detected in some	52	liver cancer: 244.3	Not detected	Not detected			Cell type enhanced	Detected in many		basophil: 5.3	Low lineage specificity	Detected in many			Group enriched	Detected in some	34	Hep G2: 26.6;RT4: 18.1					Low region specificity	Detected in all			CAB018755, HPA041487, HPA063633	Enhanced		Supported	Cytosol					210000	Cytosol		CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066			unprognostic (2.14e-1)				unprognostic (6.79e-3)							unprognostic (6.82e-2)	unprognostic (1.36e-1)		unprognostic (1.31e-2)	0.1	46.9	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0	0.1	0.1	3.9	0.1	0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1	5.3	0.8	2.3	1.3	0.4	0	0	0.1	0.1	0	0	0.4	0	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	26.6	0	0.6	0.4	0	0	0	0	0	0	0.1	0.1	0.2	0	0	0	0.2	0.1	0	0.1	0	0.3	0.2	0	18.1	0.1	0.1	0.1	0	0	0	0	0.2	0	0	0.1	0.2	0	0.1	0.1	0.1	0	0.1	0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1	0.6	0.3	1.3	1.3	1	3.1	2.3	0.4	1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	7	0.5	0.1	0.6	0.6	10.2	0	0	0	0	0	0	0	0	0.1	0	46.7	0	0	0.1	0.3	0	1127.7	0	0	0	38.6	31.7	0	2.8	0	0	0	0.2	0.2	0	0	0.4	0	2.4	0	0	0	0	0	0.5	0.8	0	0.3	Hepatocytes
HAMP	HEPC, HFE2B, LEAP-1, LEAP1	ENSG00000105697	Hepcidin antimicrobial peptide	P81172	19	35280716-35285143	Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters		Antibiotic, Antimicrobial, Fungicide, Hormone	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 716.5	Cell type enriched	Detected in many	8	Hepatocytes: 1549.8	Group enriched	Detected in many	12	glioma: 6.5;liver cancer: 16.3	Low region specificity	Detected in many			Group enriched	Detected in some	9	myeloid DC: 2.5;plasmacytoid DC: 7.6	Lineage enriched	Detected in single	13	dendritic cells: 7.6	Cell line enriched	Detected in single	229	Hep G2: 69.9					Not detected	Not detected								Secreted to blood			1900000	3900000				unprognostic (5.53e-2)	unprognostic (5.02e-4)	unprognostic (2.10e-3)	unprognostic (4.69e-3)	unprognostic (5.35e-2)	unprognostic (2.24e-1)	unprognostic (3.92e-2)	unprognostic (9.36e-2)	unprognostic (2.73e-2)	unprognostic (1.06e-1)	unprognostic (4.61e-1)	unprognostic (1.86e-1)	unprognostic (3.68e-7)	unprognostic (4.11e-2)	unprognostic (3.93e-2)	unprognostic (4.08e-2)	unprognostic (7.77e-2)	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10	1.8	0.3	716.5	0.4	1	4.2	0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4	0	0.3	0	1	0.4	0	0.5	7.6	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	69.9	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0.4	0	0	2.5	0.5	0	0	0	0.5	0	7.6	0	0	1.8	10.8	0.2	4.4	10	1.8	4.2	0	6.7	4	0	0	9.3	0.9	0.5	0	1.1	30.6	0	1.2	0	0	0.6	0	0.4	0	0.6	0	23.3	82	0.9	0.5	5.2	69.8	1549.8	198.8	0	0	28.3	41.3	0	0	3.4	0	0	1	0.5	36.6	0	0	0	0.1	0	0.9	0	0	16.3	0.6	1.5	0.2	1.7	Hepatocytes
PON3		ENSG00000105852	Paraoxonase 3	Q15166	7	95359944-95396368	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	liver: 148.0	Cell type enriched	Detected in many	14	Hepatocytes: 460.4	Group enriched	Detected in many	9	liver cancer: 30.8;lung cancer: 7.8	Not detected	Not detected			Cell type enriched	Detected in single	12	NK-cell: 1.1	Lineage enriched	Detected in single	12	NK-cells: 1.1	Cell line enhanced	Detected in some		A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6	Low region specificity	Detected in many			Not detected	Not detected			HPA014848, CAB025250	Enhanced				Secreted to blood			1760000000	350000000			CAB025250: , HPA014848: AB_1855540	unprognostic (2.67e-1)	unprognostic (1.03e-1)	unprognostic (6.28e-3)	unprognostic (5.52e-3)	unprognostic (1.36e-1)	unprognostic (4.87e-1)	unprognostic (1.44e-3)	unprognostic (6.32e-2)	unprognostic (1.11e-1)	unprognostic (6.44e-3)	unprognostic (9.14e-2)	unprognostic (7.18e-3)	unprognostic (8.30e-9)	unprognostic (1.66e-1)	unprognostic (1.04e-2)	unprognostic (8.29e-2)	unprognostic (5.12e-2)	0.4	0.7	0.3	0.1	0.6	0	6.9	0.2	0.5	0.9	1	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148	4	0	0.4	0.2	2.4	7.1	0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0	1.1	0.5	0.3	0	0	0	0	1.1	0	0	2.2	20.2	0	0	0	0	0	0	0	0	0	6.5	4.9	0	0.3	0	0	0	0	0	0	0	0	0	0	22.4	0	0	0	0	1.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	3.9	0	0	12.6	0	0	0	0.1	0	0	1.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6	32.1	1.4	0.7	0.8	0	0.3	25.5	8.1	14.8	3.5	0	1.5	1.7	0.2	9	0.5	4	0	1.8	1.9	2.6	2.2	0	460.4	0.2	0	0	8.6	7	3.6	7.5	0	13.5	0	2.3	3	1.5	0	2.8	5.2	0	0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3	Hepatocytes
TFR2	HFE3, TFRC2	ENSG00000106327	Transferrin receptor 2	Q9UP52	7	100620416-100642779	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters		Receptor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 112.6	Cell type enriched	Detected in many	4	Hepatocytes: 379.7	Cancer enriched	Detected in many	70	liver cancer: 136.2	Not detected	Not detected			Group enriched	Detected in some	46	basophil: 5.5;eosinophil: 3.9	Lineage enriched	Detected in single	54	granulocytes: 5.5	Group enriched	Detected in some	11	HEL: 28.5;HMC-1: 39.6;K-562: 26.3	Low region specificity	Detected in many			Not detected	Not detected			CAB016255, HPA017171, HPA073125	Enhanced		Approved	Golgi apparatus						Golgi apparatus		CAB016255: AB_628395, HPA017171: , HPA073125: 	unprognostic (4.18e-2)	unprognostic (1.97e-2)	unprognostic (2.74e-1)	unprognostic (1.04e-1)	unprognostic (1.26e-2)	unprognostic (4.13e-2)	prognostic favorable (2.48e-4)	unprognostic (2.29e-2)	unprognostic (4.49e-2)	unprognostic (9.26e-2)	unprognostic (1.93e-1)	unprognostic (2.90e-1)	unprognostic (1.18e-9)	unprognostic (6.51e-2)	unprognostic (1.68e-1)	unprognostic (3.28e-1)	unprognostic (8.18e-2)	0.1	0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.3	0.3	0.1	0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.5	0	2.9	0	0.6	39.6	0	0	0	0	0	0	0	26.3	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	5.5	0	3.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	7.8	0.9	0.2	5.3	0.9	12.7	0	1.2	0	7.9	0.1	0	0.4	4	0	0	93.5	0.2	1.1	0.4	0.5	0	379.7	0.3	20.6	0	7.4	6.9	5.7	0	0.5	0	0	0.2	0.3	0.1	0	0	0	1.8	0	0.7	0.7	2	0.5	0.1	2.5	0.5	0.6	Hepatocytes
C5	C5a, C5b, CPAMD4	ENSG00000106804	Complement C5	P01031	9	120952335-121050276	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	55	liver: 259.9	Cell type enriched	Detected in many	12	Hepatocytes: 458.7	Cancer enriched	Detected in many	17	liver cancer: 73.0	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 20.5;Hep G2: 21.6	Low region specificity	Detected in some			Not detected	Not detected			HPA029339	Supported				Secreted to blood			113000000000	46000000000			HPA029339: AB_10601125	unprognostic (2.51e-1)	unprognostic (5.88e-3)	unprognostic (2.50e-3)	unprognostic (1.57e-2)	unprognostic (5.05e-2)	unprognostic (9.52e-3)	prognostic favorable (9.43e-4)	unprognostic (1.83e-1)	unprognostic (3.19e-2)	unprognostic (1.55e-1)	unprognostic (2.35e-2)	unprognostic (4.41e-2)	unprognostic (1.46e-5)	unprognostic (5.91e-2)	unprognostic (1.20e-1)	unprognostic (3.67e-2)	unprognostic (2.75e-1)	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.5	4.7	8.3	6.1	7.1	0.2	2.5	2.6	0.7	1.5	0.6	2	3	0.1	1.3	2.8	8.1	0.2	0.2	1.1	0.6	0	1.2	1	21.6	1.1	0.7	0.5	3.1	0.4	1.5	2.7	1.3	0.7	1.2	0.5	2.8	1.6	4	0.3	0.1	1.2	5	8	1.8	2.1	0.3	1.3	0.6	1.2	4.9	1.1	0	2	3.4	1.6	2.7	0.9	2.1	0.1	5.5	2.4	1.7	1.2	1.2	1.6	2.8	5	0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3	6	25.8	2.2	1	0.9	4.5	0.6	38.2	5.3	12.5	1.8	0	0.1	1.7	0.1	1.3	0.5	0	0	0.4	0	0.8	0.7	0	458.7	1.5	6.4	0	8	12.9	1.7	2.8	3.1	0	1.8	0.4	3.9	1.1	0	8.5	7.8	2.5	0	1.2	1.8	2.3	1.1	0	0.7	0.9	0.1	Hepatocytes
AMBP	EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI	ENSG00000106927	Alpha-1-microglobulin/bikunin precursor	P02760	9	114060127-114078472	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Host-virus interaction	Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	75	liver: 592.2	Cell type enriched	Detected in many	5	Hepatocytes: 9824.4	Cancer enriched	Detected in many	115	liver cancer: 2620.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	154	Hep G2: 168.4	Not detected	Not detected			Not detected	Not detected			HPA001497, CAB069436, HPA075585	Approved		Approved	Golgi apparatus,Vesicles,Cytosol	Secreted to blood				71000000000	Vesicles	Golgi apparatus, Cytosol	CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: 	unprognostic (6.92e-2)	unprognostic (3.61e-1)	unprognostic (4.95e-3)	prognostic favorable (1.20e-4)	unprognostic (9.79e-2)	unprognostic (2.90e-1)	unprognostic (1.04e-3)	unprognostic (7.59e-2)	unprognostic (2.83e-2)	unprognostic (2.04e-1)	unprognostic (2.14e-1)	unprognostic (7.84e-2)	unprognostic (4.36e-2)	unprognostic (2.89e-3)	unprognostic (4.66e-2)	unprognostic (2.97e-3)	unprognostic (9.45e-3)	0	0	0	0.1	0	0	0.2	0	0.1	0	0.1	0.1	0	0	0	0.2	0	0	7.8	0.1	0	0	1.7	592.2	0.1	0	0	0	0	6.1	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0.1	0	0	0.3	0.1	0.2	0	0.1	0.1	0	0	0	0	0	0	0	0.8	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.3	0	0.1	0	0	0	0	0.5	0	0.3	0.1	168.4	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.4	0	0	1	0	0.8	0	0.2	0	0.3	0.1	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	1	42	0.6	1.3	0	0	2035.7	0	1.2	1.8	0	0	3.3	105.1	19.2	0	0.4	256.9	25.3	0.3	0.1	0.4	0	9824.4	0.7	0	2.4	175.6	182.3	40.5	0.6	0	0	6.4	0.9	0	22.8	1.1	0	9.9	0	0	0	0.2	0.1	0.4	1.1	3.8	1	0.3	Hepatocytes
CYP2C18	CPCI, CYP2C, CYP2C17, P450IIC17	ENSG00000108242	Cytochrome P450 family 2 subfamily C member 18	P33260	10	94683621-94736190	Enzymes, Plasma proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 62.9;liver: 56.1	Cell type enriched	Detected in some	6	Hepatocytes: 113.1	Cancer enhanced	Detected in many		liver cancer: 18.9	Not detected	Not detected			Cell type enriched	Detected in single	11	basophil: 1.7	Lineage enriched	Detected in single	11	granulocytes: 1.7	Cell line enhanced	Detected in some		BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4														Intracellular and membrane								unprognostic (2.40e-1)	unprognostic (1.75e-2)	unprognostic (2.69e-1)	unprognostic (1.10e-2)		unprognostic (1.32e-2)	unprognostic (2.57e-1)	unprognostic (2.71e-1)	unprognostic (9.78e-2)	unprognostic (2.28e-1)	unprognostic (4.22e-3)		unprognostic (1.62e-3)	unprognostic (1.29e-1)	unprognostic (1.08e-1)		unprognostic (6.81e-3)	0.2	0	0.2	0.8	0.2	0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0	6.7	0.2	0.2	0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19	0.2	0.2	0.3	0.2	5	3.8	0.2	3.7	0	0	1.7	0	0	0.1	0.1	0	0.3	0.1	0.3	0	0	7.9	0	0	0	0	0.9	0	0	1.4	0	0	0	0	0	0	0	0.3	0	0.2	0.1	0	0	0.1	0	2.3	0.1	0.1	0	0	0	0	0	0	0	0.1	0.5	0	4.4	0	0	0	0.9	0.5	0.2	0.3	0.6	0.2	0	0	1.2	0	0	0	0	0.3	0.2	0.6	0.1	0.5	0	0.1	0.2	0	1.7	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	3.5	0	0	0.1	0	0	17.8	0	0	0	0	0.1	0	0.6	0	0	14.7	0	6.4	0.1	0	0	0	113.1	0	0	0	1.8	1.9	0	0	0	0	0	0.4	0	5.3	3.5	0	0	0	0	0	0	0.2	1.5	1.3	0	1.5	0	Hepatocytes
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Cell adhesion	Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	42	liver: 321.7	Cell type enriched	Detected in many	4	Hepatocytes: 4765.6	Cancer enriched	Detected in many	85	liver cancer: 2216.6					Cell type enhanced	Detected in some		naive CD8 T-cell: 2.1	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	11	CACO-2: 168.9	Low region specificity	Detected in all			Not detected	Not detected			CAB016695, CAB016765, HPA060933, HPA068011	Supported		Supported	Endoplasmic reticulum,Vesicles	Secreted to blood			606000000000	32000000000	Endoplasmic reticulum, Vesicles		CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: 	unprognostic (1.19e-1)	unprognostic (2.12e-1)	unprognostic (2.29e-2)	unprognostic (6.13e-2)	unprognostic (9.74e-2)	unprognostic (8.42e-2)	prognostic favorable (3.74e-4)	unprognostic (6.20e-2)	unprognostic (3.97e-1)	unprognostic (8.95e-2)	unprognostic (3.24e-3)	unprognostic (1.01e-2)	prognostic unfavorable (4.10e-11)	unprognostic (8.82e-3)	unprognostic (2.27e-1)	unprognostic (4.86e-3)	unprognostic (7.09e-2)	0.2	7.6	0	0	0	0	0	0.7	0	0	0			0	0	0	0	0	3.6	2.2	0	0	0	321.7	0	0	0		0	0.6	0	0	2		0	0		0	0	0	0	0	0	0	0.1	0.1	0.4			0		0	0	0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0	3	0	0	0	0	0.7	0.2	0.1	0.1	0.1	168.9	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0.1	8.7	0.2	0.8	0	0	0	0	0	0.5	0	0	0.2	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.1	0.1	15.5	0.9	0	0.5	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0.2	0	1	0	0.9	0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0	0.2	0	0.1											0	0.6	55.9	0	0	10.7	14.7	1151.5	0	0	0	72.6	2.6	3.3	14.8	0	0.7	0	233.6	17.1	1.6	7.6	0	0	4765.6	4.3	36.5	0	116	117.8	0	0	0	0	35.1	0	4.8	38.2	0	1.4	2.2	24.6	0	2	0.3	0.4	0	8	0.7	0	0	Hepatocytes
UGT2B10		ENSG00000109181	UDP glucuronosyltransferase family 2 member B10	P36537	4	68815993-68831196	Enzymes, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	277	liver: 120.4	Cell type enriched	Detected in some	15	Hepatocytes: 221.7	Cancer enriched	Detected in single	296	liver cancer: 93.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	39	Hep G2: 16.1									HPA045108	Uncertain											HPA045108: AB_2679218			unprognostic (3.50e-3)				unprognostic (1.92e-3)						unprognostic (4.17e-1)					0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	120.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	12.7	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	221.7	0	0	0	1.3	4.7	1.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Hepatocytes
SULT1E1	EST, STE	ENSG00000109193	Sulfotransferase family 1E member 1	P49888	4	69841212-69860152	Cancer-related genes, Enzymes, Predicted intracellular proteins		Transferase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 37.8;liver: 26.2;vagina: 15.8	Cell type enriched	Detected in some	4	Hepatocytes: 47.0	Low cancer specificity	Detected in many			Region enriched	Detected in single	8	pons and medulla: 3.3	Cell type enhanced	Detected in single		neutrophil: 1.7	Low lineage specificity	Detected in single			Group enriched	Detected in some	16	HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4									HPA028213, HPA028728, CAB047344	Enhanced		Uncertain	Nuclear membrane,Cytosol						Nuclear membrane, Cytosol		CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894	unprognostic (5.60e-2)	prognostic favorable (4.06e-4)	unprognostic (2.48e-1)	unprognostic (1.07e-3)	unprognostic (2.42e-1)	unprognostic (1.95e-1)	unprognostic (1.70e-1)	unprognostic (1.72e-1)	unprognostic (1.41e-1)	unprognostic (2.89e-1)	unprognostic (3.22e-3)	unprognostic (8.62e-2)	unprognostic (6.48e-5)	unprognostic (2.48e-1)	unprognostic (4.11e-2)		unprognostic (5.55e-2)	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0	1.5	26.2	2	0.1	0.3	0.3	0.2	0.1	0	0.4	0.1	3.3	1	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0.2	38	0	0	17.2	14.3	0	0.4	0	10.4	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.3	0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0	0	0.1	0.3	0.1	0.4	0.1	0	0.3	0.3	3.3	0.1	0	0	0	1	10.5	0	0	0	0	0	1.8	0	0.1	0	0	0	0	0.7	0	1.2	0.2	0.1	0	0	47	0.2	0	0	1.8	1	0	0.3	0	1.7	0	0.2	0	0.5	3.4	0	0	0	0	0.1	0	0	3	1.3	0	0	0.1	Hepatocytes
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Host-virus interaction, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	949	liver: 528.6	Cell type enriched	Detected in some	46	Hepatocytes: 5619.6	Cancer enriched	Detected in many	79	liver cancer: 571.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	Hep G2: 21.3	Low region specificity	Detected in some			Low region specificity	Detected in many			CAB016725, HPA065318, HPA068847	Approved				Secreted to blood			425000000000	230000000000			CAB016725: , HPA065318: , HPA068847: 	unprognostic (3.39e-2)	unprognostic (9.26e-2)	unprognostic (3.88e-1)	unprognostic (6.19e-4)	unprognostic (2.05e-2)	unprognostic (2.41e-1)	prognostic favorable (2.26e-4)	unprognostic (6.33e-2)	unprognostic (5.67e-3)	unprognostic (3.88e-1)	unprognostic (5.08e-3)	unprognostic (2.78e-2)	unprognostic (5.82e-12)	unprognostic (2.01e-1)	unprognostic (4.48e-1)	unprognostic (1.84e-2)	unprognostic (2.14e-2)	0	0	0.1	0	0.1	0	0.3	0.1	0.1	0.1	0	0.1	0	0	0.1	0.1	0	0	0.1	0.1	0	0	0	528.6	0.1	0	0	0	0	0.4	0	0.1	0	0.1	0	0	0.1	0.1	0	0.1	0	0.1	0	0	0.3	0	0.5	0	0	0.1	0	0	0.1	0	0.4	0	0	0	0	0	0	0.2	0.1	0.4	0.2	0	0.7	0	0	0.1	0.1	0.3	1.4	0	0.8	0.1	0	0.1	0.2	0	0.1	0.1	0.2	0.2	0.7	0.1	21.3	0	2.9	0	0.8	0.6	0.1	0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0	0	0.3	0.9	0	0.1	1.4	0.2	0	0.1	0.2	0	1	3.1	0.2	0.3	1.1	0	0.4	0.3	0.2	1.1	0.1	0.3	0.2	0.9	0.2	1	0.3	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0	0	0.1	0	3	0.3	49	0.1	0.6	0.9	0.4	73.9	0	0	0	2	0	0	0.1	2.5	0.3	0.3	116.8	0.5	0.1	0.2	1.8	0	5619.6	0.2	0	0	121.5	102.4	2.8	0.3	0.3	0	0	0.2	0.2	1.3	0	0	0	1.9	0	0.2	0	0.5	0.3	0	0	0.2	0.3	Hepatocytes
APOA5	APOA-V, RAP3	ENSG00000110243	Apolipoprotein A5	Q6Q788	11	116789367-116792420	Disease related genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	209	liver: 112.2	Cell type enriched	Detected in some	55	Hepatocytes: 1283.4	Cancer enriched	Detected in single	489	liver cancer: 112.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	65	Hep G2: 36.7	Not detected	Not detected			Not detected	Not detected								Secreted to blood			114000000	15000000				unprognostic (1.57e-4)						unprognostic (4.67e-3)	unprognostic (5.57e-2)		unprognostic (2.60e-3)		unprognostic (2.40e-1)		unprognostic (2.31e-4)				0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	112.2	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	36.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	15.3	0	0	0	0	0	0	0	0	0	0	23.3	0.4	0	0	0	0	1283.4	0	0	0	13.5	13.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
APOA4		ENSG00000110244	Apolipoprotein A4	P06727	11	116820700-116823306	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	intestine: 593.6	Cell type enriched	Detected in single	618	Hepatocytes: 61.8	Cancer enriched	Detected in some	29	liver cancer: 291.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 8.1;CACO-2: 8.2;Hep G2: 7.7;NB-4: 7.5;RPMI-8226: 12.0;SH-SY5Y: 11.1	Not detected	Not detected			Low region specificity	Detected in all			HPA001352, HPA002549, CAB068250, CAB068251, CAB068252	Enhanced		Approved	Vesicles	Secreted to blood			61200000000	140000000000	Vesicles		CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177							unprognostic (8.81e-2)				unprognostic (2.12e-2)			unprognostic (1.75e-2)	unprognostic (7.91e-2)			0.1	0	0	0.1	0	0	0	0	0	0	293.8	0	0	175.5	0	0	0.1	0	0	0	0	0	0	93.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	593.6	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.1	0	0	0	0	8.2	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.5	0	0	0	0	0	12	0	0	3.3	11.1	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
APOC3		ENSG00000110245	Apolipoprotein C3	P02656	11	116829706-116833072	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 714.1	Cell type enriched	Detected in some	60	Hepatocytes: 64257.6	Cancer enriched	Detected in many	643	liver cancer: 4021.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	CACO-2: 28.5;Hep G2: 77.0					Not detected	Not detected			HPA065365, HPA073918	Supported		Approved	Nucleoplasm,Nucleoli,Cell Junctions	Secreted to blood			106000000000	97000000000	Nucleoplasm	Nucleoli, Cell Junctions	HPA065365: AB_2732733, HPA073918: 							prognostic favorable (3.77e-4)				unprognostic (2.33e-1)		prognostic unfavorable (6.87e-5)	unprognostic (1.60e-2)	unprognostic (5.21e-2)			0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	91.3	0.1	0.1	0.3	0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.1	0	0	0	0	28.5	0	0.4	0	0	0	0	0	0	0	0	0	0.8	0	77	0	2.7	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0.6	0	0	0	0	1.7	0.9	0	0	0.3	1	1	0	0	0	0	0	0.3	0	0	0	0	0	0	1	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	0	0	100.1	0	0	0	0	858.6	0	0	0	0	0	3.3	0	3.8	0	0	1074.6	0.4	0.3	0	0	0	64257.6	1	0	0	825.6	1072.7	10.3	0	0	0	0	0	0	0	0	0	44	0	0	0	0.1	0	0	0.7	3.2	0	0	Hepatocytes
SLCO1B3	OATP1B3, OATP8, SLC21A8	ENSG00000111700	Solute carrier organic anion transporter family member 1B3	Q9NPD5	12	20810702-20916911	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	liver: 88.1	Cell type enriched	Detected in some	20	Hepatocytes: 91.8	Cancer enhanced	Detected in many		liver cancer: 5.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5									HPA004943, HPA050892	Enhanced		Supported	Plasma membrane						Plasma membrane		HPA004943: AB_1854758, HPA050892: AB_2681265		unprognostic (5.36e-2)	unprognostic (1.25e-1)	unprognostic (6.95e-2)		unprognostic (1.63e-2)	unprognostic (1.89e-2)	unprognostic (7.09e-2)		unprognostic (3.08e-2)	unprognostic (1.54e-2)	unprognostic (7.37e-2)		unprognostic (1.50e-1)	unprognostic (6.61e-3)		unprognostic (2.36e-3)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	35.8	9.8	0	0	0	0	0	0	0	0	0	0.3	7.1	0	2.5	0	7.8	0	0	0.2	0	0	0	0	8.1	0	0	0	0	0	0.3	0	1.7	0.8	0	0	0	0	0	0	0	0	0	0	9.8	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	8.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0.1	0	91.8	0	0	0	0.6	1.9	4.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	Hepatocytes
GYS2		ENSG00000111713	Glycogen synthase 2	P54840	12	21536189-21604847	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Glycogen biosynthesis	Allosteric enzyme, Glycosyltransferase, Transferase	Disease mutation, Glycogen storage disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	liver: 75.1	Cell type enriched	Detected in some	46	Hepatocytes: 57.8	Cancer enriched	Detected in single	29	liver cancer: 12.6	Not detected	Not detected			Cell type enriched	Detected in single	7	naive CD4 T-cell: 1.4	Lineage enriched	Detected in single	8	T-cells: 1.4	Cell line enhanced	Detected in some		CACO-2: 5.2;HEL: 1.9;SuSa: 1.5	Not detected	Not detected			Low region specificity	Detected in many			HPA039482	Approved											HPA039482: AB_10795107	unprognostic (7.22e-3)	unprognostic (2.85e-2)	unprognostic (8.88e-2)	unprognostic (1.78e-2)	unprognostic (5.68e-2)	unprognostic (3.16e-1)	prognostic favorable (7.62e-5)	unprognostic (1.06e-1)	unprognostic (1.29e-1)	unprognostic (1.68e-1)	unprognostic (4.68e-2)	unprognostic (2.15e-1)	unprognostic (1.13e-1)	unprognostic (4.22e-2)	unprognostic (6.53e-2)	unprognostic (1.85e-1)	unprognostic (2.66e-4)	8.4	0	0	0	0	0	0.3	0	0	1.2	0.1	0	0	0	0	0	2.9	0	0.2	0	0	0	0.1	75.1	0	0	0	0	0.1	0.1	0	0	0	0	0.1	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0.2	2.4	0	0.1	0	0	0	1.4	0	0	0	0.5	0	0.2	0.1	0.1	0	0.1	0	0	5.2	0	0.2	0	0	0.1	0	0.4	0	0.4	0.2	0.6	1.9	0.2	0	0.3	0.5	0.4	0.5	0.2	0	0.4	0.1	0	0.3	0	0.1	0.6	0	0.3	0.3	0.2	0	0	0.5	0.2	0	1	0.1	0	0	0.2	0	0	1.5	0	0.1	0.2	0.1	0.4	0	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0	0	0	0	0	0	0	0.2	0	0.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	57.8	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SLC17A2	NPT3	ENSG00000112337	Solute carrier family 17 member 2	O00624	6	25912754-25930726	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	333	liver: 80.2	Cell type enriched	Detected in some	12	Hepatocytes: 29.7	Cancer enriched	Detected in some	8	liver cancer: 14.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	20	Hep G2: 9.2	Not detected	Not detected			Low region specificity	Detected in single			HPA038270	Uncertain											HPA038270: AB_10672511							prognostic favorable (8.54e-4)						unprognostic (1.90e-2)		unprognostic (4.14e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	80.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.7	0	0	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.4	0	0	0	0	0	Hepatocytes
ADGRG6	FLJ14937, GPR126	ENSG00000112414	Adhesion G protein-coupled receptor G6	Q86SQ4	6	142301854-142446266	Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	liver: 51.9;placenta: 104.9	Cell type enriched	Detected in many	5	Hepatocytes: 118.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	13	myeloid DC: 3.5	Lineage enriched	Detected in single	13	dendritic cells: 3.5	Cell line enhanced	Detected in many		A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA017346	Approved								70000000			HPA017346: AB_1849260	unprognostic (1.04e-2)	unprognostic (2.72e-2)	unprognostic (7.37e-2)	unprognostic (3.00e-2)	unprognostic (8.64e-4)	unprognostic (1.67e-1)	unprognostic (2.98e-1)	prognostic unfavorable (8.78e-4)	unprognostic (1.80e-1)	unprognostic (1.26e-1)	prognostic unfavorable (2.78e-5)	unprognostic (4.46e-1)	unprognostic (6.49e-2)	unprognostic (2.15e-1)	unprognostic (1.36e-2)	unprognostic (2.97e-2)	unprognostic (4.59e-2)	5.6	1.4	1.1	4.1	1	0	6.1	0.5	1.1	4.1	14	1	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0	3.5	0	0.2	0	0.1	0	4.8	25.7	0.5	2.7	0.1	0	0	6.7	1.2	5.1	3.2	20.5	14.9	0	6	3.8	1.4	12.1	0.7	6.4	8.4	0	2	1	4.4	24	5	4	0	0	10.4	0.1	24.4	2.9	47.1	0.1	0.1	0	2	44.2	0	0	0.2	1.7	5.9	0	2.3	5	2.6	10.9	0	0	1.9	9	4.2	4.4	4.9	0	1.6	0	2.3	2.2	3.3	0	0	0	0	0	22.2	0	0	0	0	0.2	0	0	0	0	3.5	0	0.1	0	0	0	0.1	0	0	0	1.1	1	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9	6	5.1	0.5	15.4	0	0	1.4	15.3	5.3	14.8	8.7	0	4.8	0	11.5	0	4.4	0.8	0	4.7	24.6	0.6	11.8	0	118.8	2	0	0	16.5	24.7	0.2	0.6	0.6	0	1	0.9	0	22.8	3.6	0.4	10.3	0	6.5	0.5	1.6	5.1	0	11.3	0	1.8	21	Hepatocytes
C9		ENSG00000113600	Complement C9	P02748	5	39284262-39424868	Disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity		Age-related macular degeneration, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	577	liver: 419.5	Cell type enriched	Detected in some	39	Hepatocytes: 1782.7	Cancer enriched	Detected in single	244	liver cancer: 90.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	JURKAT: 15.0	Not detected	Not detected			Not detected	Not detected			CAB002151, HPA029577	Uncertain				Secreted to blood			69600000000	97000000000			CAB002151: AB_563670, HPA029577: AB_10603779	unprognostic (1.00e-1)	unprognostic (1.57e-1)	unprognostic (1.50e-1)		unprognostic (2.01e-1)	unprognostic (6.58e-2)	unprognostic (1.30e-1)	unprognostic (2.91e-1)	unprognostic (5.49e-3)		unprognostic (1.91e-2)	unprognostic (1.29e-2)	unprognostic (2.19e-2)	unprognostic (9.43e-5)	unprognostic (1.36e-1)	unprognostic (1.80e-1)	unprognostic (2.04e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	419.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	1.2	0	0	0	0	0	0	0	15	0.1	0	0.1	0	0.4	0	0	0	0	0	0.7	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14	0	0	0	0.3	22.9	0	0	0	0	0	1.7	0	0.5	0	0	23.3	0	0	0.4	0	0	1782.7	0.9	0	0	46.1	41.4	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	2.1	1.4	0	0.2	1.3	0	0	Hepatocytes
HRG	HPRG, HRGP	ENSG00000113905	Histidine rich glycoprotein	P04196	3	186660216-186678240	Disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis	Heparin-binding	Disease mutation, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	205	liver: 425.4	Cell type enriched	Detected in some	17	Hepatocytes: 394.5	Cancer enriched	Detected in some	262	liver cancer: 406.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.8;HL-60: 5.9;RH-30: 6.9;RPTEC TERT1: 1.7;SiHa: 2.4	Not detected	Not detected			Not detected	Not detected			HPA050269, HPA054598	Supported				Secreted to blood			120000000000	30000000000			HPA050269: AB_2681068, HPA054598: AB_2682539		unprognostic (2.67e-1)		unprognostic (1.74e-2)		unprognostic (7.58e-5)	prognostic favorable (9.64e-5)	unprognostic (1.44e-1)		unprognostic (2.98e-3)	unprognostic (2.22e-1)		unprognostic (1.55e-2)	unprognostic (1.14e-1)	unprognostic (5.50e-2)	unprognostic (1.05e-1)	unprognostic (1.46e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	2	425.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	1.2	0.8	0	0.2	0.1	0	0	0	0	0	1.8	0	0	0	5.9	0.4	0	0	0	0	0	0	0.2	1.1	0	0	0	0	0	0.3	0.7	0	0	6.9	0	1.7	0	0	0	2.4	0	0	0	0	0	0.6	0	0.1	0	0	0.8	0	1.1	0	1.4	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0.1	2.5	0	0	3.5	0	0	5	0	0	0	0	23.3	0	0	0	0	0	394.5	0	0	0	13.5	15.4	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0.1	0.1	0.5	0	0	Hepatocytes
BCHE	CHE1, CHE2, E1	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Serine esterase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 145.4	Cell type enriched	Detected in many	10	Hepatocytes: 360.7	Group enriched	Detected in many	6	glioma: 24.0;liver cancer: 13.7;melanoma: 18.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	Karpas-707: 131.7	Low region specificity	Detected in all							HPA001560	Approved				Secreted to blood				13000000000			HPA001560: AB_1078271	unprognostic (4.74e-2)	unprognostic (2.00e-1)	unprognostic (9.21e-4)	unprognostic (8.19e-8)	unprognostic (2.66e-2)	prognostic unfavorable (1.06e-4)	unprognostic (1.44e-1)	unprognostic (5.04e-2)	unprognostic (6.15e-2)	unprognostic (9.59e-2)	unprognostic (5.15e-2)	unprognostic (3.65e-2)	unprognostic (3.18e-3)	unprognostic (4.46e-5)	unprognostic (2.17e-2)	unprognostic (5.92e-2)	unprognostic (4.26e-4)	14	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20	18	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1	0.8	0.4	0.5	9.7	2.9	0	0	0	0	0	0	0	0	0.4	14.3	0	0	0	0	0	0.2	0.1	1.2	0	0	0	5.4	0	0	0.1	0.9	0	1	0	0.1	0	0	0	1.1	0	0	4.2	0.2	0	1.4	4.4	0.6	5.2	0	131.7	0	0	0	0	0.3	0	0.1	0	4.8	10.9	0.1	0	0	0.1	0	0	7.5	0	5.8	0	0	3.2	0	0	1.3	0.5	0	0.2	1.3	0	14.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1	0	0	0	0.3	4.8	0.9	4.3	12.7	0	0	0	0	0	0	0	22.1	1.5	0	0	0	0	2.2	0.2	0	360.7	0.1	1.6	0	6.2	5.3	5.5	2	0	18.6	0	0	34.4	0	0	0	2.9	1	0	4.6	0.3	0.1	3	0	0	0	0.1	Hepatocytes
AADAC	CES5A1, DAC	ENSG00000114771	Arylacetamide deacetylase	P22760	3	151814037-151828488	Enzymes, Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 66.2;intestine: 81.7;liver: 123.1	Cell type enriched	Detected in some	10	Hepatocytes: 610.4	Cancer enriched	Detected in many	22	liver cancer: 153.4	Region enriched	Detected in single	7	basal ganglia: 1.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7	Not detected	Not detected							HPA002911	Approved											HPA002911: AB_1078074	unprognostic (1.26e-1)	unprognostic (1.82e-2)	unprognostic (8.11e-2)	unprognostic (4.41e-2)		unprognostic (9.23e-2)	unprognostic (7.82e-2)	unprognostic (2.15e-1)	unprognostic (9.89e-2)	prognostic favorable (5.58e-6)	prognostic unfavorable (5.02e-4)			prognostic unfavorable (2.19e-4)	unprognostic (1.22e-1)		unprognostic (1.27e-1)	3.9	66.2	0.1	0.1	1.6	0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0	0.1	1.7	0.2	0.3	0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0	0	0.2	0	0	0	0	0	11.9	0	0	4.5	0.2	0.3	0	0	0.1	0	1.1	0.1	0.2	6.4	0	0.1	0.4	0	5.7	0	0	0	0	0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0	0.1	0	0	0	0	0.1	0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0	2.3	0.2	1.9	0.3	0.1	0	0	0	0	2.5	0	2.4	1.4	0	0.4	0	0.5	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	1.6	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	11	0	0	0.2	0	1.1	58.6	4	12.5	0	0	0	0	0	0	0	0	0	44	0	0.2	0	0	610.4	0.2	0	0	3.7	10.8	0	0	0	3.3	0	0	0	3.7	0	0	0	0	0	0	0	0.1	3	0.2	0	0	0.1	Hepatocytes
PROC		ENSG00000115718	Protein C, inactivator of coagulation factors Va and VIIIa	P04070	2	127418427-127429246	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 137.5	Cell type enriched	Detected in many	4	Hepatocytes: 348.7	Cancer enriched	Detected in many	22	liver cancer: 118.3	Not detected	Not detected			Cell type enriched	Detected in some	9	plasmacytoid DC: 29.2	Lineage enriched	Detected in many	9	dendritic cells: 29.2	Cell line enriched	Detected in some	16	Hep G2: 58.9	Not detected	Not detected			Not detected	Not detected			HPA005550, CAB016721, CAB016792	Supported				Secreted to blood				6400000000			CAB016721: , CAB016792: , HPA005550: AB_1079687	unprognostic (2.46e-2)	unprognostic (1.08e-1)	unprognostic (1.38e-1)	unprognostic (1.58e-1)	unprognostic (6.64e-2)	unprognostic (3.13e-2)	unprognostic (4.90e-3)	unprognostic (2.63e-1)	unprognostic (1.67e-1)	unprognostic (3.29e-1)	unprognostic (3.74e-3)	unprognostic (2.56e-2)	unprognostic (8.12e-3)	unprognostic (2.01e-2)	unprognostic (1.71e-1)	unprognostic (4.60e-3)	unprognostic (8.06e-2)	0	0	0.4	0.1	0.1	0.2	0	0.1	0.2	0.1	0.2	0	0.1	0.2	0	0.1	0	0	0.6	0	0.4	0.2	4.2	137.5	0.2	0.1	0.1	0.1	0	0	0	0	0.1	0.4	0.1	0.1	0	0	0.1	0	0.1	0.5	0	0.1	0	0.6	0	0	0.7	0	0	0.1	0.1	0	0.4	29.2	3.1	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	0	0.9	1.6	0	0.3	0	0.1	3.7	0	0.1	0	0	0	0	2.8	58.9	0	0.1	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0.1	0.6	0.1	0.9	0.2	0	0	0	0	0.3	0.1	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	3.1	0	0	29.2	0	0.1	0.4	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.4	0	0	0	4.3	0.6	0.7	0	0.3	40.8	1.4	0	0	0	0	5	0.4	0	0	2.6	0	0.2	0	0.2	0	0	348.7	3.9	0	9.9	9.8	4.5	0	0	1.7	0	0	8.1	0	1.2	8.7	0	78.1	0	0	0	0	0.1	0.1	0.1	2.5	1.5	0.1	Hepatocytes
PRG4	bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP	ENSG00000116690	Proteoglycan 4	Q92954	1	186296279-186314562	Disease related genes, Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 20.9;liver: 76.0	Cell type enriched	Detected in some	8	Hepatocytes: 298.2	Cancer enriched	Detected in many	10	liver cancer: 28.4	Not detected	Not detected			Cell type enriched	Detected in single	4	T-reg: 4.0	Lineage enriched	Detected in single	33	T-cells: 4.0	Cell line enriched	Detected in some	7	ASC diff: 81.7	Low region specificity	Detected in many							HPA028523	Uncertain				Secreted to extracellular matrix				4300000000			HPA028523: AB_10669642	unprognostic (8.67e-2)	unprognostic (2.28e-1)	unprognostic (1.82e-3)	unprognostic (1.98e-1)	unprognostic (1.77e-1)	unprognostic (7.87e-2)	unprognostic (7.33e-2)	unprognostic (1.78e-1)	unprognostic (1.28e-1)	unprognostic (1.53e-1)	unprognostic (5.03e-2)	unprognostic (4.11e-1)	unprognostic (1.91e-13)	unprognostic (1.40e-2)	unprognostic (2.60e-1)	unprognostic (1.60e-3)	unprognostic (7.05e-3)	20.9	0.7	0.1	1	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11	0.1	0.3	0.2	76	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0	0	0	0	4	0.1	0	0	0	0	81.7	3.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	7.5	0	12.4	0	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0.6	0.2	0	0	0	0	4	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1	20.8	14.4	8.2	0	0.6	0	0.8	7.6	20.1	38.7	0	0	0	0	0	0.9	0.7	0	0	0	0	2.2	0.1	15.1	298.2	0.1	0	0	7.4	8.8	0	0	0	1.7	0	0	0	4.3	0	0	0	0	0	0.3	0	0	1	0	0.5	0	0.1	Hepatocytes
CTH		ENSG00000116761	Cystathionine gamma-lyase	P32929	1	70411218-70439851	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Amino-acid biosynthesis, Cysteine biosynthesis	Calmodulin-binding, Lyase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	liver: 104.5	Cell type enriched	Detected in many	6	Hepatocytes: 130.7	Group enriched	Detected in all	5	liver cancer: 30.0;testis cancer: 8.1	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	B-cells: 4.5;T-cells: 6.4	Cell line enhanced	Detected in many		HHSteC: 20.2;Karpas-707: 31.3;SK-MEL-30: 40.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021591, HPA023300	Enhanced								25000			HPA021591: AB_1847321, HPA023300: AB_1847322	unprognostic (3.41e-2)	unprognostic (1.36e-1)	unprognostic (1.48e-1)	unprognostic (2.76e-1)	unprognostic (7.66e-2)	unprognostic (2.45e-3)	prognostic favorable (8.69e-4)	unprognostic (1.71e-1)	unprognostic (1.95e-1)	unprognostic (1.00e-1)	unprognostic (1.43e-3)	unprognostic (5.05e-3)	unprognostic (3.25e-2)	unprognostic (1.03e-1)	unprognostic (8.97e-2)	unprognostic (3.05e-3)	unprognostic (1.26e-1)	2.2	8.3	2.3	1	3.2	2.2	2	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1	2.4	2.2	18.3	11.6	1.5	1.7	1	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.1	0.7	3.5	4.9	4.3	2.4	7.8	2.1	1.9	1.8	7.8	1.4	3.2	2.8	1.6	1.5	4.6	2.4	13.5	1.4	3.6	8.6	3	3.3	2.6	4.4	20.2	3.7	0.8	3.7	12.2	3.7	4.3	0.7	1.6	5.6	6.5	31.3	1.1	1.4	1.3	0.8	3.6	1.9	2.7	1.3	1.9	7.8	3.6	0	1.9	1.6	3.2	3.8	40.8	6.9	1.3	2.1	0.5	0.6	4	2.8	1.9	12.1	7.1	1.5	4.8	7.7	1.4	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3	6	3.5	5.6	6.2	2.3	6.8	1.6	5.1	0	1.2	5.2	9.8	0.6	10	1.6	14.9	2	11.9	0	3.5	1.3	2.8	5.2	0	130.7	1	0	2.9	4.3	2.9	3.4	1.1	1.3	18.6	0	5.9	4.3	6.4	11	3.9	22	10.1	0	5.5	1.6	0.5	1.8	0.7	4.3	4.3	2.8	Hepatocytes
HSD11B1	HSD11, HSD11B, SDR26C1	ENSG00000117594	Hydroxysteroid 11-beta dehydrogenase 1	P28845	1	209686178-209734950	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	liver: 183.4	Cell type enriched	Detected in many	13	Hepatocytes: 560.1	Cancer enriched	Detected in all	28	liver cancer: 197.4	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory CD4 T-cell: 9.2	Lineage enriched	Detected in single	20	T-cells: 9.2	Cell line enriched	Detected in some	5	ASC diff: 151.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047729	Enhanced								77000			HPA047729: AB_2680135	unprognostic (1.08e-3)	unprognostic (2.13e-1)	unprognostic (2.32e-1)	unprognostic (1.40e-1)	unprognostic (1.57e-1)	unprognostic (3.68e-1)	unprognostic (2.02e-2)	unprognostic (1.12e-1)	unprognostic (1.30e-1)	unprognostic (3.63e-2)	unprognostic (8.35e-3)	unprognostic (8.69e-2)	prognostic unfavorable (1.97e-10)	unprognostic (3.41e-2)	unprognostic (3.91e-2)	unprognostic (6.45e-2)	unprognostic (1.59e-2)	4.6	1.6	1.1	3	3.1	0.3	2.4	9.9	3.9	0.6	1	1.6	2.7	0.5	0.8	8.7	1.5	0.9	1.9	3	1.8	0.9	2.6	183.4	7.2	1.3	8.2	2	12.6	0.9	0.3	1.5	26.5	3.3	7.1	0.9	1.5	0.6	3	1.5	6.3	0.9	2.7	1.3	3.5	1.4	2.3	2.5	0	1	0.6	0.6	3.9	1.4	0.2	0	0.2	0.1	0.4	9.2	0.8	0	0	0	0	151.9	15.8	0	0	5.2	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	31.7	0	0	0.8	0	1	0	0.1	0	0	0	7.6	0	0	0	0	0	0	0	0	0.1	2.2	0	0	0	0	0	0	0	0	0	4.9	1.2	0.6	0	0	0	0.2	0	0	0.8	0.2	0	0	0.1	0	0.3	0	0.6	0.2	9.2	2	0	0	0.2	0	0.2	0.4	0	0	2.4	0.8	1.1	3.1	9.9	3.9	1.8	0.9	8.2	2	3.3	2.5	3	0	2.4	0.5	0.1	0	0.8	43.3	0	0	0	0	0	0	0	4.6	0	0	0	0	0	10.8	0.5	0	560.1	8.7	0	0	8.6	8.9	2.2	27	2.2	0	1	0	15.4	0.2	0	7.4	0	0.3	0	2.1	0	0.2	0.1	0.2	0.5	0	1.6	Hepatocytes
SERPINC1	AT3, ATIII, MGC22579	ENSG00000117601	Serpin family C member 1	P01008	1	173903804-173917378	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	203	liver: 450.5	Cell type enriched	Detected in some	54	Hepatocytes: 2236.3	Cancer enriched	Detected in some	871	liver cancer: 1504.0	Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 2.2	Lineage enhanced	Detected in single		granulocytes: 2.2	Cell line enriched	Detected in some	35	Hep G2: 42.6	Not detected	Not detected			Not detected	Not detected			HPA001816, CAB016790, HPA024007	Supported				Secreted to blood				210000000000			CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732	unprognostic (1.28e-2)	unprognostic (2.22e-1)	unprognostic (3.83e-2)	unprognostic (5.98e-2)	unprognostic (6.91e-2)	unprognostic (1.93e-2)	prognostic favorable (3.40e-5)	unprognostic (1.75e-2)	unprognostic (8.67e-2)	unprognostic (3.48e-2)	unprognostic (4.74e-2)	unprognostic (1.91e-1)	unprognostic (2.36e-2)	unprognostic (5.28e-3)	unprognostic (5.80e-2)	unprognostic (6.35e-2)	unprognostic (8.21e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	450.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0.5	0	0	0	0	0.1	0	0	1.2	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0.2	0.1	42.6	0	0.8	0.1	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.1	0	0.1	0.9	0	0	0	0	0.1	0.6	0	0	0.1	0	0.1	0.1	0	0	0	0	0.2	0	0.5	0.1	0.5	0	0	0	2.2	0.5	0	0	0	0.4	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	3	0	14	0	0	0	0.1	38.2	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0	0	0.2	0	2236.3	0.2	0	0	37.4	41.2	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0.2	0	0.3	0.2	0	0	0.1	Hepatocytes
APOA1		ENSG00000118137	Apolipoprotein A1	P02647	11	116835751-116837950	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport		Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 573.5	Cell type enriched	Detected in many	33	Hepatocytes: 19896.2	Cancer enriched	Detected in many	48	liver cancer: 4515.8	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 3.6	Group enriched	Detected in many	4	dendritic cells: 3.6;T-cells: 2.4	Cell line enriched	Detected in some	18	Hep G2: 253.4	Low region specificity	Detected in some			Low region specificity	Detected in all			CAB016778, HPA046715	Supported		Approved	Vesicles,Cytosol	Secreted to blood			1450000000000	220000000000	Vesicles	Cytosol	CAB016778: , HPA046715: AB_2679768	unprognostic (1.88e-3)	unprognostic (4.53e-2)	unprognostic (7.46e-2)	unprognostic (4.00e-3)	unprognostic (3.70e-2)	unprognostic (1.41e-1)	prognostic favorable (5.05e-4)	unprognostic (5.40e-2)	unprognostic (1.89e-1)	unprognostic (9.60e-3)	unprognostic (1.59e-3)	unprognostic (7.02e-2)	prognostic unfavorable (1.67e-8)	unprognostic (3.46e-3)	unprognostic (1.15e-1)	unprognostic (6.24e-2)	unprognostic (9.54e-2)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.3	0.2	0.2	0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0	0.7	0.7	2.4	0.5	0	0	0	0	0	0	1.3	0	0	0	0	14.1	0	0.2	0.4	0	0	0	0	0	0	0	0	0.6	0.1	253.4	0	1.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.2	0.1	0	0	0	1.3	1.6	0	0.2	0.4	1.7	0.7	0	0	0.3	0	0	0.2	0	0	0.1	0	0.1	0	0.4	0	0.4	0	0	0.2	0	2.4	0.7	0.3	0	0.2	1.8	0.8	0.5	0.8	1.7	0	0.7	0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	3	3.5	174.9	0.2	0.1	0.6	24.6	596.2	0	2.3	0	0	0.4	0	0.1	30.6	1.9	0.9	256.9	1	1.1	1.5	0.1	2.3	19896.2	3.1	0	1.7	472.6	569.9	110.5	20.8	0.6	0	0	0.5	0.1	0.2	0.3	4.6	2.2	0.6	6.5	0.7	10.3	9.1	0.5	3.5	2.9	0.3	0.3	Hepatocytes
TTR	CTS, CTS1, HsT2651, PALB	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Transport	Hormone, Thyroid hormone	Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	brain: 1008.0;liver: 680.8;retina: 332.4	Cell type enriched	Detected in many	24	Hepatocytes: 22945.1	Group enriched	Detected in many	28	liver cancer: 928.2;pancreatic cancer: 666.0	Region enriched	Detected in many	9	pons and medulla: 1008.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 31.4;EFO-21: 11.1;Hep G2: 48.2;U-2 OS: 14.5	Group enriched	Detected in many	5	basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9	Region enhanced	Detected in many		pons and medulla: 1006.9	CAB002517, HPA002550, CAB062567, CAB073406	Supported		Approved	Golgi apparatus	Secreted to blood			345000000000	180000000000	Golgi apparatus		CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419	unprognostic (6.79e-3)		unprognostic (3.38e-2)	unprognostic (4.10e-1)	unprognostic (1.74e-1)		unprognostic (1.84e-2)	unprognostic (8.15e-2)	unprognostic (3.74e-2)		unprognostic (9.66e-3)	unprognostic (8.72e-2)	unprognostic (1.23e-2)	unprognostic (8.35e-3)	unprognostic (5.26e-1)		unprognostic (3.52e-2)	0.5	0.4	3.6	0.4	3	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1	680.8	0.4	0.4	7.1	0	0.4	62.3	1.6	0.5	0.4	1008	0.4	0.5	332.4	0.4	0.4	0.4	1	0.6	0.4	4.9	0.5	2	0.4	0.6	0	0.4	0	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	31.4	0	0.6	11.1	0	0	0	0	0	0	0.5	0	1.2	0	48.2	0	2.7	0.1	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	1	0	0	2.3	0	0	0	0	0	1.6	0	0	0.1	0	0	0.3	0	14.5	0	1.1	0	0.6	4.5	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	3	5.8	60.8	115.6	4.4	7.1	0	1008	0.6	0	0	32.7	0	0.5	25.4	1.4	973.2	0	0	5.2	153.2	0.2	5	2.7	5.4	0.1	1.1	163.5	1.6	0.6	0.6	0.2	0	22945.1	2.3	25.4	342.4	228.9	289.5	6.6	0.3	0	0	0	1.5	13.2	212.8	2.9	0	1.1	45.2	0	0.4	3.4	0.6	0.1	3.3	0.5	1.6	0	Hepatocytes
ARG1		ENSG00000118520	Arginase 1	P05089	6	131573144-131584332	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle	Hydrolase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 284.1	Cell type enriched	Detected in some	19	Hepatocytes: 867.5	Cancer enriched	Detected in some	45	liver cancer: 167.7	Not detected	Not detected			Cell type enriched	Detected in some	5	neutrophil: 24.4	Lineage enriched	Detected in many	5	granulocytes: 24.4	Cell line enhanced	Detected in some		Daudi: 1.5;Hep G2: 1.7;HL-60: 4.0;RH-30: 1.6;SiHa: 1.8;U-698: 2.2	Region enhanced	Detected in single		cerebellum: 2.7	Not detected	Not detected			HPA003595, CAB009434, HPA024006, CAB056159	Enhanced								15000000			CAB009434: AB_2058955, CAB056159: AB_2665582, HPA003595: AB_1078190, HPA024006: AB_1844987	unprognostic (2.00e-1)	unprognostic (2.09e-1)	unprognostic (2.49e-1)	unprognostic (1.74e-1)	unprognostic (9.95e-2)	unprognostic (7.96e-2)	unprognostic (7.73e-2)	unprognostic (1.68e-1)	unprognostic (1.22e-1)	unprognostic (1.56e-2)	unprognostic (7.55e-3)	unprognostic (8.35e-2)	unprognostic (1.25e-2)	unprognostic (2.90e-2)	unprognostic (2.75e-1)	unprognostic (1.11e-2)	unprognostic (1.79e-2)	1	0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.2	0.3	0.1	3	0.2	0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0	0.1	1	0.1	0.1	0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0	4.7	0.1	0	0	0.1	0.4	0	0	0.8	0	0	0	0	0.3	0.1	1.5	0	0	0	0.1	0	0	0	0	0.3	0.3	0.2	1.7	0	4	1.3	0	0	0	0	0	0	0.2	0.5	0.6	0	0.5	0.1	0.4	0.1	0	0	0	1.6	0.4	0	0.3	0.2	0.1	1.8	0.4	0.3	0.2	0.1	0.5	0	0	0.2	0.3	0.1	1	0.2	2.2	0.1	0.5	0.4	0	0	0	0	0	0	0	0.5	0	0	0.1	0.4	0.1	24.4	0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0	0.2	0.1	0.1	0.1	0	0	13.9	0	0	0	0	17.8	0	0	0	0	0	0	0	0	0	0	46.7	0	0	0	0	0	867.5	0	0	0	25.2	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	Hepatocytes
CPN1		ENSG00000120054	Carboxypeptidase N subunit 1	P15169	10	100042193-100081877	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	127	liver: 76.8	Cell type enriched	Detected in some	12	Hepatocytes: 24.6	Group enriched	Detected in some	12	liver cancer: 26.6;melanoma: 7.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	17	SK-MEL-30: 56.6	Low region specificity	Detected in some			Low region specificity	Detected in all								Secreted to blood				22000000000						unprognostic (2.97e-2)	unprognostic (2.23e-2)			unprognostic (3.93e-2)		unprognostic (1.64e-1)		unprognostic (6.75e-2)		unprognostic (2.93e-2)	unprognostic (5.26e-2)	unprognostic (2.63e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	76.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.2	0	0	0.6	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56.6	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	24.6	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.6	2.1	0	0.1	0	0.1	0	Hepatocytes
A1BG		ENSG00000121410	Alpha-1-B glycoprotein	P04217	19	58345178-58353499	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	180	liver: 299.6	Cell type enriched	Detected in many	11	Hepatocytes: 1227.5	Cancer enriched	Detected in single	85	liver cancer: 22.3	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 1.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEK 293: 5.1;Hep G2: 4.9;REH: 6.6;U-266/70: 4.9					Not detected	Not detected			CAB016673, HPA044252	Supported				Secreted to blood			200000000000	49000000000			CAB016673: AB_1611892, HPA044252: AB_2678876	unprognostic (9.95e-2)	unprognostic (5.31e-2)	unprognostic (3.67e-2)	unprognostic (3.44e-2)	unprognostic (1.18e-1)	unprognostic (1.66e-2)	prognostic favorable (3.97e-4)	unprognostic (1.09e-1)	unprognostic (2.59e-1)	unprognostic (2.10e-1)	unprognostic (1.47e-2)	unprognostic (1.37e-2)	unprognostic (4.19e-5)	unprognostic (2.37e-2)	unprognostic (1.94e-1)	unprognostic (1.72e-1)	unprognostic (6.72e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	299.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	1.6	0	0.1	0	1	0.7	0	0.7	0.1	1.3	0	0.3	0.6	2	0	0	0	0.2	0	1.8	0.9	0	0.5	0	0	0	0	0.9	5.1	2.6	0	4.9	0	1	0.4	0.2	0.4	0	0	1.2	0	1.5	0.8	0	0	1.8	0.9	1.7	0.3	0.2	0.4	6.6	3.2	1.3	0	0	0	0.4	0.7	0.2	0.8	0	1.1	1.1	0	1.8	0.3	0	0	4.9	2.2	1.6	0	1.1	0	0	0.1	0	0	0	0.5	0.1	0.4	0.5	0.5	0.6	0	0.3	0	0	0	1.6	1	0.7	0	0	0	0	0	0	0	0	0	0	11.9	13.1	48	2.3	7.8	2.9	0.4	17.8	14.7	14.8	21	2	0.9	6.6	0.8	0.5	9.8	0	0	7.9	7.4	27.9	11	16.3	1227.5	26.2	7.9	1.2	36.8	96.4	1.9	1.1	50.1	109.6	47.7	0	2.2	8.5	0	1.1	1.3	5.2	25.8	52.4	1.4	5.1	3.1	1.6	34.8	0.1	0.6	Hepatocytes
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 269.9	Cell type enriched	Detected in some	7	Hepatocytes: 1391.0	Cancer enriched	Detected in some	84	liver cancer: 180.7					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6									CAB000668, CAB016678, HPA021602, HPA048823	Supported				Secreted to blood			140000000000	41000000000			CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532		unprognostic (1.70e-1)		unprognostic (2.16e-3)	unprognostic (2.44e-1)		unprognostic (8.54e-3)	unprognostic (1.41e-1)		unprognostic (1.76e-3)	unprognostic (6.28e-2)	unprognostic (7.25e-2)	prognostic favorable (4.22e-4)	unprognostic (3.97e-3)	unprognostic (5.21e-2)		unprognostic (2.33e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	24	269.9	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0			0		0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0.1	0	0	0	0	0	1.2	0	0.5	0	3.6	0.6	0	0	0	0	0	0	0	0.9	0.4	0	0	0.3	0.2	0.9	0	0	0.4	4	0	0	0	0	0	1	0	0	0	0	0	0.5	0	0.1	0	0	1	0	2	0	1.6	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	2.2	0	0	0	0.6	28.1	2.7	0	1.8	0	0	16.6	0	0.1	0	0	23.3	0	0	0	0	1.1	1391	0.1	0	0	26.4	26.6	0	0	0	0	0	0	0	0	0	0	203.6	0	0	0	0.4	0	0	0	4.9	0	0	Hepatocytes
SARDH	DMGDHL1, SDH	ENSG00000123453	Sarcosine dehydrogenase	Q9UL12	9	133663560-133739955	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	epididymis: 25.3;liver: 52.8;pancreas: 39.4	Cell type enriched	Detected in some	6	Hepatocytes: 94.3	Cancer enriched	Detected in many	8	liver cancer: 18.7	Low region specificity	Detected in many			Group enriched	Detected in many	5	memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7	Lineage enriched	Detected in single	15	T-cells: 9.7	Cell line enhanced	Detected in many		AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3	Low region specificity	Detected in all			Not detected	Not detected			HPA057267, HPA058086	Approved		Approved	Mitochondria					190000	Mitochondria		HPA057267: AB_2683388, HPA058086: AB_2683601	unprognostic (3.64e-2)	unprognostic (4.87e-2)	unprognostic (2.31e-2)	unprognostic (1.38e-1)	prognostic unfavorable (4.62e-4)	unprognostic (5.83e-2)	unprognostic (1.42e-3)	unprognostic (2.21e-1)	unprognostic (1.58e-1)	unprognostic (1.43e-1)	unprognostic (2.23e-1)	unprognostic (1.74e-1)	unprognostic (7.74e-3)	unprognostic (2.78e-1)	unprognostic (3.48e-1)	unprognostic (9.73e-2)	unprognostic (1.30e-2)	0.5	1.1	1.7	1	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0	0.1	0.9	11.1	0	0.3	1.5	0.1	0.4	0.5	0.7	0.2	0.1	0	1.5	0.2	1.4	0	0	0.2	0.4	0	0.2	1.5	0	18.7	1.2	0	0.2	2.6	0	1.3	0	0.3	0.1	8.3	0	0.2	7	1.9	13.5	1.4	1.7	1	0.1	0.9	11.6	23.4	0	0.1	1	9.3	0	0.3	2.3	0.5	1.5	0.1	0	2.1	2	0.2	0	0.1	0	0.8	1.3	0.8	0	0.1	0.1	0.1	0.4	0	1	0	4.1	1	0	0.4	8.4	1.5	0.6	0.1	0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8	0	3.4	0	0.3	0.2	0	0.6	0	0	0	1.8	0	0	0	0	0	0.1	0	0	0.9	0.1	1	0.2	1.1	94.3	0.1	0	1.2	2.5	2.4	0.2	4.4	0.2	0	0	0	2.1	0.2	0	2.8	14.7	0.2	0	1	0.1	0.9	0.1	0	2.9	0	0.1	Hepatocytes
SERPINA7	TBG	ENSG00000123561	Serpin family A member 7	P05543	X	106032442-106038738	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	414	liver: 101.8	Cell type enriched	Detected in some	19	Hepatocytes: 129.6	Cancer enriched	Detected in single	203	liver cancer: 82.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	478	Hep G2: 48.5	Not detected	Not detected			Not detected	Not detected			HPA002803	Approved				Secreted to blood			39800000000	49000000000			HPA002803: AB_1079915			unprognostic (6.22e-2)				unprognostic (1.63e-3)				unprognostic (3.34e-1)	unprognostic (2.62e-1)	unprognostic (2.15e-3)		unprognostic (2.95e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	101.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	129.6	0	0	0	6.2	6.9	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Hepatocytes
C4BPB	C4BP	ENSG00000123843	Complement component 4 binding protein beta	P20851	1	207088842-207099993	Plasma proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 156.5	Cell type enriched	Detected in many	7	Hepatocytes: 556.0	Cancer enriched	Detected in many	19	liver cancer: 83.7	Not detected	Not detected			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6	Group enriched	Detected in many	16	dendritic cells: 3.6;T-cells: 2.5	Group enriched	Detected in some	16	CACO-2: 38.6;HeLa: 16.0;Hep G2: 50.1;OE19: 18.8					Low region specificity	Detected in all			HPA051620	Approved				Secreted to blood			265000000000	1300000000			HPA051620: AB_2681554	unprognostic (1.73e-1)	unprognostic (2.62e-1)	unprognostic (3.26e-1)	unprognostic (2.07e-3)	unprognostic (1.72e-1)	unprognostic (2.54e-2)	unprognostic (4.58e-3)	unprognostic (9.49e-2)	unprognostic (1.37e-1)	unprognostic (4.25e-1)	unprognostic (6.39e-2)	unprognostic (2.64e-2)	unprognostic (1.21e-2)	unprognostic (1.55e-1)	unprognostic (1.03e-1)	unprognostic (1.05e-2)	unprognostic (8.25e-2)	0.5	0	0.1	0.5	0.1	0	0.3	0.1	0.1	0.5	2	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1	0.6	0.1	0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0	0	0	2.5	0.4	0	0.2	0	0	0	0	0	0	0	0	0	38.6	1.9	0	0.1	0	0	0	0	0	0	0	0	0	16	50.1	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.8	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	0.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	2.5	0.8	0	0	0	3.6	0	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	11.9	1.3	1.5	0	0	0	0.4	45.9	2.7	4.5	0	0	0.7	1.7	11	3.9	0	3.1	0	76.8	0.1	0.2	0.2	0	556	1.6	0	1.7	9.8	9.4	1.8	0	0.4	0	1	3.4	0	52	11.5	0	0	0	0	0.1	0	0	0	0.1	0.9	2.3	0	Hepatocytes
GNMT		ENSG00000124713	Glycine N-methyltransferase	Q14749	6	42960758-42963880	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Methyltransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	liver: 83.9;pancreas: 100.1	Cell type enriched	Detected in many	34	Hepatocytes: 729.0	Group enriched	Detected in many	20	liver cancer: 69.6;prostate cancer: 49.8	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9	Region enriched	Detected in some	4	cerebellum: 17.7	Not detected	Not detected			HPA027501	Enhanced		Approved	Cytosol					150000	Cytosol		HPA027501: AB_1849879	unprognostic (1.53e-2)	unprognostic (8.02e-4)	unprognostic (3.11e-2)	unprognostic (4.24e-3)	unprognostic (3.91e-2)	unprognostic (6.40e-4)	prognostic favorable (1.86e-4)	unprognostic (4.08e-6)	unprognostic (1.01e-1)	unprognostic (2.67e-2)	unprognostic (1.63e-3)	unprognostic (2.52e-1)	unprognostic (3.50e-3)	unprognostic (1.03e-1)	unprognostic (1.99e-1)	unprognostic (2.49e-2)	unprognostic (4.92e-2)	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0	2.5	0.1	0.4	5.2	0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2	0.9	0	1.2	0.3	0.5	0.4	1.8	5.1	0.6	0.2	0.3	0.4	2	0.8	1.2	0.1	0.1	1.7	0.2	0.4	0.9	0.6	0.3	0.3	0.2	2	1.6	1.3	1	10.5	0	1.1	2.4	0.4	0	0.4	0.2	1.2	0	3.8	1.5	1.9	0.3	2.3	2	3.7	0.2	0.5	0.5	1.7	1.6	1	0.9	0.2	12.4	1.7	0.1	1.7	0.6	0.5	7.9	3.6	0.4	0.9	0.9	0.5	1	1.3	1.2	1.5	0.2	2.1	1	0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2	0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1	0	2.1	3.4	4.2	0.2	1.2	4.5	15.3	5.3	0	1.8	0	0.1	3.3	0.4	0.2	0.1	0	0	0.7	0.1	0.2	16.1	0	729	0.5	1.6	0	16.5	21.5	0	0.9	0.3	0	0	0	0.3	0.9	0	2.5	2.2	0.3	0	0.7	0.5	0.6	0.1	0.1	0	0	1.6	Hepatocytes
PLGLB2	PLGP1	ENSG00000125551	Plasminogen-like B2	Q02325	2	87748087-87758793	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in some	28	liver: 105.2	Cell type enriched	Detected in some	9	Hepatocytes: 67.4	Cancer enriched	Detected in single	25	liver cancer: 1.2					Cell type enhanced	Detected in some		memory CD4 T-cell: 2.7;T-reg: 3.7	Lineage enriched	Detected in single	16	T-cells: 3.7	Cell line enhanced	Detected in many		hTERT-RPE1: 6.1;U-266/84: 4.9														Secreted to blood								unprognostic (1.10e-2)	unprognostic (8.78e-2)			unprognostic (3.42e-2)	unprognostic (7.03e-4)	unprognostic (1.68e-2)	unprognostic (3.77e-1)		unprognostic (1.82e-2)	unprognostic (5.74e-2)	unprognostic (2.94e-1)	unprognostic (5.04e-4)	unprognostic (6.39e-2)	unprognostic (4.06e-2)	unprognostic (3.22e-2)	unprognostic (7.11e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0.1	0	105.2	0	0.1	0.1		0.1	0.1	0	0	0		0	0		0	0	0	0.1	0	0	0	0	0	0			0		0	0	0	0.1	0	0	0.2	0	3.7	0.2	0	1.3	4.3	1.4	0	1.3	0	3.7	2.2	0.6	2.5	0	1.4	2.7	2.6	0.5	0.1	1	0.5	0	0.8	0	1.1	0.9	3.2	0	0.3	0.6	0.5	0	0	0.3	0.4	6.1	0.5	2.6	0.3	0	0.9	0	2.5	0	0	0.4	0	2.4	0	0	4.3	0.3	0	3.2	0.8	1	0.1	0.6	0.2	1.7	0	0	1.9	0.9	1.3	2.8	4.9	0.4	1.5	0	1.1	0	0.2	0	0.1	0	0.1	0	2.7	0.8	0	0.1	1.1	0	0	0	0	0	3.7	0.2											0	0	0	0	0	0	0.4	7.6	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67.4	0.1	0	0	1.3	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
C3	ARMD9, C3a, C3b, CPAMD1	ENSG00000125730	Complement C3	P01024	19	6677704-6730562	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism		Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	10	liver: 611.7	Cell type enriched	Detected in many	5	Hepatocytes: 4080.2	Cancer enhanced	Detected in all		liver cancer: 1213.6	Low region specificity	Detected in many			Cell type enhanced	Detected in many		non-classical monocyte: 13.3	Group enriched	Detected in many	4	granulocytes: 4.2;monocytes: 13.3	Group enriched	Detected in many	7	BJ hTERT+: 48.5;EFO-21: 102.2;Hep G2: 105.6;HSkMC: 75.4;SiHa: 28.2	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA003563, CAB004209, HPA020432	Enhanced				Secreted to blood			1260000000000	250000000000			CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118	unprognostic (3.26e-3)	unprognostic (3.91e-1)	unprognostic (3.92e-1)	unprognostic (5.98e-3)	unprognostic (3.31e-1)	unprognostic (1.04e-1)	prognostic favorable (8.11e-4)	unprognostic (1.99e-1)	unprognostic (9.26e-2)	unprognostic (5.80e-2)	unprognostic (8.12e-3)	unprognostic (5.48e-2)	prognostic unfavorable (1.09e-5)	unprognostic (2.63e-2)	unprognostic (2.49e-2)	unprognostic (6.03e-3)	unprognostic (3.88e-1)	59.7	34.1	9.3	20	19.6	1	47.3	0.7	10.2	28.3	17.8	13.9	3.7	3.2	9.1	19.9	17.9	38.8	37.9	57.6	7	4.1	21.6	611.7	22.6	25.2	12.3	2.2	42.4	22.2	3.1	3	2.7	12.8	12.7	9.6	3.9	18.7	7.6	6.8	5.8	15.1	19.1	29.6	1.6	12.6	11.2	10.7	0.1	10.3	3.2	14.1	25.2	38.2	1.2	0.8	4.2	13.3	2	0.4	0.8	8.4	3	0	0	1.5	5.1	10.3	0.7	48.5	0.9	1.7	0.5	6.7	0.2	102.2	0	7.5	6.3	0	5.8	0.9	3.1	0	0.4	4.5	105.6	2.3	0.8	1.2	75.4	1.7	8.4	3.8	1.3	0	0	0.2	0.1	0	0.1	0	0.2	0.2	0	0	0	0.7	0	4.4	0.8	0	0	28.2	0	0	0	2.3	1.1	0.4	0.8	1	0.6	0.4	0.2	0.5	0.5	10.4	0.6	0	1.7	1.5	0.9	0.4	2.7	0.3	0.7	0.3	0.2	0.8	1.2	0.4	0.4	4.2	2	13.3	0.7	0.2	0.8	9.3	19.6	0.7	10.2	7	4.1	12.3	2.2	12.8	10.7	71.5	405.7	102.4	11.5	24.5	0	13.3	822.9	29.4	84.2	15.7	0	1.2	5	273.3	34	21.5	0.3	70	114.7	2.1	60.9	11.5	4.7	4080.2	36.1	0	0	120.9	123.3	75.5	209.4	25.1	33.7	25.2	0.6	0.5	589.9	0	10.3	39.2	3.7	6.5	22.8	3.2	7.9	19.2	2.3	24.5	0.4	12.3	Hepatocytes
PROZ	PZ	ENSG00000126231	Protein Z, vitamin K dependent plasma glycoprotein	P22891	13	113158654-113172383	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 45.0	Cell type enriched	Detected in some	6	Hepatocytes: 56.9	Cancer enriched	Detected in single	27	liver cancer: 12.1	Not detected	Not detected			Cell type enhanced	Detected in some		intermediate monocyte: 2.7;T-reg: 1.5	Group enriched	Detected in many	12	monocytes: 2.7;T-cells: 1.5	Cell line enhanced	Detected in many		HaCaT: 4.9;Hep G2: 7.7	Not detected	Not detected							HPA052006	Supported				Secreted to blood			1720000000	510000000			HPA052006: AB_2681691	unprognostic (5.03e-2)	unprognostic (4.05e-2)	unprognostic (1.11e-1)	unprognostic (2.36e-1)	unprognostic (6.48e-2)	unprognostic (1.39e-1)	prognostic favorable (3.46e-4)	unprognostic (4.10e-1)	unprognostic (2.21e-1)	unprognostic (2.50e-1)	unprognostic (5.20e-2)	unprognostic (2.87e-1)	unprognostic (9.83e-2)	unprognostic (5.63e-2)	unprognostic (1.41e-1)	unprognostic (9.99e-2)	unprognostic (2.51e-4)	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0	9.3	45	0.1	0.1	0.1	0.1	0.1	0.2	0	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0	2.7	0	1.5	0.2	0.9	1.5	0.7	1	0	0	0.6	1.5	0	0	0	3	1.8	0.8	0	0	0.3	4.9	0	0	0	0.8	2.4	1	2.9	7.7	0.1	0.8	0.4	0	0	0	0	0.2	0	2.5	1.1	0.6	0	1	0.6	0.8	1.8	3.1	0.4	1.3	0.2	0.3	0	1.1	2.9	0.2	0	0.3	1.3	1.7	0	1	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0	0	0	0.3	2.7	0.4	0	0	0	0	0	0.1	0.1	0	0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56.9	0	0	0	0.6	1.2	0	0	0	0	0	0	0	0	0	0	9.8	0	0	0	0.1	0.1	0	0	0	0	0	Hepatocytes
LBP	BPIFD2	ENSG00000129988	Lipopolysaccharide binding protein	P18428	20	38346356-38377023	Plasma proteins, Predicted secreted proteins, Transporters	Immunity, Innate immunity, Lipid transport, Transport	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	33	liver: 429.7	Cell type enriched	Detected in some	15	Hepatocytes: 356.7	Cancer enriched	Detected in many	20	liver cancer: 356.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	ASC diff: 12.4;HSkMC: 14.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA001508, CAB025905	Approved				Secreted to blood			25000000000	910000000			CAB025905: , HPA001508: AB_1079241	unprognostic (4.20e-2)	prognostic unfavorable (5.56e-4)	unprognostic (4.54e-2)	unprognostic (2.47e-1)	unprognostic (3.80e-2)	unprognostic (2.53e-2)	unprognostic (5.50e-2)	unprognostic (2.48e-3)	unprognostic (6.15e-2)	unprognostic (2.12e-1)	unprognostic (7.93e-2)	unprognostic (2.62e-1)	prognostic unfavorable (3.62e-12)	prognostic unfavorable (5.76e-4)	unprognostic (1.69e-1)	unprognostic (1.22e-1)	unprognostic (1.67e-1)	12.8	0	0.1	4.7	0.1	0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0	0.4	0.2	0.1	0	0.1	0.4	0.1	0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	4	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0	0	0	0.9	0	0	0.1	0	0.1	0.1	0	12.4	0	0.1	0	0	0.1	0	0.1	0	0.4	0.2	0	0.3	0	0	0	0	0	0	0.4	0	0	0	0.4	0.1	14.7	0.1	0	0	0	0	0	0.2	0	0	0.1	0	0.1	1.4	0	0	0	0.1	0	0	0	0	0	0.2	1.1	0	0.1	0	0.1	0.2	0.2	0.1	0.1	0	0.1	0	0.2	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	12.7	0	0	0	0	0.1	6.6	0.3	0.6	0	0	23.3	9.1	0.1	0	0	0	356.7	0.3	0	0	11.1	8.6	0	0.6	0	0	1	0	0	8.2	0	0	10.6	0	0	0	0	0.1	0	0.1	0	0	0	Hepatocytes
ANGPTL8	C19orf80, RIFL, TD26	ENSG00000130173	Angiopoietin like 8	Q6UXH0	19	11237450-11241943	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid metabolism	Hormone	Diabetes mellitus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	liver: 81.0	Cell type enriched	Detected in some	14	Hepatocytes: 96.9	Cancer enriched	Detected in some	37	liver cancer: 84.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	27	Hep G2: 26.8;MCF7: 15.5	Not detected	Not detected			Not detected	Not detected			HPA042131			Approved	Nucleoplasm,Golgi apparatus	Secreted to blood			836000	320000	Golgi apparatus	Nucleoplasm	HPA042131: AB_10794413	unprognostic (2.37e-2)	unprognostic (1.86e-1)	unprognostic (1.15e-1)	unprognostic (1.31e-2)	unprognostic (1.17e-1)	unprognostic (1.00e-1)	unprognostic (3.73e-1)	unprognostic (2.80e-1)	unprognostic (3.49e-1)	unprognostic (1.02e-1)	unprognostic (9.67e-2)	unprognostic (1.35e-1)	prognostic unfavorable (1.84e-6)	unprognostic (1.09e-1)	unprognostic (3.55e-1)	unprognostic (4.57e-1)	unprognostic (1.75e-2)	8	0.1	0	0.6	0	0	5.1	0	0.1	0.1	5.7	0	0	0.2	0.1	0.8	0.1	0.1	1	0.6	0	0	1.5	81	0.1	3	0.2	0	0.3	0.1	0	0	0.1	0	0.2	0	0	4.8	0.1	0.7	0.3	0.1	0.1	0	0.2	0.1	0.1	0	0	0.3	0	0	1.6	0.1	0	0	0	0	0	0	0	0.1	0.4	0	0.1	0	0	0	0	0	0	0	0.3	0.1	0.1	0	0	0.1	0.2	0	0	0	0.1	0.1	0.2	0.7	26.8	0.4	0	0.5	0	0	0	0	0.4	0	0	0.1	0	0	15.5	0	0.5	0.1	0	0	0.1	0.3	0.7	0	0.2	0	0.2	0.3	0.7	0	0.3	0.4	0	0	0.3	0.1	0	0	0.1	0	0.2	0.4	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	2.5	0	0	0	0	0	0	0	0.4	0	0	0	0.2	0	0	0.1	0	96.9	0.1	0	0	6.7	5.9	1.3	0.9	0	0	0	0	1.2	0.3	0	0.4	1.8	0	0	0	0	0	0	0.2	0	0	0	Hepatocytes
APOC1		ENSG00000130208	Apolipoprotein C1	P02654	19	44914247-44919349	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	liver: 702.7	Cell type enriched	Detected in many	5	Hepatocytes: 27093.4	Cancer enriched	Detected in all	21	liver cancer: 3253.7	Low region specificity	Detected in many			Cell type enriched	Detected in some	8	myeloid DC: 8.9	Lineage enriched	Detected in single	13	dendritic cells: 8.9	Cell line enhanced	Detected in many		Hep G2: 100.3;HSkMC: 62.1;K-562: 26.1;SK-MEL-30: 46.2	Low region specificity	Detected in many							HPA051518	Supported				Secreted to blood			20300000000	26000000000			HPA051518: AB_2681519	unprognostic (3.51e-2)	unprognostic (3.31e-3)	unprognostic (1.14e-1)	unprognostic (2.59e-2)	unprognostic (2.06e-1)	unprognostic (1.47e-1)	prognostic favorable (1.15e-7)	unprognostic (9.51e-3)	unprognostic (1.30e-1)	unprognostic (4.18e-2)	unprognostic (1.11e-1)	unprognostic (2.52e-1)	unprognostic (7.13e-3)	unprognostic (3.48e-3)	unprognostic (1.65e-1)	unprognostic (2.01e-3)	unprognostic (1.65e-1)	1.5	58.9	6.6	1.6	30	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2	0.4	1.2	1.4	1	0.5	11.7	9.6	1.3	1	5.2	1	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0	0.6	0.2	0	0.6	0.4	4.7	2.1	0.9	6.9	7.2	20.3	0.2	0.3	0.8	1.3	9.9	8.9	1.4	1.7	0.1	0.6	0.3	2.8	0.3	0.4	0	11.4	6.4	0.6	100.3	6.1	4.7	3.3	62.1	0.5	0.8	0.3	1.7	0.2	0.3	26.1	0.1	0.3	0.6	0.2	0.3	20.4	1.8	1	1	2.9	0.1	1.3	0.3	0.9	0.6	3.3	0	46.2	7.2	0.4	17.4	0.7	0	0.3	0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0	0.1	0	0	0.6	0	0	0	0	8.9	0.2	0	0	0	0.2	0	1	0	0.6	6.6	30	0.6	3.1	4.1	7.8	20.2	1	6.6	5.2	107.2	247.1	115.1	4.2	15	1.6	0.7	451	44.2	99	1.8	0	32.3	41.4	3.4	0.9	5.6	0.5	186.9	3.5	299	64.1	1.9	139.7	27093.4	5056	0	2.4	451.8	716.3	1.3	250.8	243.1	28.7	215.6	2.2	120.9	3.3	0	244	10.9	8.3	19.4	5.9	1.4	3	15.6	59.8	137.1	2.1	4.9	Hepatocytes
CYP2E1	CYP2E	ENSG00000130649	Cytochrome P450 family 2 subfamily E member 1	P05181	10	133520406-133561220	Cancer-related genes, Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	87	liver: 802.4	Cell type enriched	Detected in many	65	Hepatocytes: 5979.1	Cancer enriched	Detected in some	278	liver cancer: 265.3	Not detected	Not detected			Cell type enhanced	Detected in some		MAIT T-cell: 3.9;myeloid DC: 9.1	Group enriched	Detected in many	17	dendritic cells: 9.1;T-cells: 3.9	Cell line enhanced	Detected in many		HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6	Not detected	Not detected			Not detected	Not detected			HPA009128, HPA029564	Enhanced		Approved	Endoplasmic reticulum,Mitochondria	Intracellular and membrane					Endoplasmic reticulum, Mitochondria		HPA009128: AB_1078613, HPA029564: AB_10602213	unprognostic (6.32e-2)	unprognostic (1.51e-2)	unprognostic (3.83e-5)	unprognostic (1.27e-1)	unprognostic (3.37e-2)	unprognostic (1.26e-1)	unprognostic (2.92e-3)	unprognostic (6.36e-3)	unprognostic (2.41e-2)	unprognostic (1.49e-1)	unprognostic (1.63e-1)	unprognostic (3.21e-2)	unprognostic (1.70e-4)	unprognostic (1.72e-1)	unprognostic (8.36e-2)	unprognostic (3.78e-1)	unprognostic (9.59e-2)	0.1	0	0.1	0.1	0.2	0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0	0.1	0.1	0.3	0.1	0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0	9.1	0	0.3	0.2	3.9	0.3	0.1	0	0.3	0.9	3.2	1.8	0.7	1.4	4	0	0.3	0	2.4	1.3	0.2	0.4	0	9.8	0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0	0.6	1.7	0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0	1.8	0	0	0	3.7	0	0.6	0.1	0.2	0.8	0	1.3	0.4	2	0.9	2	0.8	2.8	1.3	6.4	0.1	0	0	0	0.1	0	3.9	0	1.7	1	9.1	0	0.1	0	0	0.2	0.3	0.1	0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0	0.6	21	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0	2	0	0	0.3	1.3	0.4	0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0	7.9	0	68.2	91.8	1.9	1.4	0	0	0	0	1	2.6	0	2.5	0	5.2	0	0.5	3.6	2.2	6.6	0.1	8.7	0	0	Hepatocytes
F12		ENSG00000131187	Coagulation factor XII	P00748	5	177402140-177409576	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	26	liver: 180.1	Cell type enriched	Detected in many	8	Hepatocytes: 391.6	Cancer enriched	Detected in many	21	liver cancer: 171.0	Not detected	Not detected			Group enriched	Detected in some	5	classical monocyte: 2.5;eosinophil: 6.9	Group enriched	Detected in many	5	granulocytes: 6.9;monocytes: 2.5	Cell line enhanced	Detected in some		HDLM-2: 8.7;MCF7: 11.1;PC-3: 8.2;SH-SY5Y: 5.6;U-937: 5.8	Low region specificity	Detected in some			Low region specificity	Detected in some			HPA003825	Approved				Secreted to blood			1040000	6600000000			HPA003825: AB_1078790	unprognostic (9.75e-2)	unprognostic (1.71e-1)	unprognostic (2.93e-1)	unprognostic (4.47e-2)	unprognostic (1.01e-1)	unprognostic (2.32e-1)	prognostic favorable (4.63e-5)	unprognostic (6.97e-2)	unprognostic (1.26e-2)	unprognostic (3.96e-2)	unprognostic (4.41e-1)	unprognostic (6.54e-2)	prognostic unfavorable (7.09e-4)	unprognostic (4.11e-2)	unprognostic (3.69e-1)	unprognostic (3.40e-6)	unprognostic (6.48e-2)	0.1	0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1	6.9	2.5	0.7	0.3	1	0.8	2	0	0.6	0	0	0.2	0	0.1	0	0	2.3	1.4	0	0.4	0	0.3	1.4	0.7	0.4	0	8.7	1.9	1.4	0.3	0.9	0.2	0.7	3.1	0.2	1.3	0.1	0.4	0.1	0.2	2.1	0.4	3.3	0	11.1	0.1	2.6	0	2.6	8.2	0.6	0.2	1.9	1.1	0	2.6	5.6	0.3	1	0.7	0	0.4	0	0	0.2	1.1	0	0.3	0.5	0	0.1	0.1	5.8	0.6	0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0	0.1	0.9	0.7	0.9	1	0	1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	8.5	7.4	29.5	0.4	0.8	17.8	0	0	1.8	3.9	0	0	6.1	19.4	0.7	34.8	0	3.5	0.2	0.9	2	0	391.6	0.5	0	9.9	17.8	13.2	32.7	0.6	1.8	8.5	1	5.5	0.2	9.4	20.1	0	9.1	0.5	0	0.7	13	12.8	47.4	0.1	0.7	30.8	5.8	Hepatocytes
G6PC	G6PT, GSD1a	ENSG00000131482	Glucose-6-phosphatase catalytic subunit	P35575	17	42900797-42913369	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Gluconeogenesis	Hydrolase	Disease mutation, Glycogen storage disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	liver: 305.4	Cell type enriched	Detected in some	5	Hepatocytes: 125.4	Cancer enriched	Detected in some	72	liver cancer: 151.8	Not detected	Not detected			Cell type enhanced	Detected in some		naive B-cell: 2.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RH-30: 2.2	Not detected	Not detected			Low region specificity	Detected in many			HPA052324	Enhanced											HPA052324: AB_2681790				unprognostic (4.23e-2)	unprognostic (1.49e-2)		prognostic favorable (5.42e-5)				unprognostic (8.37e-2)		prognostic favorable (3.79e-5)	unprognostic (4.79e-2)	unprognostic (6.46e-2)		unprognostic (2.56e-3)	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	5	0	0	5.8	0.1	0	0.1	0.1	1.9	0.1	0.1	0.1	23.7	305.4	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	33.7	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	2.2	0.5	1.1	0.2	0.5	0.4	0	0.4	0.2	0.2	0.5	0.6	0	0.7	0.2	0.2	0	0.1	0.2	0.3	0.7	0.2	0.3	0.2	0.4	0	0	0.2	0.3	0.1	0.1	0.5	0.8	0	1.3	0	0.1	0	0.1	0.1	0.1	0	0.4	0.5	0.7	0	0.1	0.5	1.2	0.3	0	0.3	0.6	2.2	0.2	0.1	0.7	0.4	0.6	0.7	0.3	0	0.5	0.1	0	0	0	0.3	0.3	0	0.7	0.2	1	0.3	1.4	0.2	1.1	0.2	0.1	0.3	0.1	0.2	1	0.2	0.2	0	2.2	0.4	0.4	1.1	0.5	0.1	0.5	0.4	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1.9	0	0	0	0.3	22.9	0	0	1.8	0	0	1.7	0.2	0.1	0	0	0	0.2	0	0	0	0	125.4	0.1	0	0	3.7	4.1	0	0	0	0	0	0	0	0	0	0	23.4	0	0	0	0	0	0	0	0	0	0.1	Hepatocytes
CRP	PTX1	ENSG00000132693	C-reactive protein	P02741	1	159712289-159714589	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	66	liver: 1139.7	Cell type enriched	Detected in some	14	Hepatocytes: 2991.5	Cancer enriched	Detected in some	13	liver cancer: 1010.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1	Not detected	Not detected			Low region specificity	Detected in all			CAB005036, HPA027367, HPA027396	Supported		Approved	Nucleoplasm,Vesicles,Intermediate filaments	Secreted to blood			2920000000	5400000000	Nucleoplasm, Vesicles	Intermediate filaments	CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217	unprognostic (3.74e-1)	unprognostic (5.31e-2)				unprognostic (2.97e-2)	unprognostic (1.27e-1)	unprognostic (3.57e-2)			unprognostic (1.33e-2)	unprognostic (3.13e-1)	prognostic unfavorable (4.17e-10)	unprognostic (3.39e-2)	unprognostic (3.48e-1)	unprognostic (5.60e-2)	unprognostic (6.61e-2)	0.4	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.4	0.1	0.1	0	17.2	0.1	0.1	0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.2	0	0	0.3	0	0	0	7.8	0	0.3	0	0	0	0.3	0.1	1.1	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0	0	0	2.7	0	0	0	0	0	0.1	0	5.5	0.1	0.9	0	13.1	2	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	55.9	0	0	0	0	109.5	0	0	0	0	0	0	220.4	1.2	0	0	23.3	52.3	0	0	0	0	2991.5	0.1	0	0	82.9	72.1	0	0	0	0	17.2	0	0	97.4	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
APCS	MGC88159, PTX2, SAP	ENSG00000132703	Amyloid P component, serum	P02743	1	159587825-159588865	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	81	liver: 316.6	Cell type enriched	Detected in some	8	Hepatocytes: 3479.3	Cancer enriched	Detected in some	25	liver cancer: 826.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3	Not detected	Not detected			Low region specificity	Detected in many			CAB007817, HPA053294	Supported				Secreted to blood			27700000000	76000000000			CAB007817: AB_598185, HPA053294: AB_2682104							unprognostic (3.19e-3)				unprognostic (2.30e-2)							0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	3.8	0	0	0	0.7	316.6	0	0	0	0	0	2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0	0	0.8	0	0	0	0.3	0	1.3	0	0	0	3.3	0.5	0	0	0	0	0	0	0	0.9	0	0	0	0.5	0	1	0	0	0.7	4.3	0	0	0	0	0	2.2	0	0	0	0	0.2	0	0	1.1	0	0	0.7	0.2	1.1	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	21	0	0	0	0	451	0	0	0	0	0	0	77.6	0	0	0	70	5.1	0	0	0	0	3479.3	0	0	0	63.8	73.6	0	0	0	0	5.4	0	0	16.5	0	0	2.1	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SAA2		ENSG00000134339	Serum amyloid A2	P0DJI9	11	18239223-18248643	Disease related genes, Predicted secreted proteins	Acute phase		Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 752.1	Cell type enriched	Detected in many	23	Hepatocytes: 22104.6	Cancer enriched	Detected in many	22	liver cancer: 150.5	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 15.5;EFO-21: 11.9;GAMG: 11.3;HaCaT: 14.6;HBEC3-KT: 31.6;HSkMC: 10.3														Secreted to blood				11000000000				unprognostic (1.73e-3)	unprognostic (4.42e-2)	unprognostic (2.63e-1)	unprognostic (5.03e-2)	unprognostic (1.40e-3)	unprognostic (7.12e-2)	unprognostic (7.45e-2)	unprognostic (2.15e-2)	unprognostic (1.57e-1)	unprognostic (2.86e-2)	unprognostic (2.78e-2)	unprognostic (6.13e-2)	prognostic unfavorable (1.30e-8)	unprognostic (1.53e-1)	unprognostic (9.72e-2)	unprognostic (7.62e-3)	unprognostic (1.28e-1)	68.6	1.7	0.7	16.3	0.7	0	9.8	0.7	0.7	33.1	0.7	0.7	0.7	0	0.7	0.7	0.7	0.3	1.2	0.7	0.7	0	0.7	752.1	0.8	0.7	0.7	0.7	0.7	0.7	0	0.7	0.7	0.7	0.8	0	0.7	46	0.7	5.2	0.3	0.7	0.7	0.7	0.7	0.2	0.7	0.7	1.1	0.7	0.7	0.7	1.1	0.7	2	1	3.1	1.2	0.6	0.9	0.4	15.5	0	0.1	0.1	0.6	0	2.2	0	0.5	0	0.2	0	6.9	0.1	11.9	0.1	11.3	14.6	0	31.6	0.1	0.6	0	0.5	0.2	0	4.6	0.4	0.1	10.3	4.4	0	5.2	0.3	0.1	0	0	0.7	0.8	0	0.1	0	0.2	0.3	0	0	0.4	0	7.1	0.7	0.1	0	1.1	4.9	0	0.3	0.2	0.3	0.1	0.1	0.7	0.3	0.6	0.2	0.4	1	0	0.6	0.2	3	1.2	1	0.6	0.6	0.9	0.8	0.6	0.4	0.3	2	0.4	0.6	3.1	0.6	1	1	0.9	0.4	0.7	0.7	0.7	0.7	0.7	0	0.7	0.7	0.7	0.7	0	1	517.5	4.2	0.9	0	0.2	578.4	18.7	30.7	3.5	0	0.2	0	35.2	1.3	0	1.4	864.3	29.6	1.8	0.2	32.1	0	22104.6	0.3	0	0	951.4	647.2	0.4	0	0.4	8.5	1.8	0	0	30.1	0	0	0	0	0	0.1	0.1	0	0.1	0.5	4.8	0	62.9	Hepatocytes
CFHR4	CFHL4, FHR-4, FHR4	ENSG00000134365	Complement factor H related 4	Q92496	1	196850241-196918972	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	188	liver: 61.3	Cell type enriched	Detected in some	10	Hepatocytes: 31.7	Cancer enriched	Detected in single	145	liver cancer: 13.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 3.0;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 5.0;U-266/84: 2.1														Secreted to blood				180000000									unprognostic (5.97e-1)	prognostic favorable (1.57e-6)	unprognostic (1.89e-1)	unprognostic (4.79e-2)	unprognostic (1.26e-1)				unprognostic (1.68e-2)			unprognostic (4.71e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	61.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	3	0	0.1	0	0	0	0	0	0.1	0	2	0	0.2	0	0	0	0	0	0.4	0.9	0	0	0	0.6	2.5	0	5	2.1	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.7	0	0	0	3.1	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
CFHR5	CFHL5, FHR-5, FHR5	ENSG00000134389	Complement factor H related 5	Q9BXR6	1	196977556-197009674	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	241	liver: 85.5	Cell type enriched	Detected in some	24	Hepatocytes: 88.3	Cancer enriched	Detected in single	396	liver cancer: 57.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HL-60: 1.0									HPA038915, HPA040726	Supported				Secreted to blood				1700000000			HPA038915: AB_2676269, HPA040726: AB_2677101							unprognostic (9.12e-3)											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	85.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.4	0	0	0	0	0	0	0.2	0	0	1	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0.2	0	0	0.7	0.6	0	0	0	0.3	0	0.3	0	0	0	0.1	0	0	0	0.1	0	0	0.3	0	0.2	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.3	0	0	0	3.7	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SLCO1B1	LST-1, OATP-C, OATP1B1, SLC21A6	ENSG00000134538	Solute carrier organic anion transporter family member 1B1	Q9Y6L6	12	21131202-21239246	Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	618	liver: 121.0	Cell type enriched	Detected in some	39	Hepatocytes: 71.0	Cancer enriched	Detected in some	96	liver cancer: 52.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6									HPA050892	Supported											HPA050892: AB_2681265			unprognostic (5.45e-1)			unprognostic (1.82e-4)	unprognostic (2.43e-3)	unprognostic (1.96e-3)		unprognostic (1.80e-1)	unprognostic (2.41e-1)	unprognostic (8.82e-2)		unprognostic (5.63e-2)	unprognostic (3.86e-2)		unprognostic (3.49e-1)	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	1.9	0.3	0	0	0	0	0	0	0	0	0.1	0.7	0.1	0.1	0	0.4	0	0	0	0	0	0	0	2.9	0	0	0.1	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	2.6	0	0.6	0	0.7	3.5	0	0	0	0	0.1	0	0	5.6	0.8	0	0.4	0	0.8	0	0	1	0.4	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	71	0	0	0	1.8	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Hepatocytes
GLS2	GA, GLS, hLGA, LGA	ENSG00000135423	Glutaminase 2	Q9UI32	12	56470944-56488414	Enzymes, Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 92.2	Cell type enriched	Detected in many	5	Hepatocytes: 52.1	Cancer enhanced	Detected in single		liver cancer: 1.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	29	B-cells: 1.8;T-cells: 3.8	Cell line enhanced	Detected in some		Daudi: 25.6;RPMI-8226: 4.6;SCLC-21H: 7.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038608	Uncertain											HPA038608: AB_10673176	unprognostic (5.59e-2)	unprognostic (1.51e-2)	unprognostic (8.73e-2)	unprognostic (7.15e-2)	unprognostic (1.23e-2)	unprognostic (9.56e-2)	unprognostic (3.27e-3)	unprognostic (1.98e-6)	unprognostic (1.55e-1)	unprognostic (5.33e-2)	unprognostic (1.29e-2)	unprognostic (1.52e-1)	unprognostic (5.65e-5)	unprognostic (1.42e-2)	unprognostic (2.59e-1)	unprognostic (9.02e-2)	unprognostic (4.44e-2)	0.9	1.7	5.7	1	8.6	0.9	1.4	12.8	15	1	1.2	0.2	0	1	1.2	2	1.4	2.8	0.9	1	4.2	4.1	1.6	92.2	1.4	1.2	1.9	9.7	1.2	15.8	3	6.2	0.8	8.6	1.4	1.7	2.5	1.4	2	0.9	2	1	1.1	3.2	1.1	1.4	1.1	1.4	0	1.4	0	1.4	1.1	0.8	1.8	0	0	0	0	3.8	1.4	4.1	0	0.1	0	0	0	0.1	0	0	0	0.3	3.5	0.9	25.6	0.5	0	0	0.6	0	3.8	0	0	3.8	0	0.3	4.1	0	0	0	0	1.8	0	0	0.1	0	0	0	0.1	0	0	0.5	0	1.8	0.8	0.4	0	0.1	4.6	2.7	1.8	7.3	0.4	0.8	0.3	0	0.7	3.6	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1.1	0	3.3	1.8	3.3	1	0	0.6	3.8	3.5	0	0	0	0	0.6	1.4	5.7	8.6	12.8	15	4.2	4.1	1.9	9.7	8.6	1.4	0	2.4	1.9	4.2	1.4	9.5	0	0	2.7	6.8	0	5.9	0.1	6.6	0.4	0	0.3	0	0	1.6	0	0.1	1.5	1.1	52.1	0.1	3.2	1.2	1.3	1.5	0	0.9	0	1.7	0	0	2.3	0.8	0	0	0.5	10.2	0	0	0	1	1	0.2	0	0.2	0.3	Hepatocytes
CIDEB		ENSG00000136305	Cell death-inducing DFFA-like effector b	Q9UHD4	14	24305096-24311430	Predicted intracellular proteins	Apoptosis			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	intestine: 123.9;liver: 215.9	Cell type enriched	Detected in many	5	Hepatocytes: 219.7	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 15.2;HEL: 7.8;Hep G2: 17.0;HL-60: 10.9;Karpas-707: 7.8;U-266/84: 10.1;U-937: 12.8	Low region specificity	Detected in all			Not detected	Not detected			HPA001272	Approved											HPA001272: AB_2666255	unprognostic (2.62e-2)	unprognostic (6.55e-2)	unprognostic (2.62e-3)	unprognostic (9.35e-2)	unprognostic (2.38e-3)	unprognostic (1.83e-2)	unprognostic (1.57e-1)	unprognostic (8.48e-4)	unprognostic (1.36e-1)	unprognostic (3.06e-2)	unprognostic (3.39e-3)	unprognostic (2.36e-2)	unprognostic (6.43e-2)	unprognostic (6.04e-2)	unprognostic (5.15e-2)	unprognostic (2.09e-2)	unprognostic (2.64e-1)	2.3	5.6	0.9	1.9	1.2	3.9	2.2	3.1	0.9	2.7	43.4	1.1	1.9	26	2.2	2.7	7.1	2.5	3.1	1.2	1	0.6	24.2	215.9	2	3.3	1.2	0.9	5.5	3.9	0.5	2.5	0.8	1.3	3.1	1.3	2.4	2.8	2.2	0.6	4	123.9	1.5	1	19.5	1.4	0.9	0.9	0.8	1.4	3.2	4.5	1.3	3.8	0.7	7.1	8.7	7.1	6.3	4.9	2.5	0	0	0	0	1	0.5	0.2	0.3	0.1	0.1	0	1	0.4	0	0	0.4	0	1.4	0	0.1	0	15.2	0	7.8	0	17	0	10.9	0	0.4	0	0	0	0	3.5	0	0	7.8	0	0	0	5.1	0	4	0	1.2	0.1	3.9	0	0.5	3.3	0	4.3	0.1	0	0.1	0	3.8	0.1	0	0	0	0	6.2	10.1	0.1	0	12.8	0	0.9	7.1	8.7	4.9	2.4	4.5	0.7	3.2	3.1	7.1	0.6	2	2.6	4.1	6.3	1.2	1.7	1.6	2.5	0.9	1.2	3.1	0.9	1	0.6	1.2	0.9	1.3	0.9	0	1.7	9.5	5	6.3	0.2	0	7.6	13.4	4.5	1.8	2	0	8.3	1.4	0.1	2.8	20.6	23.3	8.5	0.2	2.5	0.9	8.1	219.7	6.4	0	1.7	13.5	28.5	0	5.8	5.6	5	0	2.5	0.5	10.4	20.1	2.8	43.4	0.6	0	1.7	0.2	1.3	5.4	0.2	8.7	1.6	0.9	Hepatocytes
BAAT	BAT	ENSG00000136881	Bile acid-CoA:amino acid N-acyltransferase	Q14032	9	101360417-101383519	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Acyltransferase, Hydrolase, Serine esterase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 128.4	Cell type enriched	Detected in some	8	Hepatocytes: 745.7	Cancer enriched	Detected in many	42	liver cancer: 181.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6	Not detected	Not detected			Not detected	Not detected			HPA021251, HPA021330	Enhanced		Uncertain	Vesicles					470000	Vesicles		HPA021251: AB_1845247, HPA021330: AB_2670674	unprognostic (2.53e-2)	unprognostic (1.81e-1)	unprognostic (9.97e-2)	unprognostic (9.33e-2)	unprognostic (7.75e-3)	unprognostic (4.68e-2)	prognostic favorable (4.97e-4)	unprognostic (2.14e-2)	unprognostic (6.19e-2)	unprognostic (4.43e-4)	unprognostic (3.65e-1)	unprognostic (2.15e-1)	prognostic unfavorable (4.24e-7)	unprognostic (1.74e-1)	unprognostic (2.12e-1)	unprognostic (2.17e-2)	unprognostic (1.75e-1)	0	0	0.1	0	0.2	0.1	0	0.1	0.2	0	0	0	0	0	0	0.3	0	0	22.8	0	0.1	0.1	0.2	128.4	0.2	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.3	0.2	0	0.7	0.1	0.1	6.1	0.4	0.3	0	0	0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0	0.9	0.3	0	1	0.1	0	0.1	0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0	0.7	0.1	0.1	0.5	0.1	0.1	0	0	0.3	0	0	0	0	0	0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0	0	0	0	0	0	11.5	0	0	0.8	0.4	89.2	0	0	0	0	0	0	8.1	0	0	0	0	0.2	0	0	0	0	745.7	0	0	0	11.1	12.7	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	Hepatocytes
TTPA	AVED	ENSG00000137561	Alpha tocopherol transfer protein	P49638	8	63048553-63086053	Disease related genes, Plasma proteins, Predicted intracellular proteins	Transport		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	liver: 74.1	Cell type enriched	Detected in some	6	Hepatocytes: 67.2	Cancer enriched	Detected in some	9	liver cancer: 21.3	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		GAMG: 3.6;SK-BR-3: 10.3;T-47d: 3.8;U-2 OS: 5.4;U-2197: 6.4	Low region specificity	Detected in all																				unprognostic (1.48e-1)	unprognostic (3.42e-1)	unprognostic (7.82e-3)	unprognostic (1.30e-7)	unprognostic (1.78e-1)	unprognostic (8.44e-2)	unprognostic (1.25e-2)	unprognostic (7.84e-2)	unprognostic (4.04e-2)	unprognostic (3.50e-1)	unprognostic (5.40e-2)	unprognostic (3.28e-1)	unprognostic (1.14e-2)	unprognostic (1.49e-2)	unprognostic (3.57e-2)	unprognostic (5.46e-3)	unprognostic (6.16e-3)	0.9	0.4	2.4	0.4	3.3	0.3	2.5	3.5	2	0.3	1.6	2.1	0	0.4	0.3	0.3	0.3	0.3	0.4	0.3	3.9	1.1	1.4	74.1	0.6	0.3	2.4	1.8	0.3	0.8	0.4	0.3	1	3.8	0.3	2.3	0	0.3	0.3	0.3	0.4	0.4	0.4	3.1	0.3	0.4	0.4	2.4	0	0.3	0	0.3	0.3	0.2	0.9	0.3	2	0.5	0.3	0.4	0	0.1	1.5	1	0.2	0.5	0	0	0.1	0	0.4	0.1	0.2	2.4	0	0.1	0	3.6	0	2.7	0.2	0.5	0	0.1	0.1	0.2	0.6	0	0	0.1	0.1	0	0.5	0	0.3	0	0.1	0.1	0.2	0.4	1.2	0.1	0.2	1	0.1	0.7	0.1	0	0	0	0.7	0.4	0.1	1	10.3	1	0.1	3.8	0.4	0.3	0.1	5.4	6.4	1.1	0.4	0	0.1	2.3	0.1	2	2	0.5	0.3	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.9	0.3	0.3	1.6	0.3	0.2	0.3	0.2	0	2.4	3.3	3.5	2	3.9	1.1	2.4	1.8	3.8	2.4	3	0.6	0	0	0	0	0.1	5.1	0	2.3	0	0	8.1	1.7	0.4	0	0	0	0	0.2	0	0.3	0	0	67.2	0.6	0	2.4	2.5	1	0	0	0	0	0	1.7	10.6	0.1	0	0	4.4	0.2	0	0.1	0	0.1	0.1	8.2	0	6.6	0.1	Hepatocytes
ABCG5	STSL	ENSG00000138075	ATP binding cassette subfamily G member 5	Q9H222	2	43812472-43838865	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	85	intestine: 54.3;liver: 40.9	Cell type enriched	Detected in some	9	Hepatocytes: 47.3	Cancer enriched	Detected in some	23	liver cancer: 11.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	47	Hep G2: 14.7	Not detected	Not detected			Not detected	Not detected																unprognostic (1.71e-1)	unprognostic (5.47e-2)	unprognostic (4.01e-1)	unprognostic (6.92e-2)	unprognostic (2.24e-1)	unprognostic (9.97e-2)	prognostic favorable (2.60e-5)	unprognostic (4.59e-2)	unprognostic (3.10e-1)	unprognostic (1.38e-3)	unprognostic (3.07e-4)	unprognostic (1.86e-1)	unprognostic (3.07e-1)	unprognostic (5.52e-3)	unprognostic (8.29e-2)	unprognostic (5.31e-2)	unprognostic (3.08e-2)	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	19.5	0	0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	54.3	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.4	1.3	5.1	0	0	0	0	0	1.7	0	0	0	0.7	0	0	0	0	0	0	47.3	0	0	0	0.6	1.5	0	0	0	0	0	0	0.1	0	0.2	0	0	0.7	0	0	0	0.2	0	0	0	0.8	0	Hepatocytes
CYP2C9	CYP2C10, P450IIC9	ENSG00000138109	Cytochrome P450 family 2 subfamily C member 9	P11712	10	94938658-94989391	Enzymes, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 233.0	Cell type enriched	Detected in some	48	Hepatocytes: 1765.4	Cancer enriched	Detected in some	41	liver cancer: 118.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6									HPA015066, CAB016123	Enhanced				Intracellular and membrane							CAB016123: AB_629363, HPA015066: AB_1847433	unprognostic (3.37e-1)	unprognostic (5.68e-2)	unprognostic (9.67e-2)	unprognostic (4.16e-2)		unprognostic (1.83e-2)	prognostic favorable (2.83e-6)	unprognostic (2.37e-1)	unprognostic (2.05e-2)		unprognostic (4.93e-2)		unprognostic (1.26e-4)	unprognostic (7.55e-2)	unprognostic (1.12e-1)	unprognostic (2.45e-2)	unprognostic (1.24e-2)	0	0	0	0	0	0	0	0	0.1	0.2	45.8	0	0	13.6	0	0.6	1.1	0	1	0	0	0	0.5	233	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0.2	43.8	0	0	0.1	2.7	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0.8	0	0.5	0	0	1.1	0.4	0	0	0	0	0.1	1	0	0.1	0	3.5	0	0	0	0	0	0	0	0	0.9	0	0	0	0	1.7	0.4	0.9	0	0	0.3	2.5	0.4	0	0.1	0.1	1.6	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0.9	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	7	0	0	0	0	30.6	0	0	1.8	0	0	0	4.7	0	0	4.2	23.3	0.6	0	0	0	0	1765.4	0	0	0	36.8	31.7	0	0	0	0	0	0.1	0	0.6	0.3	0	1.5	0	0	0	0	0	0	0.1	0.7	0.3	0	Hepatocytes
CYP2C8	CPC8	ENSG00000138115	Cytochrome P450 family 2 subfamily C member 8	P10632	10	95036772-95069497	Enzymes, Plasma proteins, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	131	liver: 247.5	Cell type enriched	Detected in some	10	Hepatocytes: 1616.5	Cancer enriched	Detected in some	82	liver cancer: 102.3	Not detected	Not detected			Cell type enriched	Detected in single	9	gdT-cell: 1.8	Lineage enriched	Detected in single	9	T-cells: 1.8	Cell line enhanced	Detected in some		Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3									HPA013547, HPA013970, HPA015066	Enhanced				Intracellular and membrane							HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433	unprognostic (3.33e-2)	unprognostic (1.38e-1)	unprognostic (1.53e-1)	unprognostic (1.55e-1)	unprognostic (4.41e-2)	unprognostic (1.09e-2)	unprognostic (1.80e-3)	unprognostic (4.29e-2)	unprognostic (1.03e-1)	unprognostic (3.38e-1)	prognostic favorable (9.82e-4)	unprognostic (2.85e-1)	unprognostic (1.44e-3)	unprognostic (2.63e-1)	unprognostic (7.88e-2)	unprognostic (1.39e-1)	unprognostic (4.05e-4)	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	1	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	1.8	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	1.8	0	0	0.1	1.1	0.2	0	0.2	0	0.7	1	0	1	0.5	2.7	0.1	0	0.2	0	0	0	0	0.1	0.3	0.4	0.3	0.7	0.1	0	0.2	0	0	0	0.8	0	0	0.4	0	0	3	0.2	0	0	0	0.4	0	0	0	0	0	3	2.3	1.2	0	0.9	0	0	0	0	1.8	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0	21	0	0	0.9	0.2	155.4	0	0	0	0	0.1	0	0	4.9	0	0	70	0.2	0	0	0.1	0	1616.5	0	4.8	1.7	61.4	65.7	5.1	0	0	0	0	0	0.2	0.6	0	0	0	1.6	0	0	2.1	0.6	0	0	0	0	0.1	Hepatocytes
RBP4		ENSG00000138207	Retinol binding protein 4	P02753	10	93591687-93601744	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Sensory transduction, Transport, Vision		Cancer-related genes, Disease mutation, Microphthalmia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	liver: 897.1	Cell type enriched	Detected in many	13	Hepatocytes: 11448.6	Cancer enriched	Detected in all	27	liver cancer: 3135.4	Low region specificity	Detected in many			Group enriched	Detected in some	14	classical monocyte: 1.2;myeloid DC: 1.5	Group enriched	Detected in many	14	dendritic cells: 1.5;monocytes: 1.2	Cell line enriched	Detected in some	4	Hep G2: 155.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA001641, CAB004555	Supported				Secreted to blood			46100000000	420000000000			CAB004555: AB_670938, HPA001641: AB_1079795	unprognostic (9.42e-3)	unprognostic (3.40e-2)	unprognostic (1.90e-1)	prognostic unfavorable (1.50e-4)	unprognostic (2.60e-2)	unprognostic (6.69e-4)	prognostic favorable (1.74e-8)	unprognostic (2.39e-1)	unprognostic (5.76e-2)	unprognostic (3.26e-2)	unprognostic (3.26e-1)	unprognostic (3.44e-1)	unprognostic (7.14e-3)	unprognostic (9.88e-3)	unprognostic (2.31e-1)	unprognostic (1.03e-1)	unprognostic (8.60e-2)	39	2	1.4	2.4	3.1	0.3	27	0	2.1	0.3	1.8	0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0	0	0.3	0.5	0.2	0.6	1.6	0	1.5	0	1.2	0	0	0.4	0	2.1	0	0	0.4	0	0	0	0	0.3	0	37.5	0	0.2	0.4	0	0	0.1	0	0	0	0	0	0.3	0.1	155.4	0	1.2	0	2.7	0	0.1	0	0	0	0	0.1	0	0.1	0	0	1	0.2	0.3	17.6	0	1	0	0	0	0.1	0	1.3	0	0	0.1	0	0.1	0	0	1.1	0	0	0.1	0	0.5	0	0.5	0	0	1.2	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0.4	1.4	3.1	0	2.1	1.4	2.2	0.2	1.1	0.4	0	0	3.4	60.7	0.2	0.7	0	0.4	853.5	1.4	1.2	22.7	5.9	0.2	82.9	7.1	2.2	0.7	2.1	46.7	0.2	11.9	6.8	1.7	0	11448.6	18.7	0	60	171.2	183.3	1.9	2.8	2	1.7	0	33	0.7	46.4	10.5	5.3	393.5	0.2	0	0.8	2.8	13.4	0.6	1.1	19.1	1.1	0.9	Hepatocytes
PLA2G12B	PLA2G13	ENSG00000138308	Phospholipase A2 group XIIB	Q9BX93	10	72935170-72954778	Plasma proteins, Predicted secreted proteins, RAS pathway related proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	intestine: 47.8;liver: 42.8	Cell type enriched	Detected in some	5	Hepatocytes: 47.8	Cancer enriched	Detected in many	8	liver cancer: 35.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	CACO-2: 12.1;Hep G2: 20.0	Not detected	Not detected			Not detected	Not detected			HPA057745, HPA059562	Approved				Secreted to blood							HPA057745: AB_2683514, HPA059562: AB_2684064			unprognostic (1.11e-2)				unprognostic (2.66e-2)	unprognostic (2.02e-3)			unprognostic (3.41e-1)		unprognostic (1.68e-1)	unprognostic (1.89e-1)	unprognostic (1.26e-1)	unprognostic (3.14e-2)		0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	25.6	0	0	15.4	0.1	0.3	0.1	0.1	0	3.5	0.1	0.1	8	42.8	0.9	0	0.1	0	0.1	0.1	0	0.1	0	0.1	0.1	0.7	0.1	0.1	0	0.1	0.1	47.8	0	0.1	0.1	0.1	0.5	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	12.1	0	0.1	0	0	0	0	0	0	0.2	0.1	0	0	0	20	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0.2	0	0.1	0.1	0.1	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0	2.6	0.9	0	0	0.5	1.2	0	0	0	0	0	0	0	0	7.9	0	10.3	0	0	0	0	0	0	47.8	0	0	0	1.8	0.6	0.5	0	0	0	0	0.1	0.3	0	2.9	0	9.8	0.2	0	0	0	0.1	0	0	0	0	0	Hepatocytes
AOX1	AO, AOH1	ENSG00000138356	Aldehyde oxidase 1	Q06278	2	200585868-200677064	Enzymes, Plasma proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	liver: 228.8	Cell type enriched	Detected in many	6	Hepatocytes: 649.9	Cancer enriched	Detected in many	9	liver cancer: 122.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA040199, HPA040215	Enhanced								410000			HPA040199: AB_10795273, HPA040215: AB_10795360	unprognostic (4.39e-2)	unprognostic (1.03e-3)	unprognostic (1.96e-1)	unprognostic (3.15e-2)	unprognostic (1.17e-4)	unprognostic (1.92e-2)	unprognostic (2.34e-2)	unprognostic (3.54e-1)	unprognostic (1.15e-1)	unprognostic (4.93e-2)	unprognostic (5.48e-2)	unprognostic (2.00e-2)	prognostic favorable (6.05e-5)	unprognostic (1.33e-2)	unprognostic (8.16e-3)	unprognostic (3.38e-2)	unprognostic (4.99e-3)	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2	11.1	3.9	8.1	4	3.5	0.3	0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0	0	0	0.5	0	0.2	0.1	0.1	0	0	0	85.8	44.1	0	1.4	2.6	1.1	2.1	0	0	0	0.1	1.7	0.5	0	0	3.9	4.8	0	0.1	0	1	4.3	5.7	0.2	0	17.7	1	5.6	17.7	1.1	0	0	0	0	3.9	0.1	0	0	1.7	0	1.1	0	0.1	0	0	0	0	0	1	0	0	0.1	0	0	6.8	3	2.4	0	0.5	0	0	0.6	2.3	0.1	0.3	0	0.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.4	0.3	0.2	0.3	0	0.2	0.2	0.6	0.2	3	0.6	13.7	0.5	1.5	0	0.7	12.7	0	0	3.5	0	0	10	0.6	0.5	1.3	0	0	22.4	0.1	10.2	8.3	0	649.9	0.4	0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0	0	0.4	18.4	0	77.1	111.5	0	0	2.8	0.7	0.6	1.4	0	0	0	0.3	Hepatocytes
MTTP	ABL, MTP	ENSG00000138823	Microsomal triglyceride transfer protein	P55157	4	99563761-99623999	Disease related genes, FDA approved drug targets, Predicted intracellular proteins	Lipid transport, Transport		Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	49	intestine: 211.4;liver: 60.8	Cell type enriched	Detected in some	8	Hepatocytes: 201.1	Cancer enriched	Detected in many	13	liver cancer: 28.7	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.0	Lineage enriched	Detected in single	10	B-cells: 1.0	Group enriched	Detected in some	6	AF22: 12.8;Hep G2: 14.0	Low region specificity	Detected in all			Not detected	Not detected			HPA051170, HPA054862	Uncertain		Uncertain	Cytosol	Intracellular and membrane				450000	Cytosol		HPA051170: , HPA054862: AB_2682628	unprognostic (1.66e-2)	unprognostic (1.14e-1)	unprognostic (5.64e-2)	unprognostic (5.33e-2)	unprognostic (3.49e-3)	unprognostic (7.38e-2)	unprognostic (1.05e-1)	unprognostic (2.74e-2)	unprognostic (1.08e-1)	unprognostic (3.66e-2)	unprognostic (1.00e-2)	unprognostic (1.62e-1)	unprognostic (1.27e-3)	unprognostic (2.02e-2)	unprognostic (3.64e-1)	unprognostic (1.53e-2)	unprognostic (1.31e-1)	0.1	0.1	0.3	0	0.3	0	0.1	0.1	0.2	0	53.2	0.2	0.1	53.4	0	0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0	0.4	0.1	1.1	0.1	0	0.3	0	0.3	0.2	0	0	0	0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0	0.3	0	1	0	0	0	0	0	0	0	0.3	12.8	0	0	0.1	1.1	0.1	0	0	0.3	0.5	0	0.4	0.2	0	0.1	0	0.1	0	0	2.3	0.2	0.3	0.1	14	0	0.1	0	0	0.1	0	0.3	0	0	0.2	0	0.1	0	0	0.1	0.7	0.6	0	0.3	0.3	0.2	1.3	0	0	0.8	1	0.2	0.1	0.4	0	0	0.1	0	0	0	0.4	0.1	0.1	0	0.1	0.5	0	0	0	0	0	0	0	0	0.4	0	0	0	1	0	0	0	0	0	0	0	0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2	0	0	0	0	0	0	2.5	7.6	0	0	1.8	0	0.1	0	0	25.5	0	0.7	0	0	0	0	0	0	201.1	0.1	0	0	5.5	3.3	7.9	0.9	0	0	1	0	0	0.3	0	0.4	18.6	0	6.5	0	21.9	1.5	0	0	0	0	0	Hepatocytes
SLC38A4	ATA3, NAT3, PAAT	ENSG00000139209	Solute carrier family 38 member 4	Q969I6	12	46764761-46832408	Predicted membrane proteins, Transporters	Amino-acid transport, Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	22	liver: 128.2	Cell type enriched	Detected in some	16	Hepatocytes: 251.9	Cancer enriched	Detected in many	14	liver cancer: 61.0	Not detected	Not detected			Group enriched	Detected in some	8	basophil: 3.0;NK-cell: 1.9	Group enriched	Detected in many	8	granulocytes: 3.0;NK-cells: 1.9	Cell line enhanced	Detected in some		ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (3.81e-2)	unprognostic (7.46e-3)	unprognostic (5.22e-3)	unprognostic (1.75e-2)	unprognostic (3.12e-1)	unprognostic (1.11e-1)	prognostic favorable (5.37e-4)	unprognostic (3.06e-2)	unprognostic (2.57e-3)	unprognostic (1.75e-2)	unprognostic (1.95e-1)	unprognostic (6.06e-2)	unprognostic (2.84e-2)	unprognostic (1.89e-2)	unprognostic (8.28e-2)	unprognostic (6.31e-3)	unprognostic (2.21e-2)	0.2	0.1	0.1	1.4	0	0	0.1	0.1	0.2	0.1	0.9	0	0.3	0	1.7	0.1	0.6	0.1	0.3	1.1	0	0	5.9	128.2	0.1	0	0	0	0.1	2.1	0	0	1	0.1	0.4	0.2	0.1	0.3	0	2.9	0.4	0.1	1.4	0	0.3	0	0.2	0	0.2	0.2	0.4	0.2	0.7	0	0.1	0.3	3	0	1.9	0.1	0	0	0	0	0	8.8	1.1	1.7	1	2.8	0.9	0.9	0.5	2	0	1.7	3.7	0	0.5	0	0.3	0.9	0	0	0	0	0.1	0.3	0.2	0	2.1	0	0	0.7	0	0	0	0.1	0	21.7	0	0	0	0.6	0	0	0	7.2	0	0	42.4	0.1	0	0.1	0	0	0.2	0	0	0	0	0.4	0	0	0.1	0	0.1	0.2	0.1	0	3	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	1.9	0	0.3	0	0	0.1	0	0.1	0.2	0	0	0	0	0.1	0	0	0	0	0	0.7	0	1.3	15.3	0	0	1.8	0	2	0	0	0.2	0.1	1	0	0	0.4	1.9	0.4	0	251.9	0.4	0	0	3.1	3.9	0.2	0.3	0	0	0	0.2	0	0.3	0.2	0	0.3	0	0	0	0	0	0.5	0.7	0	0.6	0	Hepatocytes
INHBE	activin, MGC4638	ENSG00000139269	Inhibin beta E subunit	P58166	12	57452323-57459280	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	40	liver: 127.6	Cell type enriched	Detected in single	51	Hepatocytes: 32.6	Cancer enriched	Detected in some	27	liver cancer: 34.4	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 3.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HHSteC: 15.2;Karpas-707: 22.8;RH-30: 10.7;U-266/70: 76.9	Not detected	Not detected			Not detected	Not detected			HPA016843, CAB034017	Enhanced		Supported	Vesicles	Secreted to blood				1400000	Vesicles		CAB034017: AB_2233745, HPA016843: AB_1851796	unprognostic (7.34e-2)	unprognostic (6.73e-2)	unprognostic (3.45e-1)	unprognostic (4.69e-5)	unprognostic (2.61e-1)	unprognostic (2.50e-1)	unprognostic (3.13e-1)	unprognostic (1.24e-1)	unprognostic (8.79e-3)	unprognostic (1.44e-1)	unprognostic (3.22e-1)	unprognostic (2.70e-1)	prognostic unfavorable (5.66e-8)	unprognostic (4.09e-3)	unprognostic (1.56e-1)	unprognostic (3.57e-2)	unprognostic (7.52e-3)	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.1	127.6	0	0	0	0	0	0.7	0	0.3	0	0.2	0.1	0	0	0.2	0	0.6	0	0	0	0	0.1	0	0	0	0	0.6	0.2	0	0.1	0	1	0.9	3.1	0.6	0.6	0.5	0.1	0	0.1	0	0.1	0	0.1	0.1	0.8	2.2	0	2.7	0.1	0	1.1	0.5	0.2	0	0.1	0.5	0	0.3	5.1	0	0	0	3.3	15.2	0.6	0.7	1.4	1.5	0.3	3.3	0.1	0	0.5	1.3	22.8	0	0	0	0	0.1	0	0	0	10.7	2.3	0	0	5.7	0.2	0	0	2.1	0.1	0.1	2.4	0	0	1.2	0	0.1	76.9	2.4	1	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0	0	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32.6	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
AMDHD1	MGC35366	ENSG00000139344	Amidohydrolase domain containing 1	Q96NU7	12	95943293-95968716	Enzymes, Predicted intracellular proteins	Histidine metabolism	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	liver: 99.0	Cell type enriched	Detected in many	5	Hepatocytes: 125.2	Cancer enriched	Detected in many	14	liver cancer: 23.4	Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2	Not detected	Not detected			Low region specificity	Detected in many			HPA039720, HPA040149	Uncertain		Approved	Nucleoplasm,Plasma membrane,Cytosol		No			410000	Cytosol	Nucleoplasm, Plasma membrane	HPA039720: AB_10672967, HPA040149: 	unprognostic (4.81e-2)	unprognostic (2.91e-1)	unprognostic (1.53e-1)	unprognostic (2.09e-2)	unprognostic (1.80e-2)	unprognostic (2.88e-2)	unprognostic (2.33e-2)	unprognostic (6.62e-3)	unprognostic (1.06e-1)	unprognostic (7.01e-2)	unprognostic (3.35e-3)	unprognostic (1.17e-1)	unprognostic (4.63e-3)	unprognostic (3.98e-2)	unprognostic (1.70e-1)	unprognostic (4.08e-3)	unprognostic (2.61e-1)	1.1	5.7	0.5	2.4	0.8	2	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99	1.3	1.4	0.5	0.4	0.7	1.1	0	1.2	0.6	1	0.7	0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.5	4.3	0.3	2.8	0.1	0	4.4	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0	1.1	3.7	0.1	0	0.1	6.8	0.7	1.9	3	3.8	0	2.5	21.5	0	0.1	0.3	0	0.1	0.1	1.7	1.3	26.6	0	3	1.6	4.8	2	0.7	1	3.5	0.1	2.2	0	1.8	2.2	3.2	17.8	20	2.3	0	2.1	3.6	0	2.8	9.7	3.5	2.4	21.5	25.2	2.7	1.9	5.2	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1	1	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1	0.5	0	0.3	2.2	0.2	0.3	0	0.4	0	0	1.2	3.5	0	0.5	3.3	0.1	0.6	0.3	0	0	1	0.1	0.3	0	0	125.2	4.1	1.6	1.7	11.1	3.7	0	0.3	1.1	3.3	0	0	1.9	0.3	0	0	23.2	0	0	0	1.2	1.9	0.3	0.2	2.9	0	0.1	Hepatocytes
RDH16	RODH-4, SDR9C8	ENSG00000139547	Retinol dehydrogenase 16 (all-trans)	O75452	12	56951431-56959374	Predicted membrane proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	59	liver: 114.6	Cell type enriched	Detected in some	12	Hepatocytes: 276.0	Cancer enriched	Detected in many	20	liver cancer: 44.0					Cell type enhanced	Detected in single		gdT-cell: 1.9	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HaCaT: 3.4;hTCEpi: 7.7;OE19: 1.8					Low region specificity	Detected in single			HPA038518	Enhanced											HPA038518: AB_10672713	unprognostic (5.42e-3)	unprognostic (4.20e-2)	unprognostic (2.99e-2)	unprognostic (1.14e-1)	unprognostic (1.88e-1)	unprognostic (2.92e-2)	prognostic favorable (2.16e-5)	unprognostic (8.83e-3)	unprognostic (1.04e-1)	unprognostic (2.84e-1)	unprognostic (6.85e-2)	unprognostic (6.10e-1)	unprognostic (7.99e-12)	unprognostic (2.24e-1)	unprognostic (1.29e-2)	unprognostic (1.62e-1)	unprognostic (2.01e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0.1	0	0	0	0	0	0	114.6	0	0	0		0	0	0	0	0		0.8	0		0	0.2	0	0.3	0	0	0	0.3	0	0			0		0.1	0	0.1	0.2	0	0	0.8	0	1.9	0.2	0	0	0	0	0.4	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	3.4	0.1	0.1	0.1	0	0	0.3	0	0.1	0	0.6	0.1	0	7.7	0	0.8	0	0	0.1	0.1	0.2	0	0.4	0	0.2	0	1.8	0	0	0.4	0.6	0	0	0	0	0.3	0.2	0.1	0.2	0.9	0	0	0	0	0	0	0.7	0.1	0.1	0	0	0	0	0	0	1.9	0	0.3	0.2	0.2	0.5	0	0	0.3	0.1	0	0	0.8	0	0	0.2											0	0	4.5	1	0	2.2	2	5.1	0	0	0	0	0.1	0	0	5.3	0.1	0	23.3	0.3	0	0.1	4.2	0	276	0.2	1.6	0	3.1	5.1	4.1	0	0.1	0	0	0	0.2	0.1	0	0	0	0.8	0	0	0.9	0.4	0.3	0	0	0	0.4	Hepatocytes
SERPINA10	PZI, ZPI	ENSG00000140093	Serpin family A member 10	Q9UK55	14	94280455-94293271	Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	223	liver: 169.5	Cell type enriched	Detected in some	9	Hepatocytes: 200.2	Cancer enriched	Detected in some	51	liver cancer: 40.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in many	8	Hep G2: 21.2	Not detected	Not detected							HPA048739			Approved	Nucleoplasm,Cytosol	Secreted to blood			3960000000	5900000000	Nucleoplasm	Cytosol	HPA048739: AB_2797237	unprognostic (7.14e-2)	unprognostic (2.03e-1)	unprognostic (2.69e-2)	unprognostic (2.01e-1)	unprognostic (1.21e-1)	unprognostic (1.45e-1)	prognostic favorable (9.00e-4)	unprognostic (6.11e-2)		unprognostic (2.81e-4)	unprognostic (2.31e-4)	unprognostic (2.77e-2)	unprognostic (2.91e-3)	unprognostic (1.38e-1)	unprognostic (1.58e-1)	unprognostic (1.11e-1)	unprognostic (7.93e-3)	0.1	0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0	0.6	0.3	2.1	0.8	0.8	0.8	0.5	0.6	0.6	1	0.9	2.6	0.6	2.3	0.4	0.4	0.2	0.3	2.4	0.6	1.5	0.9	1.5	2.1	0.7	21.2	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.2	1.1	1.1	0.6	1.4	1.1	0.3	1.4	1.1	0.9	0.2	0.6	1	1.1	0.9	0.6	0.7	1	0.9	0.5	0.5	0.2	1.2	1.5	0.9	0.6	0.8	0.4	0.7	0.6	1.2	0.5	1	1	1.9	0.5	0.7	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.2	0	0.1	0.5	0.1	0	0.2	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	1.9	0	0	0.2	0.4	2.5	0	0	0	13.7	0	0	0	0	0	0	23.3	0	0	0	0	0	200.2	0	0	6.3	4.3	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SLC25A47	C14orf68	ENSG00000140107	Solute carrier family 25 member 47	Q6Q0C1	14	100323337-100330378	Predicted membrane proteins, Transporters	Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	88	liver: 127.2	Cell type enriched	Detected in some	21	Hepatocytes: 185.9	Cancer enriched	Detected in single	273	liver cancer: 56.9	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.4	Lineage enhanced	Detected in single		granulocytes: 1.4	Cell line enhanced	Detected in some		Hep G2: 5.7;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0	Low region specificity	Detected in all			Not detected	Not detected																unprognostic (2.54e-3)	unprognostic (2.57e-3)	unprognostic (5.12e-2)	unprognostic (2.27e-2)	unprognostic (6.07e-2)	unprognostic (1.30e-2)	unprognostic (4.25e-2)	unprognostic (1.14e-1)	unprognostic (2.89e-2)	unprognostic (2.50e-1)	unprognostic (1.96e-3)	unprognostic (4.46e-1)	unprognostic (1.44e-1)	unprognostic (4.50e-1)	unprognostic (5.64e-2)	unprognostic (1.02e-2)	unprognostic (1.94e-1)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	127.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0.3	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0.2	0	0	0	0	0.1	0.2	0	0.1	0	0.2	0	0.1	0	5.7	0	1.4	0	0.1	0	0.1	0	0	0	0.1	0.1	0	0	0	0.1	0.4	0	0	0	0.1	1.4	0	0	0.1	2	0.2	0.6	0.2	0.2	0	0	0	0	0	0	0.2	0	0	0.1	0.5	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3.2	0	0	0	0.3	0	0	0	1.8	0	0.1	0	0	0.4	0	0	0	0.3	0	0	0	0	185.9	0	0	0	4.3	8.8	0.4	0	0	0	0	0.3	0	0.1	0	0	1.4	0	0	0	0.2	0.1	0	0.6	0	0	0	Hepatocytes
CYP1A2	CP12, P3-450	ENSG00000140505	Cytochrome P450 family 1 subfamily A member 2	P05177	15	74748844-74756202	Cancer-related genes, Enzymes, Predicted membrane proteins	Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Lyase, Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 143.0	Cell type enriched	Detected in some	18	Hepatocytes: 44.0	Group enriched	Detected in some	22	liver cancer: 25.3;urothelial cancer: 6.5	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		SK-BR-3: 6.0	Not detected	Not detected			Not detected	Not detected			CAB016531	Enhanced											CAB016531: AB_629359				unprognostic (1.54e-4)			unprognostic (1.29e-1)	unprognostic (1.98e-1)	unprognostic (1.74e-1)	unprognostic (1.59e-2)		unprognostic (1.76e-1)	unprognostic (1.17e-2)	unprognostic (5.48e-2)	unprognostic (2.33e-2)	unprognostic (7.41e-2)	unprognostic (2.53e-1)	0	0	0	0	0	0.1	0	0	0.1	0	0	0.1	1.1	0	0	0.1	0	0	0	0	0	0	0	143	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.5	0	0	0	0	1.7	1.1	4.5	1.2	1.1	0.7	0.3	1.1	0.9	2.7	2.1	0.2	0	1.6	0.7	0	0	0.2	0.6	1.3	2.2	0.5	0	1.8	1.2	0.1	0.2	0.1	0.5	1.2	2.8	1.6	0.8	0.1	1.9	1.1	0.4	0.3	0.1	0	0.7	0.2	3.9	1.9	4	0	0.8	2.5	1.3	1.7	0.9	0.6	2.6	2.4	0.9	0	2.2	2.2	1.1	2.1	6	0.4	2.3	1.6	1	0.4	1.1	1.4	1.1	1.2	1	0.7	1.6	1.1	2.4	1.2	3.2	1.2	1.2	0.6	0.6	0.5	0.8	0.7	0.5	0.4	1.7	0.7	0.7	4.5	1.1	0.8	1.1	0.4	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	44	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	Hepatocytes
SLC13A5	INDY, NACT	ENSG00000141485	Solute carrier family 13 member 5	Q86YT5	17	6684713-6713567	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport		Amelogenesis imperfecta, Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	65	liver: 150.4;salivary gland: 153.9	Cell type enriched	Detected in some	16	Hepatocytes: 374.3	Cancer enriched	Detected in some	15	liver cancer: 27.8	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	61	Hep G2: 35.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044343	Approved		Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA044343: AB_10961771	unprognostic (8.46e-3)	unprognostic (3.89e-2)	unprognostic (3.24e-2)	unprognostic (1.75e-2)	unprognostic (7.33e-2)	unprognostic (1.07e-1)	unprognostic (6.79e-2)	unprognostic (8.79e-3)	unprognostic (1.32e-1)	unprognostic (3.23e-1)	unprognostic (1.26e-3)	unprognostic (1.30e-3)	unprognostic (3.78e-11)	unprognostic (2.42e-2)	unprognostic (2.46e-1)	unprognostic (2.05e-2)	unprognostic (2.04e-1)	0.2	0.8	1	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0	0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	35.9	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0	0	0	7	0.6	0.5	0.2	0.6	7.6	0	0	0	0	0	0	0	0.1	0.6	0	23.3	0.4	0.1	0	0.3	0	374.3	0	0	0	15.4	21	0	0.6	0.3	0	0	0	7.4	9.8	0	0	0	1.4	0	0	0.9	1.5	0.4	0.1	0	0	0.2	Hepatocytes
ASGR1	CLEC4H1	ENSG00000141505	Asialoglycoprotein receptor 1	P07306	17	7173431-7179564	Predicted intracellular proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 171.0	Cell type enriched	Detected in many	5	Hepatocytes: 1020.7	Cancer enriched	Detected in many	90	liver cancer: 131.6	Low region specificity	Detected in some			Group enriched	Detected in many	5	classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7	Group enriched	Detected in many	13	dendritic cells: 13.7;monocytes: 39.1	Cell line enriched	Detected in some	30	Hep G2: 104.5	Region enriched	Detected in many	9	cerebellum: 49.4	Not detected	Not detected			HPA011954, HPA012852	Enhanced		Supported	Vesicles,Cell Junctions	Intracellular and membrane					Vesicles	Cell Junctions	HPA011954: AB_1845079, HPA012852: AB_1845080	unprognostic (3.56e-3)	unprognostic (3.57e-1)	unprognostic (8.76e-2)	unprognostic (4.05e-2)	unprognostic (1.88e-1)	unprognostic (1.22e-1)	unprognostic (1.86e-2)	unprognostic (5.37e-2)	unprognostic (2.15e-1)	unprognostic (2.39e-1)	unprognostic (8.55e-5)	unprognostic (1.55e-1)	unprognostic (8.33e-11)	unprognostic (1.45e-1)	unprognostic (2.00e-1)	unprognostic (1.73e-3)	unprognostic (4.46e-3)	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0	0.1	2	0.9	0	0	0.1	0.1	0.2	0.2	0.3	3.5	0.1	0	0.2	0	0.1	0	0	0	0.1	0	0.2	0.2	0.3	104.5	0	0.1	0.4	0.2	0	0.1	0	0.1	1.8	1.6	0.2	0.1	0.1	0	0.1	0.2	0.3	0	0.1	0.1	0.8	0	0	0.1	0.1	0.8	0.1	0	0.1	0.3	0.1	0	0.2	0.2	0.7	0.1	0.1	0	0	0.1	0.1	0.1	0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0	0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2	0	6.6	13	1	2.9	31.7	1.2	73.9	1.4	2.3	3.5	151.2	3.2	3.3	0.8	212.5	12.7	0.3	23.3	0.2	3.6	2	0.8	0	1020.7	41.3	14.3	15	23.9	110.6	80.2	2.3	18.3	0	0	0.7	2.6	0.4	0.6	1.1	1.6	39.8	0	0.4	4.5	7.8	4.3	10.4	0.7	1	2.4	Hepatocytes
NR1I3	CAR, CAR1, MB67	ENSG00000143257	Nuclear receptor subfamily 1 group I member 3	Q14994	1	161229666-161238302	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	18	liver: 63.1	Cell type enriched	Detected in many	4	Hepatocytes: 124.3	Cancer enriched	Detected in single	67	liver cancer: 17.6	Region enriched	Detected in single	6	basal ganglia: 1.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		CACO-2: 9.4	Not detected	Not detected			Low region specificity	Detected in single			HPA051365			Approved	Nucleoplasm						Nucleoplasm		HPA051365: AB_2616454	unprognostic (2.59e-3)	unprognostic (1.06e-2)	unprognostic (9.33e-2)	unprognostic (6.92e-4)	unprognostic (2.55e-1)	unprognostic (1.88e-2)	unprognostic (1.91e-2)	unprognostic (5.51e-2)	unprognostic (8.69e-2)	unprognostic (1.85e-1)	unprognostic (6.23e-2)	unprognostic (5.63e-3)	unprognostic (2.71e-1)	unprognostic (5.79e-2)	unprognostic (6.44e-2)	unprognostic (5.48e-3)	unprognostic (2.62e-2)	0.1	0	0.2	0.1	1.9	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.1	0.9	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	3.5	63.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.5	0.3	2.3	0.1	0.1	0.1	0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.2	0.7	0.3	0	0.6	0.3	0.3	0.9	1.1	0.6	0	0	0.9	0.4	0	0	0	9.4	0.3	1	0.6	0	0.3	0.6	0	0	0	1	0.9	0	0.2	2.2	0	1.7	1.7	0	0	0	0	0.6	0	0.9	1.2	0.4	0	0.8	0.3	0.6	1.7	1.8	1.3	0.9	0.8	0.6	0	1.8	2.3	1.4	0.3	2.9	0.4	1.4	2.1	1.2	2.2	0.7	0.7	1.5	0.2	1.5	2.2	1.3	0.5	2.9	0.5	0.7	0.2	0	0.6	0.3	0	0	0.1	0	0.2	0	0	0.4	0	0	0	0.2	0	0.3	0.2	1.9	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	20.8	16	2.2	1.1	0.6	0.7	0.3	2.5	8.1	9.1	3.5	0	0.1	3.3	0.1	1.7	0.3	0	0	0	0.1	0.4	0.4	12.7	124.3	0.3	0	0	3.1	5.3	1.2	0.3	0.6	0	0	0	0.3	0.1	0	0.4	28.7	1.7	0	0.4	0.2	0	0	0	0.5	0	0.8	Hepatocytes
F13B	FXIIIB	ENSG00000143278	Coagulation factor XIII B chain	P05160	1	197039191-197067267	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	95	liver: 76.3	Cell type enriched	Detected in some	19	Hepatocytes: 49.0	Cancer enriched	Detected in single	816	liver cancer: 46.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 1.8;Hep G2: 2.3	Not detected	Not detected			Low region specificity	Detected in all			HPA003827, HPA052139	Supported				Secreted to blood				3400000000			HPA003827: AB_1078794, HPA052139: AB_2681744					unprognostic (1.46e-1)		prognostic favorable (6.78e-5)							unprognostic (1.21e-2)				0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	0	0	0	0.2	0	0	0	0	76.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0.1	0	0	0	0.2	0	0	0	0	0	0	0.3	0	0	0	0.1	0.1	0	0	0	0	0	0.3	2.3	0	0.5	0.1	0	0.1	0	0	0	0	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.5	0	0.1	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	49	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Hepatocytes
ABCG8	GBD4	ENSG00000143921	ATP binding cassette subfamily G member 8	Q9H221	2	43831942-43882987	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	30	intestine: 62.4;liver: 64.4	Cell type enriched	Detected in some	5	Hepatocytes: 24.1	Cancer enriched	Detected in some	30	liver cancer: 21.6	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	47	Hep G2: 14.7	Not detected	Not detected			Low region specificity	Detected in all			HPA019556	Uncertain		Approved	Vesicles						Vesicles		HPA019556: AB_1844444	unprognostic (1.99e-1)	unprognostic (4.49e-1)	unprognostic (3.22e-1)	unprognostic (1.37e-1)	unprognostic (3.09e-2)	unprognostic (2.43e-1)	unprognostic (1.99e-3)	unprognostic (1.27e-1)	unprognostic (6.28e-1)	unprognostic (6.14e-3)	unprognostic (4.69e-1)	unprognostic (1.76e-1)	unprognostic (2.68e-1)	unprognostic (7.86e-3)	unprognostic (5.03e-1)		unprognostic (1.50e-1)	0.1	0.1	0.2	0	0.3	0	0.1	0.1	0.4	0.1	21.2	0	0	24	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0	0.2	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	62.4	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0	0.1	0	0.1	0	0	0.2	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0	0	0.1	0.1	0.1	0.2	14.7	0	0.1	0.3	0	0	0	0	0	0	0.1	0.1	0.2	0	0.1	0.1	0.2	0.1	0	0	0	0.1	0.1	0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0	0.1	0.1	0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0	0	0	0	0	0	0	0	0	0.2	5.1	0	1.2	1.8	0	0	1.7	0	0	0	0	0	0	0	0	0	0	24.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
AHSG	A2HS, FETUA, HSGA	ENSG00000145192	Alpha 2-HS glycoprotein	P02765	3	186612923-186621318	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Mineral balance		Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	269	liver: 402.0	Cell type enriched	Detected in some	21	Hepatocytes: 986.2	Cancer enriched	Detected in some	284	liver cancer: 1231.6	Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 1.4	Lineage enhanced	Detected in single		NK-cells: 1.4	Cell line enriched	Detected in some	77	Hep G2: 215.4	Not detected	Not detected			Not detected	Not detected			HPA001524, HPA001525, CAB026209	Enhanced		Enhanced	Golgi apparatus	Secreted to blood			864000000000	140000000000	Golgi apparatus		CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849		unprognostic (6.40e-2)	unprognostic (1.31e-1)	unprognostic (2.03e-2)	unprognostic (3.20e-2)	unprognostic (1.07e-2)	unprognostic (1.16e-2)	unprognostic (7.47e-3)	unprognostic (3.05e-1)	unprognostic (5.27e-2)	unprognostic (8.64e-2)		unprognostic (3.99e-7)	unprognostic (5.21e-2)	unprognostic (5.21e-2)	unprognostic (1.04e-1)		0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	402	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	1.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	215.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	7.2	0	0	0	0.2	10.2	0	0	0	0	0.1	3.3	0.1	4.6	0	0	46.7	0.5	0.6	0	0	0	986.2	1.2	0	0	29.4	29.9	16.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	1.6	0	0	0.1	Hepatocytes
IGFBP1	AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12	ENSG00000146678	Insulin like growth factor binding protein 1	P08833	7	45888357-45893668	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins		Growth factor binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	liver: 157.6;placenta: 292.3	Cell type enriched	Detected in some	23	Hepatocytes: 863.0	Cancer enriched	Detected in many	29	liver cancer: 385.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0	Not detected	Not detected			Not detected	Not detected			CAB004445, HPA046972, HPA050640	Enhanced		Approved	Golgi apparatus	Secreted to blood			28100000	22000000	Golgi apparatus		CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197	unprognostic (8.66e-3)	unprognostic (1.45e-1)	unprognostic (9.41e-2)	unprognostic (7.80e-2)	unprognostic (7.04e-2)	unprognostic (2.93e-1)	unprognostic (1.01e-1)	prognostic unfavorable (1.03e-4)	unprognostic (1.89e-2)	unprognostic (2.09e-3)	unprognostic (8.95e-2)		prognostic unfavorable (6.90e-11)	prognostic unfavorable (6.64e-4)	unprognostic (7.20e-2)	unprognostic (7.98e-2)	unprognostic (3.43e-1)	0.4	0	0.1	0.1	0.1	0	0.2	0	0.1	0	0.1	0	0.1	0	10.7	0	0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0	0.1	0	9.3	0	0	0.2	292.3	0.2	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0.1	0	0	0	0	0	1.9	0.1	0.5	0	0.5	0.1	0	0	0.2	0	0	0.1	0.1	18	0.1	0.3	0	0	0.2	3.9	0	0.2	0.1	0	0	0	0.4	0	0	0	0	0	0.9	0	0.1	0	0.7	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0	29.5	0	0	0	0	51	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0	0.3	0	0	0	0	0.8	38.2	0	1.2	0	0	0.7	0	6.7	0.1	0	0	23.3	0	2	1	0	0	863	1.6	0	3.4	9.2	11.5	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0.2	0	2.9	0	0	0	Hepatocytes
RIPPLY1		ENSG00000147223	Ripply transcriptional repressor 1	Q0D2K3	X	106900063-106903335	Predicted intracellular proteins	Transcription, Transcription regulation	Developmental protein, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		kidney: 6.4;liver: 11.5	Cell type enriched	Detected in single	4	Hepatocytes: 2.9	Group enriched	Detected in some	6	liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	RH-30: 12.3					Low region specificity	Detected in many			HPA052284	Uncertain				Intracellular and membrane							HPA052284: AB_2681785	unprognostic (1.48e-1)	unprognostic (4.35e-2)	unprognostic (1.67e-1)	unprognostic (9.52e-3)	unprognostic (7.00e-3)	unprognostic (1.13e-2)	unprognostic (1.66e-3)	unprognostic (1.50e-1)	unprognostic (2.42e-1)	unprognostic (5.37e-2)	unprognostic (2.53e-1)	unprognostic (1.36e-1)	unprognostic (2.49e-3)	unprognostic (1.97e-1)	unprognostic (1.97e-1)	unprognostic (1.97e-3)	unprognostic (1.31e-1)	0.2	0.9	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0	6.4	11.5	0.2	0.2	0.2	0.2	0.2	0.4	0	0.2	0.2	0.2	0.2	0	2.4	0.2	1.8	0.4	0	0.2	0.2	0.2	0.2	0	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0	1.4	0	0	0	0	0	0.1	0	0.5	0	0	0	0	0	0	0.1	0	0	0.3	0	0	12.3	0	0.3	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
SAA4	C-SAA, CSAA	ENSG00000148965	Serum amyloid A4, constitutive	P35542	11	18231349-18236893	Plasma proteins, Predicted secreted proteins	Acute phase			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	132	liver: 263.3	Cell type enriched	Detected in some	47	Hepatocytes: 1790.2	Cancer enriched	Detected in many	141	liver cancer: 118.6	Not detected	Not detected			Cell type enriched	Detected in single	20	memory B-cell: 1.9	Lineage enriched	Detected in single	20	B-cells: 1.9	Cell line enriched	Detected in some	18	Hep G2: 22.6	Not detected	Not detected			Not detected	Not detected			CAB026061, HPA060139	Supported				Secreted to blood			65000000000	72000000000			CAB026061: , HPA060139: AB_2684210	unprognostic (4.70e-4)	unprognostic (1.17e-1)	unprognostic (1.17e-1)	unprognostic (4.83e-1)	unprognostic (4.15e-2)	unprognostic (6.05e-2)	unprognostic (3.63e-3)	unprognostic (5.94e-2)		unprognostic (2.40e-2)	unprognostic (1.41e-1)	unprognostic (7.35e-2)	unprognostic (2.54e-8)	unprognostic (2.49e-1)			unprognostic (6.46e-2)	0.7	0	0.1	0.1	0.1	0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	263.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	1.2	0.1	0.3	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0	0	0	0	0	0	1.2	0	0	0	0	0	0.1	0	0	0	0	0	0.5	0	0.6	0	0.2	0.7	0	0.1	0	0	0	0.2	0	22.6	0.2	0.1	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	14.7	0	0	0	0	25.5	0	4.5	0	0	0	0	3.5	0.4	0	0	23.3	1.1	0	0	0.1	0	1790.2	0.1	0	0	32.5	38.1	0.7	0	0	1.7	0	0	0	2.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	Hepatocytes
MAT1A	MAT, MATA1, SAMS, SAMS1	ENSG00000151224	Methionine adenosyltransferase 1A	Q00266	10	80271820-80289684	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	One-carbon metabolism	Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	liver: 178.8	Cell type enriched	Detected in many	51	Hepatocytes: 4835.7	Cancer enriched	Detected in many	54	liver cancer: 209.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	Hep G2: 45.9	Not detected	Not detected			Not detected	Not detected			HPA048627	Supported								530000			HPA048627: AB_2680465	unprognostic (6.92e-2)	unprognostic (2.63e-1)	unprognostic (2.88e-2)	unprognostic (9.43e-2)	unprognostic (3.79e-2)	unprognostic (2.49e-2)	unprognostic (2.03e-3)	unprognostic (1.46e-1)	unprognostic (1.09e-1)	unprognostic (2.58e-2)	unprognostic (1.76e-1)	unprognostic (8.66e-2)	unprognostic (1.11e-16)	unprognostic (8.59e-3)	unprognostic (9.90e-2)	unprognostic (3.58e-1)	unprognostic (5.98e-2)	0	0.1	0	0	0.1	0	0	0.1	0	0	0	0	1.2	0	0	12.5	0.1	0.2	0.2	0.1	0	0	0.3	178.8	0.1	0.1	0.1	0	0.7	9.9	0	0.6	0	0.2	0	0	0.3	0	0.2	0	0.7	0	0	0.4	0.2	0	0.6	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0.1	0.1	0	1.6	0	0	0	0	0.1	0.2	0.7	0	45.9	0	0.2	0	0	0	0	0	0.1	0	1	0.1	0	0	0	0.1	0	0	0	0	0.1	0.5	0.1	0	0.2	0	0	0.1	0	0.6	0	0	0	0	0	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0.2	0	0	0.3	14	0	1.8	0	0.5	76.5	8.1	1.2	1.8	0	0	1.7	0	22.5	0	0	46.7	3.8	0	0	0	0	4835.7	0.1	0	0	88.4	94.8	4.2	0.3	0	0	0	0	0	3.9	0	0.4	0	0	0	0	2.4	0.1	2.4	0	0	0	0	Hepatocytes
THRSP	Lpgp, LPGP1, S14, SPOT14, THRP	ENSG00000151365	Thyroid hormone responsive	Q92748	11	78063861-78068351	Predicted intracellular proteins	Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6	Cell type enriched	Detected in some	8	Hepatocytes: 65.3	Cancer enhanced	Detected in many		liver cancer: 44.1	Region enriched	Detected in single	10	cerebellum: 1.0	Cell type enhanced	Detected in some		NK-cell: 1.5	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	13	ASC diff: 42.5	Low region specificity	Detected in all							HPA040642	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA040642: AB_10794878	unprognostic (1.19e-1)	unprognostic (2.88e-1)	unprognostic (2.84e-1)	unprognostic (2.73e-2)	unprognostic (3.07e-1)	unprognostic (9.91e-3)	unprognostic (1.59e-2)	unprognostic (9.60e-2)	unprognostic (1.07e-2)	unprognostic (8.23e-2)	unprognostic (1.68e-1)	unprognostic (2.58e-1)	prognostic unfavorable (1.16e-4)	unprognostic (9.64e-2)	unprognostic (1.57e-1)	prognostic favorable (3.28e-4)	unprognostic (1.69e-3)	62	1.6	0	18.3	0	0	22.7	1	0	0	12.2	0	2.8	0	0.1	1.2	0.1	0.3	16.5	11.7	0	0	2.1	92.5	0	2.9	0.1	0	0	1.1	0.3	0	0	0.1	0	0.1	0.2	45.6	2	9.3	7.2	1.3	0.2	0.1	0	0.1	0	0	0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0	0.2	1.5	1	0	0	0	0	0	42.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	3.2	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.4	0.1	0.5	0.1	0.5	0.2	1	0	1.5	0.2	0	0	0	0	0	1	0	0	0	0.1	0	0.1	0	0	0	0.5	0	0.1	2	0	0	0	0	0	0	0	8.3	0	0	0	0	0	0	0	0	0.1	0	65.3	0	0	0	0.6	3.1	0	0	0	0	0	0.1	0.5	0	0	0	0.4	0.6	0	0	0	0.1	0	0	0	0	0	Hepatocytes
ITIH2	H2P	ENSG00000151655	Inter-alpha-trypsin inhibitor heavy chain 2	P19823	10	7703269-7749520	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	202	liver: 249.0	Cell type enriched	Detected in some	5	Hepatocytes: 455.1	Cancer enriched	Detected in many	279	liver cancer: 626.9	Low region specificity	Detected in single			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	445	Hep G2: 155.6	Low region specificity	Detected in many			Not detected	Not detected			HPA059150	Supported		Approved	Golgi apparatus	Secreted to blood				22000000000	Golgi apparatus		HPA059150: AB_2683930	unprognostic (4.82e-2)	unprognostic (6.10e-2)	unprognostic (2.48e-2)	unprognostic (1.21e-2)	unprognostic (2.01e-2)	unprognostic (2.55e-3)	prognostic favorable (1.48e-4)	unprognostic (1.37e-1)	unprognostic (1.79e-1)	unprognostic (1.47e-2)	unprognostic (2.28e-1)	unprognostic (2.02e-1)	unprognostic (2.10e-8)	unprognostic (9.91e-3)	unprognostic (1.70e-1)	unprognostic (2.35e-1)	unprognostic (4.46e-4)	0	0	0.1	0	0.6	0	0.3	0.1	0.4	0	0	0.5	0	0	0	0	0	0	0	0	0.4	0.3	0.2	249	0.1	0	0.5	0.5	0	0	0	0.3	0	1.1	0	0	0.2	0	0	0	0	0	0	0.8	0.1	0	0.2	0.1	0	0	0	0	0	0	0.5	1.2	0.4	0.3	0.8	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	155.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1	0	2.1	0	0	0	0	0.3	94.3	0	0	0	0	0	0	1.1	3.9	0	0	0	0.2	0	0	0	0	455.1	0.1	0	0	11.1	9.2	0.7	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
TDO2	TDO, TPH2	ENSG00000151790	Tryptophan 2,3-dioxygenase	P48775	4	155854738-155920406	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Tryptophan catabolism	Dioxygenase, Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	32	liver: 187.9	Cell type enriched	Detected in some	8	Hepatocytes: 1048.1	Cancer enriched	Detected in many	18	liver cancer: 35.7	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8	Group enriched	Detected in some	9	cerebellum: 7.0;hippocampal formation: 5.9	Not detected	Not detected			HPA039611	Uncertain		Uncertain	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA039611: 	unprognostic (1.10e-1)	unprognostic (3.00e-3)	unprognostic (3.84e-2)	unprognostic (1.95e-1)	unprognostic (7.06e-2)	unprognostic (3.50e-1)	unprognostic (1.18e-1)	unprognostic (1.03e-1)	unprognostic (1.00e-1)	unprognostic (2.13e-2)	unprognostic (1.42e-1)	unprognostic (1.01e-1)	unprognostic (4.68e-8)	unprognostic (7.99e-2)	unprognostic (9.29e-3)	unprognostic (1.28e-1)	unprognostic (1.95e-2)	0.2	0.5	0.2	2.5	0.5	0	0.1	0.1	2	0.1	0.2	0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0	5.8	0.1	0.1	0.1	0.2	0	0.1	0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0	0	0.1	0	0.4	1.2	0.1	0	0	0.2	0.1	0	0.2	0	0	1.8	0	0	0.1	0	0	0	1.5	0	0	0.1	0	0	8.6	0	0.2	0	0.1	0	0	16.7	0	0.1	0	0	0.3	0.2	0	0.9	0	0	0	0.8	0	0	0.1	2.9	0.3	0	0	0	0.8	0	0	0	0.1	1.3	0	0.3	0	0	0	0.4	0	0	0	0.1	0	1.1	0.4	0.4	0	2.7	0	0	9.8	0.1	0	0	0.1	0	0.2	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.5	0.1	2	1.5	0.2	0.2	0.7	0.1	0	0	0	7	0	0	0	0.4	132.5	0	0	0	0	0.1	0	0.4	0.4	0	0	23.3	0	0	0.1	0.3	0	1048.1	0.9	0	0	25.2	23.8	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0.8	0.2	0.2	0	0.2	0	0	0	Hepatocytes
KDM8	FLJ13798, JMJD5	ENSG00000155666	Lysine demethylase 8	Q8N371	16	27203495-27221768	Enzymes, Predicted intracellular proteins	Biological rhythms, Cell cycle, Transcription, Transcription regulation	Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		liver: 44.9	Cell type enriched	Detected in many	5	Hepatocytes: 46.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA026545: AB_1852015	unprognostic (1.39e-1)	unprognostic (1.37e-3)	unprognostic (2.80e-1)	unprognostic (2.16e-2)	unprognostic (3.21e-1)	unprognostic (1.22e-2)	unprognostic (2.41e-3)	unprognostic (1.33e-2)	unprognostic (7.95e-2)	unprognostic (3.41e-1)	prognostic favorable (1.75e-4)	unprognostic (1.22e-1)	unprognostic (2.75e-2)	unprognostic (5.33e-2)	unprognostic (2.71e-1)	unprognostic (2.04e-1)	unprognostic (3.92e-3)	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12	3.1	2.2	2.1	2.5	2.5	2	2.7	3.2	2.3	44.9	2	3.3	2.3	5.1	3	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.4	3.3	1.6	1.9	3.4	2.1	2.4	4.8	4.3	3.1	2.9	9.6	3.7	3.5	2.4	1.9	3.7	3.2	2.8	11	5.5	6.1	4.1	7.3	3.4	4.3	7.3	2.5	2.6	3.2	2.1	2.8	3.7	4.6	7.7	5.9	2.9	2.8	4.3	7.7	11.1	1.3	2.2	6.3	3.9	8.6	1.8	1.9	6	3.8	0.9	3	2.3	2.2	3.2	5.7	4.1	5.7	3	2.1	2.2	3.7	3.8	7.7	2.3	4	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6	3	5.6	6	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2	0	1.7	0.5	0.2	0.2	1	1	0	9.4	2.3	0	2	1.3	3.3	0.9	0.4	1	1.6	0	0.6	0.4	0.8	0.4	0	46	1.6	0	5.2	1.3	1.3	0	0.3	1.2	0	1	1.3	1.6	0.7	0	1.1	1.2	2.5	0	0.8	0.9	2.5	0	1.1	0.5	1.1	0.1	Hepatocytes
UGT2B4	UGT2B11	ENSG00000156096	UDP glucuronosyltransferase family 2 member B4	P06133	4	69480165-69526014	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	105	liver: 175.1	Cell type enriched	Detected in some	12	Hepatocytes: 831.9	Cancer enriched	Detected in some	96	liver cancer: 351.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	RH-30: 10.4									CAB033260, HPA045108	Enhanced				Intracellular and membrane							CAB033260: AB_2241496, HPA045108: AB_2679218	unprognostic (7.46e-2)						unprognostic (1.50e-1)	unprognostic (9.37e-2)			unprognostic (1.51e-1)	unprognostic (2.47e-2)	unprognostic (1.47e-1)	unprognostic (9.43e-3)	unprognostic (3.52e-1)			0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	1.6	0	0	0.1	175.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0.1	0	0	0	0	0	0.3	0	0.7	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	10.4	0.1	0.3	0	0	0	0.5	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	34.2	15.3	0	0	0	0	0	0	0	0	0	0	70	0	0	0	0	0	831.9	0.1	0	0	14.7	12.7	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Hepatocytes
C8A		ENSG00000157131	Complement C8 alpha chain	P07357	1	56854806-56918221	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	305	liver: 210.3	Cell type enriched	Detected in some	11	Hepatocytes: 254.8	Cancer enriched	Detected in single	279	liver cancer: 85.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	Hep G2: 5.5	Low region specificity	Detected in single			Not detected	Not detected								Secreted to blood				3400000000										unprognostic (3.73e-3)	unprognostic (2.44e-1)			unprognostic (1.28e-1)			unprognostic (6.40e-2)		unprognostic (9.82e-2)		0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0.6	0	0	0	0	210.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0.3	0	0	0	0	0	0.1	0	5.5	0	1.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0	0	0	1.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	5.1	0	0	0	0	0	0	0.1	0	0	0	23.3	4.3	0	0	0	0	254.8	0	0	0	6.2	6	0	0	0	0	0	0	0	1.8	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Hepatocytes
PFKFB1	PFRX	ENSG00000158571	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1	P16118	X	54932961-54998534	Enzymes, Predicted intracellular proteins		Hydrolase, Kinase, Multifunctional enzyme, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3	Cell type enriched	Detected in some	10	Hepatocytes: 15.5	Cancer enriched	Detected in some	11	liver cancer: 7.9	Not detected	Not detected			Cell type enhanced	Detected in some		MAIT T-cell: 2.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	4	ASC diff: 13.9;Hep G2: 5.5	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (2.51e-1)	unprognostic (2.39e-2)	unprognostic (1.17e-2)	unprognostic (4.38e-3)	unprognostic (1.64e-1)	unprognostic (6.12e-2)	unprognostic (1.18e-3)	unprognostic (1.51e-1)	unprognostic (2.50e-1)	unprognostic (3.33e-1)	unprognostic (3.26e-3)	unprognostic (2.88e-1)	unprognostic (5.36e-3)	unprognostic (5.06e-1)	unprognostic (4.87e-2)	unprognostic (1.16e-4)	unprognostic (1.96e-3)	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0	0.1	0.2	0.5	0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2	1.5	0.1	0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.9	0.3	1	0	0.1	0.2	0	0.9	0.2	0.6	0.3	0.1	0.6	0.5	0.1	0.3	0.5	0.4	1.1	0.4	0.1	5.5	0	0.1	0.6	0.2	0.6	0.1	0.4	0	0	1.3	0.1	2.2	0.2	0.7	0.6	0.3	0.4	0.4	0.3	0.5	0.2	0.2	0	0.4	0.4	0.3	0.5	1.6	0.2	1.2	0.4	0	0.2	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0	0	0	0.2	0.7	2.1	1.5	0.2	0	0	0.8	0	0.8	0	1.3	0.1	0.1	0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	15.5	0.1	0	0	0.6	1.6	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0.2	0	0.1	0	0	0	Hepatocytes
APOA2		ENSG00000158874	Apolipoprotein A2	P02652	1	161222292-161223631	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Host-virus interaction, Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	321	liver: 932.2	Cell type enriched	Detected in some	61	Hepatocytes: 43650.4	Cancer enriched	Detected in many	329	liver cancer: 11230.1	Not detected	Not detected			Cell type enhanced	Detected in some		intermediate monocyte: 2.1;neutrophil: 2.9	Group enriched	Detected in many	20	dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1	Cell line enriched	Detected in some	9	Hep G2: 610.7	Low region specificity	Detected in all			Not detected	Not detected			CAB025885, HPA072575	Supported				Secreted to blood			115000000000	210000000000			CAB025885: , HPA072575: 		unprognostic (2.05e-1)	unprognostic (4.70e-2)	unprognostic (1.12e-1)	unprognostic (2.99e-1)		unprognostic (9.82e-2)	unprognostic (1.92e-1)	unprognostic (3.16e-1)	unprognostic (2.79e-1)	unprognostic (1.57e-2)		unprognostic (4.40e-3)	unprognostic (3.16e-2)	unprognostic (2.22e-1)	unprognostic (1.60e-1)	unprognostic (6.09e-2)	0.1	0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	1	2.9	2.1	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	67.2	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0.3	610.7	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0.4	0	0	0.2	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.2	0	0.2	0	0	1.1	0	0	2.1	0	0	0	0	1	0	0	0	2.9	0	0.8	0.7	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	153.8	0	0	0	0	647.1	0	0	0	0	0.5	1.7	0	1.2	0	0	186.9	0.5	1.1	0	0	0	43650.4	4.6	0	0	550	711.3	5.3	0	0	0	0	0	0	0.8	0	0	1.4	0	0	0	0.6	0.5	0	4.7	0	0	0	Hepatocytes
UROC1	FLJ31300, HMFN0320	ENSG00000159650	Urocanate hydratase 1	Q96N76	3	126481281-126517773	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Histidine metabolism	Lyase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	32	liver: 50.7	Cell type enriched	Detected in some	17	Hepatocytes: 31.8	Cancer enriched	Detected in single	100	liver cancer: 12.1	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.5	Lineage enhanced	Detected in single		granulocytes: 1.5	Cell line enriched	Detected in some	8	NB-4: 9.5	Not detected	Not detected			Low region specificity	Detected in all			HPA069863	Enhanced								510000			HPA069863: AB_2732143	unprognostic (1.28e-1)	unprognostic (2.74e-2)	unprognostic (1.08e-1)	unprognostic (7.43e-2)	unprognostic (6.43e-2)	unprognostic (1.43e-1)	unprognostic (2.23e-3)	unprognostic (2.95e-1)	unprognostic (2.57e-2)	unprognostic (7.71e-2)	unprognostic (9.97e-2)	unprognostic (3.04e-1)	unprognostic (3.65e-5)	unprognostic (3.97e-2)	unprognostic (2.66e-1)		unprognostic (5.52e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	50.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	1.1	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	9.5	0	0	0	0.1	0	0.4	0	0	0.5	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	31.8	0.3	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
LRRC3	C21orf102	ENSG00000160233	Leucine rich repeat containing 3	Q9BY71	21	44455486-44462196	Plasma proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 35.3;liver: 19.1	Cell type enriched	Detected in many	5	Hepatocytes: 26.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 11.2;U-2 OS: 8.4	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA017975	Uncertain											HPA017975: AB_1853307	unprognostic (1.36e-2)	unprognostic (5.48e-3)	unprognostic (1.49e-2)	unprognostic (2.10e-4)	unprognostic (1.55e-1)	unprognostic (1.74e-2)	unprognostic (7.20e-3)	unprognostic (2.59e-1)	unprognostic (4.61e-1)	unprognostic (7.43e-2)	unprognostic (1.37e-1)	unprognostic (1.38e-2)	unprognostic (1.74e-5)	unprognostic (6.44e-2)	unprognostic (2.01e-1)	unprognostic (7.51e-2)	unprognostic (6.66e-3)	3.7	2.7	1.1	2.5	1.6	1	3.9	0.3	1	4.5	7.6	1.1	2.5	3.1	2.1	3.3	3.7	1.9	35.3	2.8	1.2	1.4	1.1	19.1	3.8	3.7	0.5	0.2	5.7	2.3	0.1	2	1.8	0.9	4.1	1.6	2.1	2.6	1.3	1	3.3	3	5.2	0.8	1.9	5.4	5.4	0	2.2	1	2.2	1.6	4.5	5.8	0.9	0.5	2.1	0.8	0.5	1.1	0.1	0.7	0.5	4.5	3.7	0	0	11.2	1.9	0	0.2	0	1.7	1.5	0	3.4	0.9	2.5	0.2	2.1	0	0.1	0.3	4.9	0	0.5	5	0.8	0	2.9	1.4	1.8	0	0	0	1.8	0.7	0.4	5.7	0	1.6	0.7	0.2	1.2	5.5	1.8	2.4	0	1.8	0.1	0.2	3.7	4.1	1.7	0.3	0.7	2.6	1.1	2.3	3.5	0	8.4	0	0	3.2	6.2	0	0	2	0.6	1.8	0.8	0.2	0.3	0.7	1.1	0.6	0.5	0.2	0.3	0.9	0.4	0.4	2.1	0.5	0.6	0.5	0.2	0.1	1.1	1.6	0.3	1	1.2	1.4	0.5	0.2	0.9	0	0	1	1.4	0.5	0.6	0.7	1.5	2.5	0	0	1.8	0	0.2	0	0.4	0.2	0.2	1.3	0	0.3	4.7	1.3	1.1	1.1	26.8	2.2	0	4.1	0	2.1	1.4	0.6	1.1	0	5.4	2.2	1.5	1.2	0	0.7	0	0	0	1	0.5	1.3	0.5	0.2	0	1.5	0.7	Hepatocytes
CYP3A4	CYP3A3	ENSG00000160868	Cytochrome P450 family 3 subfamily A member 4	P08684	7	99756960-99784265	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	45	intestine: 145.3;liver: 464.6	Cell type enriched	Detected in some	45	Hepatocytes: 2276.5	Cancer enriched	Detected in some	240	liver cancer: 351.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0									CAB033671, HPA072245, HPA075539	Enhanced		Approved	Vesicles,Cytosol						Cytosol	Vesicles	CAB033671: AB_782375, HPA072245: , HPA075539: 	unprognostic (4.55e-2)	unprognostic (8.95e-2)	unprognostic (8.08e-2)	unprognostic (1.63e-1)	unprognostic (5.89e-2)	unprognostic (5.37e-2)	unprognostic (7.07e-3)	unprognostic (9.09e-2)	unprognostic (8.27e-3)	unprognostic (4.92e-2)	unprognostic (3.78e-2)	unprognostic (6.42e-2)	unprognostic (1.89e-8)	unprognostic (2.59e-1)	unprognostic (1.75e-2)	unprognostic (9.79e-2)	unprognostic (6.82e-2)	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0	0.1	0	0	0	0	4.2	0	0	0	0	0	0	1	0	0	0	0.3	0	0	0	0	0	1.4	0.1	0.2	0	1.9	0.4	0	1.2	0	0.4	0	0	0.1	0.5	0	0.5	0	0.1	4.5	0.3	0	0	0	2.2	6.7	0	0.5	2.6	5	0.5	0	0	0	0.1	0	0.8	0	0	1.4	0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0	0	0	0	0	0.1	0	0	0.4	0.1	0.2	0.6	0.6	0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	4.3	1	0.3	0	0.3	40.8	0	0	0	0	0.1	0	0.1	0.3	0	2.6	46.7	0.8	0	0	0.5	0	2276.5	0	0	0	39.3	50.2	0	0	0	0	0	0.7	0	0.1	0.3	0	1.4	0	0	0	0	0	0.6	0.1	0	0.4	0.9	Hepatocytes
PGLYRP2	PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like	ENSG00000161031	Peptidoglycan recognition protein 2	Q96PD5	19	15468645-15498956	Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 95.8	Cell type enriched	Detected in some	16	Hepatocytes: 136.1	Cancer enriched	Detected in some	16	liver cancer: 42.9	Not detected	Not detected			Low cell type specificity	Detected in many			Group enriched	Detected in many	7	granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7	Group enriched	Detected in some	6	MCF7: 10.9;T-47d: 10.9	Not detected	Not detected			Not detected	Not detected			CAB033468, HPA046311, HPA075237	Supported		Approved	Cell Junctions	Secreted to blood				160000000000	Cell Junctions		CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739	unprognostic (7.39e-3)	unprognostic (1.52e-2)	unprognostic (5.22e-2)	unprognostic (8.79e-2)	unprognostic (3.97e-1)	unprognostic (4.88e-4)	unprognostic (5.93e-3)	unprognostic (6.48e-2)	unprognostic (1.99e-1)	unprognostic (1.18e-2)	unprognostic (3.15e-2)	unprognostic (2.40e-1)	unprognostic (6.66e-16)	unprognostic (6.35e-3)	unprognostic (2.80e-1)	unprognostic (2.45e-2)	unprognostic (2.81e-4)	0	0	0	0	0	0	0.5	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	95.8	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	1.7	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	10.9	0	0	0.1	0	0	0	0.5	0.1	0	0.7	0	0	0.2	0	0	0	10.9	0	0.1	0	0	0	0	0	0	0.2	0	0.4	0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0	3.6	3.7	2.5	0.6	7.1	0	0.1	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0.2	0	0	0.2	2.5	0	0	0	0	0	0	0	2	0	0	0	0	0.1	0	0.3	0	136.1	0.3	0	0	3.1	1.3	2.5	0.3	0	8.5	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0	2.9	0	0	Hepatocytes
ASGR2	CLEC4H2	ENSG00000161944	Asialoglycoprotein receptor 2	P07307	17	7101322-7115700	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 154.1	Cell type enriched	Detected in some	4	Hepatocytes: 660.0	Cancer enriched	Detected in many	66	liver cancer: 214.2	Not detected	Not detected			Group enriched	Detected in some	8	classical monocyte: 36.9;myeloid DC: 21.7	Group enriched	Detected in many	52	dendritic cells: 21.7;monocytes: 36.9	Cell line enriched	Detected in some	8	Hep G2: 107.9	Not detected	Not detected			Not detected	Not detected			HPA014899, HPA015998	Enhanced		Supported	Endoplasmic reticulum,Plasma membrane					4700000	Endoplasmic reticulum, Plasma membrane		HPA014899: AB_1845085, HPA015998: AB_1845084	unprognostic (6.76e-2)	unprognostic (7.45e-7)	unprognostic (1.61e-1)	unprognostic (2.55e-2)	unprognostic (1.03e-2)	unprognostic (4.99e-2)	unprognostic (1.16e-3)	unprognostic (1.32e-1)	unprognostic (1.81e-1)	unprognostic (9.74e-2)	unprognostic (1.63e-1)	unprognostic (1.66e-1)	unprognostic (9.35e-4)	unprognostic (1.54e-3)	unprognostic (6.95e-2)	unprognostic (1.86e-1)	unprognostic (7.31e-2)	0.2	0	0.3	1.4	0.1	1	0.1	0.1	0.2	0.1	0.1	0	0	0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0	0	0	0.1	0.2	0	0	0.1	0.1	0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0	21.7	0.5	36.9	0	0.1	9.5	0	0	0	0	0	0	0	0	0	0	0	12.9	0	0	0	0	0	0	0	0	0	0	0	0	0	107.9	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.2	0	0.3	36.9	0.2	0	3.8	0	0	0	0	21.7	0	0	0	0.5	0	0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0	0.1	0.1	0.2	0.1	0	9	14	0	0	0	0	152.8	0	0	0	0	0.1	1.7	0	0.3	0	0	23.3	0	0.1	0	0.1	2.3	660	6.9	0	6.8	16	35.5	0.4	0	9.9	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0.3	0.3	1.5	0	0	Hepatocytes
ITIH3	H3P	ENSG00000162267	Inter-alpha-trypsin inhibitor heavy chain 3	Q06033	3	52794768-52809009	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	233	liver: 326.9	Cell type enriched	Detected in some	10	Hepatocytes: 931.8	Cancer enriched	Detected in some	247	liver cancer: 273.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	24	Hep G2: 19.7	Low region specificity	Detected in all			Not detected	Not detected			HPA017373	Approved				Secreted to blood				4500000000			HPA017373: AB_1851954	unprognostic (2.07e-2)	unprognostic (5.79e-2)	unprognostic (1.89e-1)	unprognostic (3.30e-4)	unprognostic (4.28e-2)	unprognostic (3.26e-2)	unprognostic (5.97e-2)	unprognostic (6.07e-2)	unprognostic (1.49e-1)	unprognostic (7.05e-2)	unprognostic (1.04e-1)	unprognostic (3.19e-1)	prognostic unfavorable (4.49e-8)	unprognostic (2.09e-4)	unprognostic (1.70e-1)	unprognostic (2.55e-2)	unprognostic (9.31e-2)	0.9	0	0.1	0.2	0.1	0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0	0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	19.7	0.2	0.2	0.1	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0.8	0.4	0	0	0	0	0	0.2	0	0.1	0	0	0	0.1	0	0	0	0	0.2	0	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.2	0.1	0.2	0.1	0	0	35	0	0.1	0.5	0.4	91.7	0	0	0	0	0	0	0	17.1	0.5	0	23.3	0	0	0.1	0	0	931.8	0	0	0	69.3	71.7	90.2	1.1	0	1.7	0	0	0.2	0	0	11	0	0	0	6.7	0.2	0.1	0.1	0.2	0.5	0	0	Hepatocytes
CYP4A22		ENSG00000162365	Cytochrome P450 family 4 subfamily A member 22	Q5TCH4	1	47137435-47149741	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 71.0	Cell type enriched	Detected in some	13	Hepatocytes: 99.2	Cancer enriched	Detected in some	13	liver cancer: 20.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RH-30: 5.1;SuSa: 2.6																						unprognostic (5.34e-2)	unprognostic (1.24e-1)		unprognostic (3.19e-2)			unprognostic (2.88e-3)	unprognostic (2.76e-3)		unprognostic (1.50e-3)	unprognostic (2.21e-1)	unprognostic (2.75e-1)	unprognostic (1.93e-2)	unprognostic (5.29e-3)	unprognostic (1.02e-1)	unprognostic (1.71e-1)	unprognostic (8.59e-4)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0	0.1	1.2	0.1	0	0.1	0.1	0.1	0	14.4	71	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.4	0.2	0.1	0.6	0	0	0.1	0.5	0.1	0	0.1	0.2	0.1	0	0	0	0.4	0.5	0.5	0.2	0.1	0	0.2	0.3	0	0.1	0.2	0.2	0.1	0.5	0	0	0.6	0.6	0.2	0	0.1	0.2	0	0.1	0.3	0.2	0.5	0.1	0.1	0.4	0.4	0.4	0	0	0	5.1	0	0	0.4	0.5	0.2	0.3	0.1	0	2.6	0.4	0.6	0.7	0.2	0.1	0.2	0	0	0.5	0.6	0.2	1.1	0	0	0.2	0.4	0.5	0	0.4	0.5	0.5	0.6	0.1	0.6	0.5	0.6	0	0.1	0	0.1	0.2	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	5.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	99.2	0	0	0	1.8	1.6	0	0	0	0	0	0	0	0	0	0	7.8	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SLC2A2	GLUT2	ENSG00000163581	Solute carrier family 2 member 2	P11168	3	170996348-171026750	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Sugar transport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	intestine: 77.4;liver: 172.8	Cell type enriched	Detected in some	5	Hepatocytes: 433.3	Cancer enriched	Detected in some	12	liver cancer: 105.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	68	CACO-2: 7.3;Hep G2: 24.3	Not detected	Not detected			Low region specificity	Detected in some			CAB010444, HPA028997	Enhanced		Supported	Plasma membrane						Plasma membrane		CAB010444: AB_641068, HPA028997: AB_2672860			unprognostic (9.56e-2)		unprognostic (1.24e-1)		prognostic favorable (2.63e-5)				unprognostic (3.10e-1)		unprognostic (1.02e-1)	unprognostic (2.95e-2)	unprognostic (6.31e-2)			0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	27.9	0	0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0	0.1	0	0.1	0.6	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	77.4	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0.2	24.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	86.6	0	0	0	0	0	1.7	0.2	4.6	0	0	0	0	0	0	0	0	433.3	0	0	0	6.7	8.9	0.4	0	0	0	0	0.3	0	0.1	0	0	49.1	0	0	0	0	0	0	0.1	1.9	0	0	Hepatocytes
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	81	liver: 3075.8	Cell type enriched	Detected in many	4	Hepatocytes: 49859.9	Cancer enriched	Detected in many	384	liver cancer: 14213.7	Not detected	Not detected			Cell type enriched	Detected in single	13	naive CD4 T-cell: 1.3	Lineage enriched	Detected in single	13	T-cells: 1.3	Cell line enriched	Detected in some	39	Hep G2: 315.9	Not detected	Not detected			Not detected	Not detected			CAB006262, HPA031024, HPA031025	Enhanced		Enhanced	Endoplasmic reticulum,Golgi apparatus	Secreted to blood			40000000000000		Golgi apparatus	Endoplasmic reticulum	CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704	unprognostic (1.38e-1)	unprognostic (8.72e-2)	unprognostic (1.73e-1)	unprognostic (2.60e-1)	unprognostic (4.44e-1)	unprognostic (2.46e-1)	unprognostic (9.53e-3)	unprognostic (2.16e-2)	unprognostic (2.40e-1)	unprognostic (6.43e-2)	unprognostic (3.84e-2)	unprognostic (5.37e-2)	unprognostic (1.25e-1)	prognostic unfavorable (7.87e-4)	unprognostic (7.23e-2)	unprognostic (1.05e-3)	unprognostic (1.02e-2)	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0.1	0.8	0.1	0	0.1	0.1	0.1	0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38	0	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	1	0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0	0	0	0.1	0	0	0	0	0	2.2	0.1	315.9	0	8.1	0.2	0	0	0	0	0	0	0	1.1	0	0	0	0.1	0	0.2	0	0	0.1	7	0	0	0.2	0	0	3.7	0	0	0	0	0	0.9	0	0.1	0	0	0.5	0	2.6	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0.1	0.1	0.1	0.3	0.1	0	0.1	0.1	0.2	0.1	0	0	683.8	0	0	0	0.1	12066.1	0	0	36.6	0	0.8	61.3	4.3	2	0	0	1612	237.4	2.3	0.2	0.1	0	49859.9	8.2	0	1.7	1417.3	1529.6	0	0	0	0	1.8	0	0	261.7	0	0	442.7	0	0	0.4	0.2	0.2	0.1	17.7	22.3	0	0	Hepatocytes
RTP3	LTM1, TMEM7, Z3CXXC3	ENSG00000163825	Receptor transporter protein 3	Q9BQQ7	3	46497491-46500949	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	91	liver: 43.3	Cell type enriched	Detected in some	19	Hepatocytes: 59.6	Group enriched	Detected in some	17	liver cancer: 22.9;testis cancer: 5.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	SiHa: 15.1									HPA075932			Uncertain	Mitochondria						Mitochondria		HPA075932: 		unprognostic (2.09e-1)				unprognostic (1.64e-1)	prognostic favorable (3.11e-6)								unprognostic (1.08e-1)	unprognostic (1.58e-1)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	43.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	0.1	0.2	0	1.7	0	0	0	0	0	0	0.7	0	0	0	0	15.1	0	0	2.2	0	0	0	0	0.4	0.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0	0	0	59.6	0	0	0	3.1	0.6	0	0	0	0	0	0	0	0.1	0	0	0.8	0	0	0	0.5	1.3	0	0	0	0	0	Hepatocytes
KLKB1	KLK3	ENSG00000164344	Kallikrein B1	P03952	4	186208979-186258471	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	76	liver: 102.9	Cell type enriched	Detected in some	11	Hepatocytes: 203.0	Cancer enriched	Detected in some	17	liver cancer: 27.6	Low region specificity	Detected in single			Cell type enriched	Detected in single	7	gdT-cell: 1.3	Lineage enriched	Detected in single	8	T-cells: 1.3	Cell line enhanced	Detected in some		NTERA-2: 7.3;SCLC-21H: 5.0;SK-MEL-30: 2.2;U-937: 2.5	Not detected	Not detected			Low region specificity	Detected in many								Secreted to blood			28900000000	4900000000				unprognostic (4.80e-2)	unprognostic (4.53e-3)	unprognostic (4.36e-2)	unprognostic (4.17e-2)	unprognostic (5.93e-2)	unprognostic (1.90e-2)	unprognostic (1.15e-2)	unprognostic (2.83e-1)	unprognostic (8.14e-2)	unprognostic (1.35e-1)	unprognostic (1.38e-2)	unprognostic (1.15e-1)	unprognostic (1.45e-2)	unprognostic (6.01e-2)	unprognostic (7.30e-2)	unprognostic (1.20e-1)	unprognostic (1.59e-2)	0.3	0.3	0.8	0.3	1.2	0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0	0	0	1.3	0	0	0	0	0	0.2	0.8	0.2	0	0	0	0.2	0	0.4	0.3	0.3	0	0.2	0.2	0	0	0	0.7	0	0	0	0	0	0.2	0.2	0.2	0	0	0	0.1	0	0.6	0	0.2	0	0	0.4	0	7.3	0.1	0	0.1	0	0.2	1.3	0	5	0.4	0.2	0	2.2	0.1	0	0	0	0	0	0	0	0	0	0	0	2.5	0.1	0	0	0	1.3	0	0	0.1	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3	0	0	0	0	0	4.2	3.9	17.8	1.4	0	1.8	15.7	0	0	1.1	2.2	0.4	0.2	0	0.5	0	0	0	0	203	0.2	0	2.9	5.5	3.2	0.8	0.6	0	0	0	0.3	14.6	0.7	0.3	0	0.9	3.6	0	0.2	1.4	0.9	0	0	0	0.4	0	Hepatocytes
LEAP2	LEAP-2	ENSG00000164406	Liver enriched antimicrobial peptide 2	Q969E1	5	132872322-132875046	Plasma proteins, Predicted secreted proteins		Antibiotic, Antimicrobial		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	liver: 52.4	Cell type enriched	Detected in many	19	Hepatocytes: 1416.7	Cancer enriched	Detected in many	17	liver cancer: 40.0					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood				1300000				unprognostic (2.14e-2)	unprognostic (8.78e-2)	unprognostic (4.75e-1)	unprognostic (2.16e-1)	unprognostic (2.82e-1)	unprognostic (1.06e-2)	unprognostic (2.78e-3)	unprognostic (6.53e-2)	unprognostic (3.86e-2)	unprognostic (1.62e-1)	unprognostic (7.08e-3)	unprognostic (2.91e-2)	unprognostic (1.02e-1)	unprognostic (2.39e-1)	unprognostic (3.97e-1)	unprognostic (1.11e-1)	prognostic favorable (2.68e-4)	0.1	0.1	0	0.2	0.1	0	0.2	1.5	0	0.2	0.3			1.5	0.1	0.1	0.3	0.2	0.4	0.2	0.1	0	1.4	52.4	0.2	0.3	0.1		0.2	0.5	0.5	0.2	0		0.7	0.5		0.3	0.1	0.9	0.4	2.6	0	0.1	0.7	0.5	0.1			0.6		0.5	1.8	0.4	1.6	0.9	4.2	1.3	0.9	2	0.3	0.5	2.3	2.4	4.8	2.7	1.3	1.8	1	0.2	0.7	1.6	2.4	2.8	2	0.4	0.3	0.8	4.2	3.8	1.1	0.5	3.6	1.7	1.7	5.7	1.7	0.7	0.9	1.3	1.1	1.9	0.7	1.3	2	0.7	3.5	1.4	4.9	0.7	1.2	1.6	3.9	1.4	1.9	1.1	1.4	1.6	1.5	1	2	1.6	1.1	1	1	0.8	1.1	1.5	1.2	0.4	2.7	1.6	1.2	0.6	5.8	4.3	1.7	0.7	2.7	1.1	4.2	1.3	0.2	1.3	0.9	1.4	1.5	0.9	0.6	0.9	1.6	1.1	1.2	3.2	0.9	0.5	0.8	2	0.3											0	1.6	16.9	9.6	9	15.8	1.2	76.5	1.4	1.2	0	31.4	2.7	8.3	2.3	3.7	3.8	75.4	0	8.7	4.9	6.7	7.2	6.9	1416.7	1.2	12.7	4.6	21.5	19.4	0.2	1.4	3.4	5	0	3.4	4.6	2.5	34.5	1.8	36.3	23.1	0	6.2	4.1	1.9	6.8	6.1	10	4.4	7.8	Hepatocytes
MBL2	COLEC1, MBL	ENSG00000165471	Mannose binding lectin 2	P11226	10	52765380-52771700	Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	825	liver: 82.5	Cell type enriched	Detected in some	62	Hepatocytes: 190.6	Cancer enriched	Detected in single	275	liver cancer: 22.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	Hep G2: 7.0	Region enriched	Detected in single	5	pons and medulla: 0.5	Not detected	Not detected			HPA002027, CAB016782	Enhanced				Secreted to blood			1220000000	1700000000			CAB016782: , HPA002027: AB_1079324							unprognostic (1.72e-2)		unprognostic (3.03e-1)									0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	82.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	7	0	0.6	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0.5	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	190.6	0	0	0	3.1	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
CYP2C19	CPCJ, CYP2C, P450IIC19	ENSG00000165841	Cytochrome P450 family 2 subfamily C member 19	P33261	10	94762681-94853205	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	16	intestine: 47.7;liver: 76.4	Cell type enriched	Detected in single	31	Hepatocytes: 10.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.8;RPMI-8226: 1.6									HPA015066	Supported				Intracellular and membrane							HPA015066: AB_1847433			unprognostic (3.15e-2)			unprognostic (2.13e-1)	unprognostic (2.48e-1)				unprognostic (1.83e-2)			unprognostic (1.53e-1)				0	0	0	0	0	0	0	0.1	0.1	0.2	30	0	0	14.7	0	0	1	0	3.7	0	0	0	0	76.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	47.7	0	0	0	0.5	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.5	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	1.6	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	10.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
LIPC	HL, HTGL	ENSG00000166035	Lipase C, hepatic type	P11150	15	58410569-58569843	Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Heparin-binding, Hydrolase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 91.7	Cell type enriched	Detected in some	10	Hepatocytes: 125.3	Group enriched	Detected in some	14	liver cancer: 20.4;renal cancer: 10.4	Low region specificity	Detected in some			Low cell type specificity	Detected in many			Group enriched	Detected in many	8	granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5	Cell line enhanced	Detected in some		CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8	Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood				3200000				unprognostic (1.76e-2)	unprognostic (9.15e-3)	unprognostic (7.89e-2)	unprognostic (7.15e-4)	unprognostic (1.40e-1)	unprognostic (1.33e-2)	unprognostic (9.93e-3)	unprognostic (6.25e-2)	unprognostic (3.79e-2)	unprognostic (1.10e-2)	unprognostic (3.06e-1)	unprognostic (2.31e-1)	unprognostic (2.82e-2)	unprognostic (1.41e-1)	unprognostic (2.87e-2)	unprognostic (1.80e-2)	unprognostic (2.27e-2)	0.2	0.1	0.4	1.1	0.7	0	0.7	0.1	0.4	0.3	0.2	0.6	0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3	91.7	0.3	0.2	1.2	0.2	0.3	1	0	1	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3	4.5	2.5	0	0	0	0	0.2	0.9	0	0	0.7	0	0	7	0	0	5.3	0.2	0.2	0	0	0	0	0.4	0	2.5	0	20	0.4	0	5.9	0	0	0	0	0	0	1	0.1	0	0.1	0.1	4.5	0.6	0	0	0	0.9	0.3	0	2.2	0.4	0	0	0	0.1	0	0	0	0	0.2	0	0.1	15.8	0	0	0	0.1	0.1	0.4	0	3.7	0.3	0	3	0.2	4.5	0	0.8	2.2	0.2	0.1	1	3.2	0.4	3	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0	0	5.1	0	0.2	0	0.8	12.7	0	1.2	3.5	0	0	5	3.7	0	0	0	0	3.3	0	1.2	0.2	0	125.3	0.1	0	0	5.5	4	0	0.3	0	1.7	1	0	0	0.3	0	0	9.6	0	0	0.9	0	0	0.5	0	0	0	0	Hepatocytes
NNMT		ENSG00000166741	Nicotinamide N-methyltransferase	P40261	11	114257787-114313285	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Methyltransferase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 97.7	Cell type enriched	Detected in many	9	Hepatocytes: 3284.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9	Low region specificity	Detected in many			Not detected	Not detected			HPA059180	Approved		Approved	Golgi apparatus,Cytosol					15000	Golgi apparatus	Cytosol	HPA059180: AB_2683940	unprognostic (1.62e-1)	unprognostic (2.33e-2)	unprognostic (1.61e-2)	unprognostic (6.14e-2)	unprognostic (3.51e-1)	prognostic unfavorable (2.07e-4)	unprognostic (1.76e-1)	unprognostic (5.84e-2)	unprognostic (2.71e-2)	unprognostic (2.48e-2)	unprognostic (1.20e-1)	unprognostic (1.69e-2)	prognostic unfavorable (1.02e-6)	prognostic unfavorable (1.75e-4)	unprognostic (1.11e-1)	unprognostic (3.37e-3)	unprognostic (2.77e-2)	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12	8.3	15.3	8.2	1.6	0	4.7	97.7	10	3.4	1.1	0.6	11.2	2	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0	0.9	0	0	4.8	0	4.3	24.8	32.2	0	6.1	16.3	9.8	19.5	0	6.6	0	21.8	12.5	1.3	0	0	2.2	9.9	0	0	0	7.6	0	33.8	0	0	68.8	23.8	6.9	10.3	8.2	13.5	0	0	0	40.9	0	0	0	0	0	0.1	0	27.4	0	105.9	0	0	0	30.7	0	0	1.5	0	0	9.5	5.6	22.6	8.7	1	0	0	0	1.7	0	0.4	0	0.2	0	0.2	0.1	0.9	0.2	0	0.2	0.1	0.6	0	0.2	0.7	0	0	0.1	0	0	0.6	0.9	0.6	1.7	1.6	0	1.1	0.6	3.3	0.6	41.7	380.8	30.2	10.6	92	0.5	4	76.5	18.7	20.5	76.8	0	0.9	8.3	207.6	0.2	191.1	0	163.5	133.3	1.9	375.3	11.6	12.8	3284.1	21.8	0	5.1	176.1	103.2	1	68.7	12.7	91.1	10	0	0	366	0	12.4	27.9	0.1	0	113.1	0.3	0.4	80.5	1.8	46	0	2.4	Hepatocytes
PLIN1	PLIN	ENSG00000166819	Perilipin 1	O60240	15	89664365-89679427	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid metabolism			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	12	adipose tissue: 187.5;breast: 62.6	Cell type enriched	Detected in some	9	Hepatocytes: 49.1	Cancer enhanced	Detected in many		breast cancer: 8.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	176	ASC diff: 70.4	Low region specificity	Detected in single			Not detected	Not detected			HPA024299, CAB033821, CAB037333	Enhanced		Uncertain	Peroxisomes					8900	Peroxisomes		CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467	unprognostic (4.62e-2)	unprognostic (2.22e-1)	unprognostic (2.13e-1)	unprognostic (1.67e-1)	unprognostic (1.90e-1)	unprognostic (3.51e-3)	unprognostic (9.89e-3)	unprognostic (3.54e-1)	unprognostic (7.01e-2)	unprognostic (2.13e-2)	unprognostic (8.00e-3)	unprognostic (2.28e-3)	unprognostic (2.62e-6)	unprognostic (5.56e-2)	unprognostic (1.22e-1)	unprognostic (1.63e-1)	unprognostic (4.85e-2)	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1	0.4	1.1	0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0	0.7	8	0.3	1.5	1.5	0	0	0.6	0.1	0	0.1	0.1	0	0	0	0	70.4	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.2	0.1	0	0.2	0	0	0	0.2	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0.4	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1	1.8	0	0	0	0.2	0.1	0.1	0.8	0	0	0	0	0	0	0	0.1	5.6	0.1	0	0	0.2	0	0	0.3	0	49.1	0	0	0	1.8	1.3	4.9	0.9	0	0	0	0	0.2	0.2	0.2	0	0	0	0	0	5.4	0.2	0.4	0	0	0	0.7	Hepatocytes
SERPINF2	A2AP, AAP, ALPHA-2-PI, API, PLI	ENSG00000167711	Serpin family F member 2	P08697	17	1742836-1755268	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Acute phase	Protease inhibitor, Serine protease inhibitor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	21	liver: 417.7	Cell type enriched	Detected in many	11	Hepatocytes: 830.3	Cancer enriched	Detected in all	6	liver cancer: 450.6	Not detected	Not detected			Cell type enriched	Detected in some	4	plasmacytoid DC: 19.8	Lineage enriched	Detected in single	27	dendritic cells: 19.8	Cell line enriched	Detected in some	32	Hep G2: 57.1	Low region specificity	Detected in single			Not detected	Not detected			HPA001885, CAB024863	Approved				Secreted to blood			11900	110000000000			CAB024863: , HPA001885: AB_1079922	unprognostic (2.17e-3)	unprognostic (2.56e-3)	unprognostic (2.48e-1)	unprognostic (7.57e-3)	unprognostic (3.69e-2)	unprognostic (1.45e-2)	prognostic favorable (2.26e-5)	unprognostic (1.44e-1)	unprognostic (2.32e-2)	unprognostic (1.38e-1)	unprognostic (1.88e-3)	unprognostic (2.18e-1)	unprognostic (1.09e-3)	unprognostic (7.05e-2)	unprognostic (2.81e-1)	unprognostic (7.68e-3)	unprognostic (2.93e-1)	0.9	0	0.2	0.6	0.2	0	1.8	0.2	0.2	0.6	0.3	0.2	6.6	0	0.7	17.2	0.2	2.1	0.2	0.3	0.2	0	10.2	417.7	1.3	3.4	0.2	0.2	0.7	0.8	0	0.2	0.2	0.8	2.1	0	1.8	0.5	9	0.2	0.4	1	0.2	0.2	0.6	0.2	1.7	0.2	0.2	0.7	0.2	0.5	0.6	0.4	0.2	19.8	0.5	0.7	0.4	0	0.4	0.3	1.7	0	0	0.1	0.1	0	0	0	0	0	0	1.1	0.2	0.3	0	0	0.1	0	0.6	0	0	0	0	0.2	57.1	0.4	0.1	0	0.5	0.4	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0.2	0	0	0	0	0.2	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.7	0.5	0	0.2	0	0.2	0	0	4.6	0.1	0	0	0	0.4	0	19.8	0	0.4	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.8	0.2	3	15.8	13.7	5.7	1.3	0.1	0.6	25.5	5.3	4.5	1.8	5.9	0.1	8.3	0	0.5	0.6	1	23.3	4.4	0.1	1.9	2.5	1.1	830.3	7.4	0	4.1	10.4	21.5	0	31.4	11.4	1.7	16.2	1	0	5.7	3.5	25.1	73.8	0.4	0	2.3	0.2	0.5	1.4	0.2	4.4	1.7	1	Hepatocytes
CYP7A1	CYP7	ENSG00000167910	Cytochrome P450 family 7 subfamily A member 1	P22680	8	58490178-58500236	Enzymes, Predicted intracellular proteins	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	70	liver: 50.4	Cell type enriched	Detected in single	12	Hepatocytes: 4.7	Cancer enriched	Detected in single	96	liver cancer: 28.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BJ hTERT+: 1.4	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (5.20e-2)			unprognostic (1.93e-2)	unprognostic (1.77e-2)		prognostic favorable (3.19e-4)	unprognostic (7.60e-2)	unprognostic (5.31e-2)	unprognostic (1.50e-1)	unprognostic (1.18e-1)	unprognostic (2.64e-1)	unprognostic (8.43e-3)	unprognostic (3.01e-1)	unprognostic (1.57e-2)	unprognostic (1.51e-1)		0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	50.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.1	0.3	0.3	0.5	0	0	1.4	0.1	0.1	0	0.1	0	0	0	0.5	0.1	0	0	0	0	0	0.2	0	0.2	0.2	0	0.1	0.9	0	0.2	0.5	0	0.4	0.1	0.2	0	0.2	0.2	0	0.1	0	0.1	0	0.1	0	0	0	0	0.1	0	0.5	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	Hepatocytes
HFE2	haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC	ENSG00000168509	Hemochromatosis type 2 (juvenile)	Q6ZVN8	1	146017468-146036746	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		liver: 49.4;skeletal muscle: 128.9;tongue: 28.2	Cell type enriched	Detected in some	21	Hepatocytes: 163.4	Cancer enriched	Detected in some	96	liver cancer: 87.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.1;HSkMC: 5.0;K-562: 4.8;RH-30: 1.7	Low region specificity	Detected in many																42000				unprognostic (2.30e-1)			unprognostic (6.98e-4)	unprognostic (7.06e-2)	unprognostic (1.11e-2)	unprognostic (2.77e-3)	unprognostic (2.55e-1)	unprognostic (8.50e-2)	unprognostic (2.36e-1)	unprognostic (7.14e-2)	unprognostic (1.18e-1)	unprognostic (8.96e-8)	unprognostic (6.61e-2)	unprognostic (2.72e-1)		unprognostic (1.76e-2)	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	2.5	0	0	14	0	0	0	49.4	0	0	0	0	0	0	0	0	0	0	0.4	0	0	1.9	0	128.9	0	0	0	0	0	0	0.3	0	0	0.8	28.2	2	0.1	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	1.1	0	0	0.1	0	0	0	0	0.2	0	0	0.1	0.1	0	0.1	0	0.4	0.1	5	0	0	0	0	0	0	4.8	0.1	0.7	0	0	0	0.5	0	0	0.1	1.7	0	0	0	0	0	0.5	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	7.6	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1	0	0	0	163.4	0	0	0	2.5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
LRG1	LRG	ENSG00000171236	Leucine rich alpha-2-glycoprotein 1	P02750	19	4536409-4540474	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 636.5	Cell type enriched	Detected in many	9	Hepatocytes: 728.6	Cancer enriched	Detected in many	9	liver cancer: 160.9	Not detected	Not detected			Cell type enriched	Detected in some	19	neutrophil: 58.9	Lineage enriched	Detected in many	42	granulocytes: 58.9	Cell line enhanced	Detected in some		Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA001888, HPA001889	Enhanced		Approved	Vesicles	Secreted to blood			21000000000	74000000000	Vesicles		HPA001888: AB_1079276, HPA001889: AB_1079275	unprognostic (5.54e-3)	unprognostic (1.78e-1)	unprognostic (1.78e-1)	unprognostic (1.42e-1)	unprognostic (2.64e-2)	unprognostic (1.05e-1)	unprognostic (1.88e-1)	unprognostic (1.13e-1)	unprognostic (1.01e-1)	unprognostic (1.16e-2)	unprognostic (1.46e-3)	unprognostic (9.83e-2)	prognostic unfavorable (3.66e-6)	unprognostic (4.06e-2)	unprognostic (1.45e-1)	prognostic favorable (3.49e-4)	unprognostic (2.60e-2)	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0	0.2	0.4	5.9	0.1	0	0	0	0	4.6	0	0	0	0	0.6	4.3	2.1	7.7	0	0.3	0.8	0	1	0	7.7	0.2	0.1	0.1	8.2	0	0.2	8.3	2.3	0	0	0	0	0	0	5.4	0.1	0	0.3	0	6	0.1	4.7	0	0	0.1	6.2	0.6	1.1	0	0	0	8.8	0.1	0.8	2.6	14.8	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0	27.4	0	0.5	1.4	3	0	0.4	0	0.1	0	0	0.3	0.1	0	0	58.9	0	0.2	0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3	11.9	51.2	16.5	26.9	7.1	0	0.4	58.6	78.9	39.8	14	0	0.5	1.7	54.6	0	8.3	25.4	0	54.4	10.6	1.4	2.9	11.5	728.6	5.4	1.6	4.7	42.4	17.4	0	0	7.6	1.7	10	20	0	55.9	7	0	3.6	0	0	2.1	0	0.2	5.1	1.1	2.9	16.7	29.6	Hepatocytes
FGG		ENSG00000171557	Fibrinogen gamma chain	P02679	4	154604134-154612967	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	495	liver: 2225.7	Cell type enriched	Detected in many	15	Hepatocytes: 7797.1	Cancer enriched	Detected in many	19	liver cancer: 1503.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	55	Hep G2: 128.7	Not detected	Not detected			Not detected	Not detected			HPA027529, CAB033120, HPA074638	Supported		Approved	Endoplasmic reticulum	Secreted to blood			267000000000	68000000000	Endoplasmic reticulum		CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: 	unprognostic (1.26e-2)				unprognostic (4.77e-3)	unprognostic (6.33e-3)	unprognostic (3.69e-3)	unprognostic (2.18e-3)		unprognostic (9.63e-2)	unprognostic (7.57e-3)		prognostic unfavorable (1.00e-6)	unprognostic (1.75e-3)	unprognostic (3.21e-1)		unprognostic (1.14e-1)	0	1.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.9	0	0	0	2.7	2225.7	4.4	0	0	0	0.2	0.7	0	0	1	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	1.8	0	0.2	0	0	0	0.1	0	0	0	0	0	0.6	0	128.7	0	1.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0.1	0	0	0.9	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0.7	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	17.9	218.6	146.9	0	0	0	0.2	507	2.7	4.5	0	0	0	0	3.8	2.8	0	0	327.1	40	0.1	0	0	10.5	7797.1	0.2	0	0	232.7	240.6	0	0	0	0	3.6	0	0	266.1	0	0	0.3	0	0	0	0.5	0.6	0	0.3	20.1	0	0	Hepatocytes
FGA		ENSG00000171560	Fibrinogen alpha chain	P02671	4	154583126-154590766	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	740	liver: 2009.3	Cell type enriched	Detected in many	40	Hepatocytes: 16694.6	Cancer enriched	Detected in many	43	liver cancer: 2431.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	Hep G2: 96.9	Not detected	Not detected							CAB016776, HPA051370, HPA064755	Supported		Approved	Endoplasmic reticulum	Secreted to blood			407000000	170000000000	Endoplasmic reticulum		CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345		unprognostic (5.95e-2)	unprognostic (6.25e-2)	unprognostic (2.02e-1)		unprognostic (5.68e-2)	prognostic favorable (7.33e-4)	unprognostic (1.29e-3)			unprognostic (1.84e-1)		prognostic unfavorable (4.23e-6)	unprognostic (4.20e-1)	unprognostic (1.41e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	2.7	2009.3	0.1	0	0	0	0	1.4	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.4	1.5	0	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0	0	0	6.6	0	0	0	0	0	0	0	0	0	5.5	0	0.6	0	0	0	0.1	0	0	0	0	0	0.7	0	96.9	0	1.4	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0.1	1.4	0	0	0.1	0	0	0.8	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0.5	0	0.4	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	24.4	83.9	0	0	0	0.4	420.4	17.4	5.7	0	0	0	1.7	5.5	23.9	0	0	256.9	1.5	0	0	0	0	16694.6	0.1	0	0	255.3	257.1	29.3	0.6	0	0	0	0	0	31.5	0	1.1	1	0	0	0	14.4	0.6	0	0.1	4.3	0	0	Hepatocytes
FGB		ENSG00000171564	Fibrinogen beta chain	P02675	4	154562956-154571086	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	189	liver: 1908.6	Cell type enriched	Detected in some	33	Hepatocytes: 15347.2	Cancer enriched	Detected in many	42	liver cancer: 2262.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	12	Hep G2: 77.7	Not detected	Not detected			Not detected	Not detected			HPA001900, HPA001901, CAB008624	Enhanced		Enhanced	Endoplasmic reticulum	Secreted to blood				120000000000	Endoplasmic reticulum		CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864	unprognostic (1.16e-1)	unprognostic (3.89e-2)	unprognostic (4.65e-2)	unprognostic (3.44e-1)			unprognostic (2.20e-3)	unprognostic (1.42e-2)			unprognostic (1.79e-1)		prognostic unfavorable (5.72e-5)	unprognostic (2.48e-2)	unprognostic (7.91e-2)			0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	10.1	1908.6	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0	0	0	0	4.5	0	0.6	0.1	0	0	0.1	0	0	0	0	0	0.7	0	77.7	0	1.8	0.1	0	0	0	0	0	0	0	0.4	0	0	0.5	0	0	0.1	0	0	0	1.3	0	0	0	0	0	1	0.1	0	0	0	0	0.4	0	0	0.2	0	0.2	0	0.7	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.4	153.8	0	0	0	0.4	257.4	0	0	3.5	0	0	1.7	3	0.4	0	0	467.2	3.2	0.1	0	0	0	15347.2	0.3	0	1.7	349.9	342.6	0	0	0	0	0	0	0	1.3	0	0	19.3	0	0	0	0	0	0	0.1	3.8	0	0	Hepatocytes
AGXT	AGT, AGT1, AGXT1, PH1, SPAT, SPT	ENSG00000172482	Alanine-glyoxylate aminotransferase	P21549	2	240868479-240880502	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Aminotransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	172	liver: 247.3	Cell type enriched	Detected in many	17	Hepatocytes: 1878.6	Cancer enriched	Detected in some	425	liver cancer: 253.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	Hep G2: 13.4	Not detected	Not detected			Not detected	Not detected			HPA035370, HPA035371	Enhanced		Supported	Vesicles					5200000	Vesicles		HPA035370: AB_10673218, HPA035371: AB_2674593	unprognostic (3.14e-2)	unprognostic (2.58e-1)	unprognostic (3.37e-4)	unprognostic (1.04e-1)	unprognostic (1.23e-2)	unprognostic (9.56e-2)	prognostic favorable (5.92e-5)	unprognostic (8.28e-2)	unprognostic (2.77e-1)	unprognostic (5.39e-2)	unprognostic (1.55e-1)	unprognostic (7.57e-3)	unprognostic (2.54e-1)	unprognostic (9.22e-2)	unprognostic (1.37e-1)		unprognostic (3.26e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	247.3	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0.2	0	0	0	0.4	0	0	0	0	0	0.5	0	13.4	0	1	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0.2	1.3	0	0	0	0.1	0	0.8	2.6	0	0	0	0	0.3	0	0	0	0	0.2	0	0.4	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	11.5	0	0	0	0.8	28.1	0	0	7	0	0.5	19.9	0	0	0	2.6	46.7	1.6	22.7	0	0.5	0	1878.6	0.2	0	8.6	45.4	38.8	0	0.9	0	0	0	3.9	0	0.2	7	0.4	108	0	0	0	0	0	0	1.6	8.2	1.2	0	Hepatocytes
ACOT12	Cach, STARD15, THEAL	ENSG00000172497	Acyl-CoA thioesterase 12	Q8WYK0	5	81330005-81394179	Enzymes, Predicted intracellular proteins, Transporters	Fatty acid metabolism, Lipid metabolism	Hydrolase, Serine esterase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	38	liver: 49.6	Cell type enriched	Detected in some	7	Hepatocytes: 37.1	Cancer enriched	Detected in single	76	liver cancer: 13.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2	Not detected	Not detected			Low region specificity	Detected in single			HPA037723, HPA037724			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA037723: AB_10672606, HPA037724: AB_2675631	unprognostic (6.06e-2)				unprognostic (1.39e-1)		prognostic favorable (5.30e-4)		unprognostic (7.68e-2)	unprognostic (8.22e-2)	unprognostic (5.68e-3)	unprognostic (2.46e-1)	unprognostic (6.86e-2)	unprognostic (1.46e-2)	unprognostic (3.07e-1)	unprognostic (1.06e-1)		0	0	0.3	0	0.1	0	0	0	0.2	0	0	0.2	0	0.1	0	0.1	0	0	0	0	0.1	0.1	1.2	49.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.7	0	0.5	0.1	0	0.1	2.5	0	0	0.1	0	0	0	0.1	0	0.2	0	0	0	0	0	0.1	0	0.9	0	0.1	0	0	0.3	0	0.4	0	1.8	0	0	0	0.1	0.5	0	0	0.3	0	0	0	0	0.3	0	0	0	4.2	0.4	0	0	0	0	0	0	0	0.9	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0.2	0.1	0.1	0	0	0.1	0	0	0	0.9	0	0	0	0.3	5.1	0	0	1.8	0	0	0	0	1.6	0	0	0	0	0	0	0	0	37.1	0.4	0	0	0.6	1.2	0.4	0	0	0	0	0	0	0	0	0.4	2.2	0	0	0	0.2	0.1	0	0	0	0	0	Hepatocytes
SAA1	PIG4, SAA, TP53I4	ENSG00000173432	Serum amyloid A1	P0DJI8	11	18266174-18269977	Disease related genes, Predicted secreted proteins	Acute phase	Heparin-binding	Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	11	adipose tissue: 216.6;liver: 849.2	Cell type enriched	Detected in many	26	Hepatocytes: 59557.7	Cancer enriched	Detected in many	16	liver cancer: 1249.6	Not detected	Not detected			Group enriched	Detected in some	6	gdT-cell: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1	Group enriched	Detected in many	6	B-cells: 2.1;monocytes: 2.6;T-cells: 1.1	Cell line enriched	Detected in some	5	HBEC3-KT: 163.9														Secreted to blood			300000000	22000000000				unprognostic (2.86e-3)	unprognostic (1.41e-1)	unprognostic (2.82e-1)	unprognostic (1.50e-1)	unprognostic (4.54e-3)	unprognostic (1.79e-2)	unprognostic (1.63e-2)	unprognostic (7.04e-2)	unprognostic (1.54e-1)	unprognostic (1.08e-2)	unprognostic (8.95e-2)	unprognostic (1.90e-2)	prognostic unfavorable (4.57e-12)	unprognostic (5.15e-2)	unprognostic (9.78e-2)	unprognostic (9.23e-3)	unprognostic (1.64e-1)	216.6	4.3	0.8	17.4	0.8	0	31.9	0.8	0.8	28.5	3.2	0.8	0.8	0	0.8	1.1	1	1	2.9	1	0.8	0	1.1	849.2	1.7	2.4	0.8	0.8	0.8	4.7	0	1	0.9	0.8	1.1	0.3	0.8	50.3	1	11.5	1.2	1.2	1.5	0.8	0.8	0.6	0.8	0.8	1	1	1.1	1.1	1.1	1.3	2.1	0.3	0	2.6	0	1.1	0	11.1	0	0	0	8.1	0	4.4	0.3	0.2	0	0	0	3.9	0	9	0	3	10.5	0	163.9	0	0.1	0	0.1	0	0	35.7	0.2	0	14.5	19.5	0	18.9	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0.4	0	6.6	0.2	0	0	0.9	1.2	0	0	0.1	0	0	0	1.2	0	0.3	0	0.2	0.3	0	0.1	0	0	0	0	1.1	2.6	0	2.1	0	0	0.3	0.1	0	0.3	0	0	0	0	0	0	0.8	0.8	0.8	0.8	0.8	0	0.8	0.8	0.8	0.8	6	3.2	650.1	44.2	8.2	0	0	1340.1	38.8	118.3	52.4	0	0.9	0	161.5	0	0	2.5	1565.2	69.5	20.1	0.8	164.4	2.3	59557.7	0.9	0	1.7	2316.5	1468.3	0	0	0.1	49	4.6	0	0	82.2	0	0	0	0	0	1	0	0	0.1	1.7	34.8	0	187.8	Hepatocytes
MST1	D3F15S2, DNF15S2, HGFL, MSP, NF15S2	ENSG00000173531	Macrophage stimulating 1		3	49683947-49689501	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes	Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in many	8	liver: 117.0	Cell type enriched	Detected in many	7	Hepatocytes: 361.8	Cancer enriched	Detected in many	7	liver cancer: 42.6	Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 1.1;memory B-cell: 1.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5	Not detected	Not detected			Low region specificity	Detected in all			HPA024036	Approved				Secreted to blood							HPA024036: AB_1854147	unprognostic (5.13e-3)	unprognostic (1.45e-1)	unprognostic (1.58e-1)	unprognostic (1.04e-1)	unprognostic (1.83e-1)	unprognostic (2.00e-2)	unprognostic (1.16e-2)	unprognostic (9.42e-3)	unprognostic (8.24e-2)	unprognostic (2.97e-1)	prognostic favorable (7.14e-4)	unprognostic (3.07e-2)	unprognostic (1.57e-2)	unprognostic (1.11e-1)	unprognostic (2.48e-1)	unprognostic (8.03e-2)	unprognostic (1.68e-3)	3.7	3.5	4	0.3	4.8	1.4	1	4.9	5.4	0.9	1.4	2.5	1.9	14.4	1.2	3.3	0.8	1.7	1.9	0.5	6.5	1.1	8.8	117	1.6	0.7	2	2.9	1.7	1.9	3.8	4.8	1.5	4.8	1.5	0.5	1.6	3.4	3.7	2.8	4	8.2	1.3	4.2	1.7	0.8	9.9	2.3	0.9	5	0.3	1.1	0.8	0.7	1.2	0.9	0	0.2	0	1.1	0.2	0.1	0.2	0.6	1	1.9	4.1	1.9	0.5	0.7	0.3	0.4	2	0.6	0.1	1.3	0.6	0.3	0.4	0.3	0.8	0.3	0.6	0.3	0.3	0.9	42.3	3.1	0	0.8	5.5	1.3	0.3	1.1	7.5	0.7	1.8	0.3	5.2	1	0.3	0.2	8.6	0.1	0.5	0.5	0.2	0.2	1.1	2.3	0.3	0.1	1.5	0	0.9	0.2	1.3	0.7	2.8	0.5	1	0.3	0	0.1	11.5	1.4	0.2	1.1	1.6	0.7	0	0	0	1.1	0	0	1.2	0	0	0.3	0.4	0	0	0	0	0.2	0.9	0	0.2	4	4.8	4.9	5.4	6.5	1.1	2	2.9	4.8	2.3	6	3.8	6	4.8	2.6	7.2	1.7	38.2	5.3	4.5	26.2	7.9	3.6	53	5.4	4.2	2.1	4.6	46.7	3.3	13.8	3.3	1.1	1.1	361.8	1.2	1.6	7.9	11.6	9.5	0.5	2.8	1.4	3.3	0	7.3	7.7	2.3	7	1.8	54.1	6.9	0	2	18.7	4.4	4.1	4.2	2.1	12.1	2.7	Hepatocytes
PC	PCB	ENSG00000173599	Pyruvate carboxylase	P11498	11	66848233-66958376	Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Gluconeogenesis, Lipid biosynthesis, Lipid metabolism	Ligase, Multifunctional enzyme	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		adipose tissue: 41.1;liver: 76.0	Cell type enriched	Detected in many	5	Hepatocytes: 192.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9	Cell line enhanced	Detected in many		HeLa: 28.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB033742, HPA043922, HPA058765	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812	unprognostic (2.10e-1)	unprognostic (1.51e-1)	unprognostic (1.36e-2)	unprognostic (8.24e-3)	unprognostic (3.67e-1)	unprognostic (3.18e-2)	unprognostic (2.97e-1)	unprognostic (3.00e-1)	unprognostic (3.63e-1)	prognostic unfavorable (7.86e-5)	unprognostic (1.54e-1)	unprognostic (1.17e-1)	prognostic favorable (8.22e-5)	unprognostic (8.58e-3)	unprognostic (5.67e-2)	unprognostic (9.15e-3)	unprognostic (1.05e-1)	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5	2.7	2.9	4	11.3	8.9	18.7	76	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0	3.8	0.3	2.9	2	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0	3.8	2.9	4.8	3.9	3.8	21	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0	5.9	21	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4	3.7	4.7	2.1	2	2.3	0	4.1	2.9	3.4	0	3.8	0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0	0.3	0.5	1	1.5	2	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0	1.2	3.5	2	15.6	1.7	3.1	15.2	1.4	18.6	0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0	8.6	4.3	6.9	39.9	0.6	1.6	5	32.5	4.2	9.2	2.3	7	3.9	37.8	4.7	0	1.4	6	4.2	0.5	21.3	1.3	6	1.1	Hepatocytes
CA5A	CA5, CAV, CAVA	ENSG00000174990	Carbonic anhydrase 5A	P35218	16	87881546-87936529	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Lyase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 26.4	Cell type enriched	Detected in many	6	Hepatocytes: 35.0	Cancer enriched	Detected in single	26	liver cancer: 2.0					Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Hep G2: 6.8	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (1.91e-1)	unprognostic (8.64e-3)	unprognostic (3.36e-2)	unprognostic (6.11e-2)	unprognostic (2.49e-2)	unprognostic (2.96e-1)	unprognostic (8.39e-3)	unprognostic (3.50e-3)	unprognostic (1.42e-2)	unprognostic (1.12e-1)	unprognostic (6.55e-2)	unprognostic (4.23e-2)	unprognostic (7.99e-3)	unprognostic (1.77e-1)	unprognostic (5.03e-3)	unprognostic (3.37e-2)	unprognostic (2.76e-2)	0	0	0.3	0.8	0.4	2.7	0	0.1	0.7	0	0			0.1	0.1	0.6	0	0	0	0	0.4	0.3	0	26.4	0.2	0.3	0.4		0	0	0	0	0.1		0	0.1		0	0	0.3	0.7	0.1	0	0.3	0.8	0	0.3			0.1		0	0	0	1.9	1.6	4.7	1.1	1.9	1.1	0.4	0.2	0.3	0.3	0.7	0.1	0	0.5	0.4	0.1	0	0.1	0.5	0.6	0.6	0.2	0.2	0.3	0.6	0.2	0.3	0.1	0.4	0.3	0.4	1.1	6.8	0	0.4	1.7	0.8	0	0.2	0.4	0.5	0.3	0.5	0.4	1.6	0.1	0.5	0.2	1	0.5	0.3	0.6	0.4	0.4	0.2	0.2	0.6	0.4	0.2	0.2	0.3	0.1	0.5	0.6	0.3	0.4	0.8	0.2	0.5	0.3	0.7	0.4	0.4	0.6	0.9	0.4	4.1	1.1	1	0.8	0.7	0.8	0.9	0.8	0.6	0.3	1.9	1.1	1.1	4.7	1.9	0.7	1.6	0.5	0.4											0	4.3	0	2.5	0.3	1.7	1.4	0	2.7	2.3	1.8	3.9	0.3	0	0	0.2	0	0	0	0	0.2	0.4	1.4	5.8	35	0.1	3.2	0	1.3	0.6	0.8	0.3	1.9	0	0	0	0.9	0	0	1.1	0	2.6	0	0	0.3	0.6	0.3	0.2	0	0	1.3	Hepatocytes
SLC22A1	OCT1	ENSG00000175003	Solute carrier family 22 member 1	O15245	6	160121789-160158718	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	liver: 175.8	Cell type enriched	Detected in some	16	Hepatocytes: 709.2	Cancer enriched	Detected in some	81	liver cancer: 83.0	Not detected	Not detected			Cell type enriched	Detected in single	13	neutrophil: 7.3	Lineage enriched	Detected in single	13	granulocytes: 7.3	Low cell line specificity	Detected in many			Region enhanced	Detected in single		cerebral cortex: 0.7	Not detected	Not detected			HPA029846	Approved											HPA029846: AB_10603026	unprognostic (8.28e-2)	unprognostic (2.10e-1)	unprognostic (7.80e-2)	unprognostic (2.68e-1)	unprognostic (1.93e-1)	unprognostic (2.10e-2)	prognostic favorable (1.35e-5)	unprognostic (2.28e-1)	unprognostic (8.61e-2)	unprognostic (3.35e-1)	unprognostic (9.11e-2)	unprognostic (9.94e-2)	unprognostic (1.46e-7)	unprognostic (1.58e-1)	unprognostic (1.24e-1)	unprognostic (4.72e-2)	unprognostic (8.07e-4)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0.1	175.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0.1	0	0	0.1	0	0	0	0	0.3	0.2	7.3	0.3	0	0.5	0	0	0.9	0.9	1.8	1.6	0.6	0.7	0.4	0.2	0.5	0.5	1.4	0.4	0.5	1	0.1	3.1	0.3	0	1.8	0.7	1.5	0.9	0.6	0.6	2.4	0	1.5	1.1	0	2	0	1	0.3	0.1	0.9	0.5	0.3	0.3	0.2	0	1.1	0	0.3	0.7	0	1.8	1.5	0.2	0.9	0.6	0	2.5	0	1.6	1.5	0.3	0.1	0	0.6	0.7	1.7	1.2	1.4	2.8	0.9	0.2	1	0.3	0	0.3	0	0.5	0	0	0	0.1	0.4	0	0.3	0	0.1	7.3	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	2.2	0	0.1	0	0	0.3	43.3	0	0	0	2	0	0	0.5	0.1	0	0	0	0.2	0	0.2	0.3	0	709.2	0.1	0	0	14.1	12.6	0	0.3	0	0	0	0	1	0.1	0	0.7	1.1	0	0	0.2	0	0	0.3	0.1	2.9	0	0.1	Hepatocytes
INHBC		ENSG00000175189	Inhibin beta C subunit	P55103	12	57434760-57450828	Plasma proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	256	liver: 121.3	Cell type enriched	Detected in some	4	Hepatocytes: 5.0	Cancer enriched	Detected in single	85	liver cancer: 22.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 9.7;Karpas-707: 10.0;RH-30: 5.0;U-266/70: 5.1	Not detected	Not detected			Not detected	Not detected								Secreted to blood				11000000				unprognostic (5.26e-2)	unprognostic (4.58e-1)	unprognostic (3.43e-3)	unprognostic (4.08e-3)	unprognostic (3.76e-1)	unprognostic (1.98e-2)	unprognostic (1.03e-2)	unprognostic (1.10e-1)	unprognostic (1.34e-1)	unprognostic (1.23e-1)	unprognostic (6.10e-2)	unprognostic (2.48e-2)	unprognostic (1.68e-4)	unprognostic (2.90e-2)	unprognostic (1.52e-1)	unprognostic (3.55e-3)	unprognostic (5.05e-2)	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121.3	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0.1	0	0	0.2	0.4	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0.1	0.1	0	0.1	0	2.3	0.1	0	0	0.2	0.2	0.1	0.1	1.5	0.1	0.5	0	9.7	0	0.4	0.1	0.4	0	0	0.7	0	0	2.7	0.1	10	0	0.2	0.1	0	0	0	0.1	0.3	5	0.7	0	0	1.2	0.1	0.1	0	0	0	0	0	0	0	0.4	0	0	5.1	0.5	0.9	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0.2	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	5	0	0	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Hepatocytes
APOF		ENSG00000175336	Apolipoprotein F	Q13790	12	56360569-56362823	Plasma proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	53	liver: 114.0	Cell type enriched	Detected in some	42	Hepatocytes: 377.1	Cancer enriched	Detected in some	6	liver cancer: 34.8	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	10	Hep G2: 9.9	Not detected	Not detected												Secreted to blood			18000000000	4000000000				unprognostic (3.55e-2)	unprognostic (1.13e-1)	unprognostic (1.48e-2)	unprognostic (8.99e-3)	unprognostic (9.84e-2)	unprognostic (3.29e-2)	unprognostic (2.08e-3)	unprognostic (7.84e-2)	unprognostic (4.22e-1)	unprognostic (5.69e-2)	unprognostic (2.68e-3)	unprognostic (8.55e-2)	unprognostic (2.42e-2)	unprognostic (2.77e-1)	unprognostic (5.57e-2)	unprognostic (2.87e-1)	unprognostic (4.43e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	114	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	2.1	0.9	1.8	0.5	1.1	1.4	0.1	0.2	0.3	0.1	0.3	0	0	0.1	0	0	0	0	0.2	0.5	0.7	0.1	0	0	0.5	0	0	0	0.3	0.3	0.7	1	9.9	0	0.9	0.3	0.2	0	0.1	0.1	0.1	0	0.5	0.6	0.4	0.1	0.3	0.2	0.1	0.6	0.1	0.4	0.3	0.5	0.6	0.5	0.4	0.3	0.1	0.4	0.4	0.1	0.2	0.2	0	0	0.1	0.1	0.3	0	0.8	0.4	0.5	0.2	0.4	0.4	1.8	0.5	0.3	0.5	0.2	0.8	1.6	0.7	0.6	0.1	2.1	1.4	1.1	1.3	1.1	0.4	0.9	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	7	0.2	0	0	0.2	7.6	0	0	0	2	0	0	0	0	0	0.1	0	0.2	0	0	0.9	0	377.1	0	0	0	4.9	9.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1	0	0	0	0.1	Hepatocytes
C8G		ENSG00000176919	Complement C8 gamma chain	P07360	9	136945246-136946974	Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 165.8	Cell type enriched	Detected in some	19	Hepatocytes: 942.4	Cancer enriched	Detected in all	58	liver cancer: 260.0	Not detected	Not detected			Cell type enhanced	Detected in some		gdT-cell: 3.4	Group enriched	Detected in many	18	dendritic cells: 1.5;T-cells: 3.4	Cell line enriched	Detected in some	13	HMC-1: 61.0	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA046269	Approved				Secreted to blood				1500000000			HPA046269: AB_2679606	unprognostic (5.00e-2)	unprognostic (4.05e-3)	prognostic unfavorable (2.99e-4)	unprognostic (3.94e-1)	unprognostic (4.53e-1)	unprognostic (2.75e-2)	unprognostic (1.71e-3)	unprognostic (2.79e-1)	unprognostic (1.88e-1)	unprognostic (3.67e-1)	unprognostic (2.96e-2)	unprognostic (3.00e-1)	unprognostic (5.02e-3)	unprognostic (2.16e-1)	unprognostic (7.67e-2)	unprognostic (1.65e-1)	unprognostic (1.05e-2)	0.2	0.7	0.2	0.3	0.2	0	0.2	0.2	0.2	0.2	6	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	1.5	0	0.1	0	3.4	0.3	0.1	0.9	0.1	0.2	0.1	0	0.6	0.3	0	0	0	1.1	0.6	1.1	0.7	0	0.2	1	0	0.1	0	1.1	0.1	0.4	1.7	4.6	0	0.1	61	0	0.2	0.2	0	0.2	0.2	0.4	0.1	0.6	0.2	0.8	0.1	0.5	0	0.1	0.2	0.1	0.2	0.9	0.2	0.5	0.2	0.2	0.2	1.7	0.3	0.1	1.5	0.4	0.7	0.3	0.1	0.1	0.2	0.3	0.5	0	0.2	0.5	0.2	0	0.1	0	3.4	0	0.4	0	0.7	1.8	0	0	0	2.2	0	0	0	1.5	0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0	0	0	0.1	0.3	0	0.3	48.4	0	0	0	2	0.3	0	0.2	0.8	0.4	38.4	0	0.7	0.8	0.2	0.1	9.2	942.4	0.2	0	1.7	22.7	24.1	0.9	0	0	0	0	0.7	0.8	0.6	3.5	0.7	1.4	0.5	0	0	0.7	0.7	0.4	2.9	3.8	1.7	0.1	Hepatocytes
CPN2	ACBP	ENSG00000178772	Carboxypeptidase N subunit 2	P22792	3	194339765-194351328	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	26	liver: 225.5	Cell type enriched	Detected in some	12	Hepatocytes: 157.2	Cancer enriched	Detected in some	32	liver cancer: 72.7	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	25	Hep G2: 37.1	Not detected	Not detected			Low region specificity	Detected in single			HPA004732	Uncertain				Secreted to blood				42000000000			HPA004732: AB_1078561	unprognostic (4.27e-2)	unprognostic (3.04e-1)	unprognostic (1.42e-1)			unprognostic (4.12e-2)	prognostic favorable (2.05e-4)	unprognostic (1.27e-1)	unprognostic (8.65e-2)	unprognostic (8.56e-2)	unprognostic (1.64e-1)		prognostic unfavorable (4.59e-4)	unprognostic (2.91e-2)	unprognostic (2.40e-1)	unprognostic (6.90e-5)	unprognostic (8.42e-2)	0.2	1.1	0	0	0.1	0.3	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0	8.5	225.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	0	0	0.1	0	0	0.1	0.3	0	0.1	0	0	0	0	0	0	0	0.6	0.4	2.5	0.3	0.2	0.6	0	0.1	0	0.2	0.2	0	0.5	0.1	0.2	0	0	0	0.2	0.1	0.1	0.1	0.5	0.3	0.3	0	0	0.1	0	0.1	0.2	0.3	37.1	0	0.1	0.1	0.1	0	0.1	0	0.2	0	0.1	0.3	0.4	0	0.1	0.1	0.2	0.2	0.1	0	0.1	0.3	0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.9	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	157.2	0.2	0	0	3.7	2.2	0	0	0	0	0	0	0	0	0	0	13.2	0	0	0	0	0	0	0	0	0	0	Hepatocytes
F2		ENSG00000180210	Coagulation factor II, thrombin	P00734	11	46719180-46739506	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	593	liver: 324.8	Cell type enriched	Detected in some	37	Hepatocytes: 904.6	Cancer enriched	Detected in some	110	liver cancer: 508.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	21	Hep G2: 78.4	Not detected	Not detected			Not detected	Not detected			CAB016780, HPA051476, HPA054698	Enhanced				Secreted to blood			108000000000	43000000000			CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578	unprognostic (1.98e-1)	unprognostic (2.52e-1)	unprognostic (2.64e-2)	unprognostic (1.85e-1)	unprognostic (2.29e-1)	unprognostic (2.81e-1)	unprognostic (2.23e-2)	unprognostic (3.94e-2)		unprognostic (5.79e-2)	unprognostic (8.29e-2)	unprognostic (4.46e-2)	prognostic unfavorable (6.75e-12)	unprognostic (5.65e-3)	unprognostic (5.80e-2)		unprognostic (1.54e-3)	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	324.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0.1	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0	3.7	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	78.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0.5	0	0.5	0	0.1	0.4	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	7	0	0	0	0.6	22.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	904.6	0	0	0	24.5	19.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	Hepatocytes
CYP8B1	CYP12	ENSG00000180432	Cytochrome P450 family 8 subfamily B member 1	Q9UNU6	3	42856005-42876165	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 132.7	Cell type enriched	Detected in some	57	Hepatocytes: 737.2	Cancer enriched	Detected in some	46	liver cancer: 69.6	Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 1.4	Lineage enriched	Detected in single	5	granulocytes: 1.4	Group enriched	Detected in some	5	BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1	Not detected	Not detected			Not detected	Not detected																unprognostic (1.58e-2)	unprognostic (5.41e-2)	unprognostic (6.38e-2)	unprognostic (1.15e-2)	unprognostic (8.95e-2)	unprognostic (1.42e-3)	unprognostic (4.47e-3)	unprognostic (1.49e-1)	unprognostic (9.85e-2)	unprognostic (4.04e-3)	unprognostic (5.86e-3)	unprognostic (2.74e-1)	unprognostic (3.37e-1)	unprognostic (1.03e-1)	unprognostic (3.63e-1)	unprognostic (3.19e-1)	unprognostic (1.24e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.7	0	0	0.1	0	0	0	6.7	132.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	1.4	0.2	0.1	0.2	0.1	0.4	0.7	0.3	0.2	0	0	6.8	0.1	0	0	0	0.5	0.3	0.2	0.3	0	0.4	0.3	0	0	0	0	0.2	1.7	0.2	2.6	0	0.7	0.2	0	0	0	0	0.2	0	0.4	0.4	0.2	0	0.4	0.2	0	0.3	0.1	0.4	0.5	0.6	0.3	0.3	0.5	0.1	0	0.6	3.1	0.3	0.4	0.3	0.1	0.3	0.3	0.6	0.3	0.2	0.4	0.1	0.3	0.3	0.4	0.1	1.4	0.2	0.3	0.1	0.1	0.1	0	0.1	0.2	0	0.2	0.1	0.1	0.9	0.1	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	10.2	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.1	0	737.2	0.1	0	0	10.4	10.5	0.5	0	0	0	0	0	0	0	0	0	13	0	0	0	0	0	0	0.3	0	0	0	Hepatocytes
TSKU	E2IG4, LRRC54, TSK	ENSG00000182704	Tsukushi, small leucine rich proteoglycan	Q8WUA8	11	76782251-76798154	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 86.8	Cell type enriched	Detected in many	7	Hepatocytes: 427.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 41.4;ASC diff: 70.9;OE19: 44.7	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA008164	Approved		Approved	Nucleoplasm,Nuclear bodies	Secreted - unknown location				2100000	Nucleoplasm	Nuclear bodies	HPA008164: AB_1853327	unprognostic (1.07e-2)	unprognostic (2.29e-3)	unprognostic (6.15e-2)	prognostic favorable (3.66e-4)	unprognostic (7.05e-2)	unprognostic (2.39e-1)	unprognostic (3.08e-1)	unprognostic (2.17e-3)	unprognostic (4.81e-2)	unprognostic (4.62e-2)	prognostic unfavorable (2.87e-4)	prognostic favorable (1.66e-4)	prognostic unfavorable (2.80e-8)	unprognostic (1.47e-1)	unprognostic (4.93e-2)	unprognostic (6.71e-2)	unprognostic (3.88e-2)	33.1	2.8	1	3.6	1.4	0.6	26.9	1.5	2	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43	3.4	15.7	4.5	48.5	9.3	10.8	7	15	21.4	13	0.8	3	8.7	9	0.8	1.5	12.2	16	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1	1.4	1.5	2	1.2	0.3	1.7	1.3	3.4	0.8	0	0.3	0	13	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0	42.8	0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0	7.5	8.6	9.5	1.2	34.5	1.6	5	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17	Hepatocytes
PLGLB1	PLGL, PRP-B	ENSG00000183281	Plasminogen-like B1	Q02325	2	87002559-87021852	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in many	5	liver: 66.8	Cell type enriched	Detected in many	5	Hepatocytes: 67.6	Cancer enriched	Detected in single	7	liver cancer: 0.7					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many																Secreted to blood								unprognostic (7.25e-2)	unprognostic (7.25e-2)	unprognostic (2.35e-1)	unprognostic (1.15e-1)	unprognostic (1.75e-2)	unprognostic (1.39e-5)	unprognostic (7.04e-3)	unprognostic (1.15e-1)	unprognostic (8.53e-4)	unprognostic (1.60e-1)	unprognostic (4.56e-4)	unprognostic (9.90e-3)	unprognostic (2.96e-5)	unprognostic (1.02e-1)	unprognostic (1.16e-1)	unprognostic (4.32e-2)	unprognostic (3.98e-5)	0.3	1.3	2	0.7	3.4	1.7	0.7	14.3	2.1	0.4	0.5			0.7	1.3	2.1	0.3	0.8	1	0.6	1.9	2.1	1	66.8	0.6	1.5	1.4		1.5	0.4	0.7	1.6	0.3		1	0.3		1.1	0.5	1.9	3.4	0.8	0.2	1.1	1.3	0.7	0.8			1.1		0.5	0.7	0.5	2.7	1.6	5.1	0.8	0.9	2.7	0.4	2.9	4.2	4.8	2.6	4.5	5.4	5.1	3.4	2.5	2.1	2.8	3.3	7.6	7.6	3.4	1.2	1.5	2.5	1.3	0.6	2.1	9.1	3.5	6.6	6.4	3.5	3.1	4.1	1.6	5.6	4.6	5.6	5.7	8.3	0.9	8.7	3.1	6.6	2.6	4.4	13.3	11.3	6.9	2.4	2.7	2.2	2.1	4.5	4.6	3	3.8	4.2	2.9	2.6	3	5.1	1.2	7	5.5	3.8	2.5	2.2	2.1	6.9	5.3	3.4	2.1	5.5	2.6	5.1	0.4	0.9	1.9	0.2	1.2	2.7	2	1.4	0.2	2.2	2.7	1.6	1.9	0.9	0.8	1.6	2.6	0.4											0	4.3	0.8	0.2	1	10.8	1.8	2.5	2.7	2.3	0	5.9	0.2	0	0.7	0.5	1.5	0.1	0	0.2	0.2	0.9	0.4	0	67.6	0.2	4.8	1.2	1.8	1.8	0	1.1	0.9	3.3	1	2.3	2.4	0.2	0	1.8	0.6	14.1	0	0.9	0.3	0.2	1.1	0	0.8	0.7	0.3	Hepatocytes
ACSM5	FLJ20581	ENSG00000183549	Acyl-CoA synthetase medium chain family member 5	Q6NUN0	16	20409534-20441336	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Ligase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	liver: 94.6	Cell type enriched	Detected in some	6	Hepatocytes: 179.6	Group enriched	Detected in some	7	liver cancer: 20.5;renal cancer: 9.6	Low region specificity	Detected in all			Group enriched	Detected in some	6	classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3	Group enriched	Detected in many	8	dendritic cells: 3.2;monocytes: 2.8	Group enriched	Detected in some	5	ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA041435	Uncertain		Uncertain	Vesicles						Vesicles		HPA041435: AB_10961121	unprognostic (1.01e-1)	unprognostic (1.61e-3)	unprognostic (3.73e-2)	unprognostic (1.98e-2)	unprognostic (1.03e-1)	unprognostic (1.59e-2)	unprognostic (1.84e-2)	unprognostic (4.64e-3)	unprognostic (1.64e-1)	unprognostic (2.01e-2)	unprognostic (2.15e-2)	unprognostic (2.33e-1)	unprognostic (5.11e-3)	unprognostic (2.09e-2)	unprognostic (3.85e-2)	unprognostic (2.78e-2)	unprognostic (1.57e-1)	11.1	1.1	1.9	0.7	2.1	0.4	3.2	1.3	1.6	1	1	2.9	0	0.5	0.3	2.8	0.5	0.6	1	0.9	3	1.9	8.9	94.6	0.9	1.6	2.9	2.1	0.4	1.4	0.4	0.1	0.7	2	0.4	0.6	0.5	0.5	0.5	4.4	0.6	0.6	0.5	2.9	1.7	0.9	1	3	0.1	1.7	0.6	0.4	0.5	0.7	0.3	3.2	0.3	2.8	0	0.3	0.5	0	0	0.1	0.1	5.8	12.6	0	0.1	1.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.2	0	0.2	0	15	0	0.8	0.1	0.3	0	0	0.1	0.6	1.7	0	0	0.3	0.2	0	0	0	0.1	2.2	0	0.1	0	0	0.3	0	0	0	0	0.4	0	0.3	0.1	0	0	0.1	0	0	9.2	0.1	0	0.3	2.8	0.1	0.1	1.9	0.1	0.1	0.3	0.2	3.2	0.3	0.2	0.3	0.1	0	1.3	0.1	0	0.5	1.9	2.1	1.3	1.6	3	1.9	2.9	2.1	2	3	0	0	0	0.1	0	0	1.6	0	0	0	0	0	0	6.6	0.3	0.4	0.6	0	0	0	0	0.7	0.3	0	179.6	3.3	0	0	6.7	8.8	0.2	8.6	1.2	0	1.8	0	1.1	0	0	5.6	31.5	0	0	0.1	0	0.2	0.5	0	0	0	0.1	Hepatocytes
SLC22A10	hOAT5, OAT5	ENSG00000184999	Solute carrier family 22 member 10	Q63ZE4	11	63137867-63369718	Predicted membrane proteins, Transporters	Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	32	liver: 41.7	Cell type enriched	Detected in some	13	Hepatocytes: 15.5	Cancer enriched	Detected in single	14	liver cancer: 6.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																								unprognostic (1.17e-2)				unprognostic (9.77e-2)		unprognostic (7.07e-3)	unprognostic (7.46e-4)			unprognostic (7.62e-3)	unprognostic (2.87e-1)	unprognostic (1.56e-1)	unprognostic (6.52e-2)	unprognostic (4.25e-1)			0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	41.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.5	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	15.5	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
CYP4F2		ENSG00000186115	Cytochrome P450 family 4 subfamily F member 2	P78329	19	15878023-15898120	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	intestine: 69.1;liver: 102.9	Cell type enriched	Detected in some	8	Hepatocytes: 132.0	Cancer enriched	Detected in some	9	liver cancer: 29.6	Not detected	Not detected			Cell type enriched	Detected in single	12	basophil: 8.5	Lineage enriched	Detected in single	86	granulocytes: 8.5	Cell line enriched	Detected in some	4	Hep G2: 9.0									HPA014048, HPA017265, HPA058960	Supported				Intracellular and membrane							HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862	unprognostic (7.46e-3)	unprognostic (3.58e-1)	unprognostic (3.01e-1)	unprognostic (9.39e-2)	unprognostic (1.74e-1)	unprognostic (2.87e-2)	unprognostic (4.55e-3)	unprognostic (6.52e-2)	unprognostic (2.05e-1)	unprognostic (4.64e-2)	unprognostic (9.82e-2)	unprognostic (2.92e-1)	unprognostic (8.69e-4)	unprognostic (3.24e-1)	unprognostic (1.89e-1)		unprognostic (7.79e-3)	0.1	0.1	0.2	0.5	0.1	0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.2	1.9	0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0	0	8.5	0	0	0	0	0.1	0	0.2	0	0	0	2.2	0	0	0	0.3	0.7	0.1	0.3	0.1	0	0	0.6	0	0.3	0	0	0.1	0	0.2	9	0	1	0.5	0	0.2	0.1	0	0	0	0	0.1	0.1	0	0	0.5	1.6	0.1	0	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.9	0.1	0	0	0.2	0	0	0	0	0.4	0.2	0	0.4	0	0	0	0.1	0	8.5	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0	0	0	0.1	0.3	0	0.5	5.1	0	0	0	0	0	1.7	0	6.2	0	16.2	0	0.3	0	0	0.6	0	132	0	0	1.7	0.6	3.9	11	0	0	0	0	3.6	0	0	5.8	0	14.7	0	0	0	0	0.2	0.1	0	0	3	0.1	Hepatocytes
CYP4F3	CYP4F, LTB4H	ENSG00000186529	Cytochrome P450 family 4 subfamily F member 3	Q08477	19	15640897-15662825	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 159.2	Cell type enriched	Detected in many	6	Hepatocytes: 506.3	Cancer enhanced	Detected in many		liver cancer: 30.6	Low region specificity	Detected in many			Cell type enriched	Detected in single	68	neutrophil: 33.1	Lineage enriched	Detected in single	166	granulocytes: 33.1	Cell line enhanced	Detected in some		CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3									HPA058960	Approved											HPA058960: AB_2683862	unprognostic (1.73e-2)	unprognostic (9.70e-3)	unprognostic (1.21e-1)	unprognostic (1.16e-3)	unprognostic (5.40e-1)	unprognostic (1.57e-1)	unprognostic (7.15e-3)	unprognostic (5.19e-2)	unprognostic (2.12e-1)	unprognostic (3.61e-2)	unprognostic (1.26e-2)	unprognostic (2.32e-1)	unprognostic (1.59e-3)	unprognostic (2.36e-1)	unprognostic (1.12e-1)	unprognostic (1.07e-2)	unprognostic (2.07e-1)	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0	0.4	1.9	0.1	0.2	0	0.2	0	1.6	0.3	0.5	0	1.3	0.1	0.1	1.2	13.4	0.1	1	2.6	1.7	0.2	1.8	0	0.1	1.1	0.8	1.8	2.7	0	0	33.1	0.1	0	0	0	0.2	4.4	0	0	0	0	0	0	0	0.2	0	0	20	0	0.1	0	0	9.1	0	0.1	0	0.3	0	0.1	1.9	10.9	0	0.1	0.1	0	0.9	0	0	0	0	0	0	0.2	0	0	0	0.1	0	29.3	0	0	0	0	0	0.5	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.6	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	33.1	0	0	0	0	0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8	8.9	5.9	5.1	2.3	0.9	0	0.8	91.7	0	0	0	0	0	0	1.2	0	0.1	13.5	23.3	0.2	0.1	0.3	1.7	1.1	506.3	0	0	50.9	6.2	10.2	0.4	0	0.4	0	0	5.6	0	2.5	7	0	31.2	0	0	0.2	0	0.1	5.6	0	0.8	8.3	10.8	Hepatocytes
SERPINA11		ENSG00000186910	Serpin family A member 11	Q86U17	14	94442464-94452790	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	140	liver: 189.6	Cell type enriched	Detected in some	50	Hepatocytes: 255.3	Cancer enriched	Detected in some	9	liver cancer: 94.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	Hep G2: 19.6	Not detected	Not detected			Not detected	Not detected								Secreted to blood				460000000				unprognostic (2.50e-2)	unprognostic (3.26e-1)	unprognostic (9.00e-2)	prognostic favorable (6.30e-4)		unprognostic (7.44e-2)	unprognostic (2.02e-2)	unprognostic (1.70e-1)	unprognostic (3.44e-1)		unprognostic (5.14e-2)	unprognostic (1.53e-1)		unprognostic (1.64e-1)				0	0	0	0.1	0	0	0.9	0	0	1.3	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	189.6	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0.7	0	0	0	0	0	0.9	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	19.6	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	0	1.2	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	255.3	0	0	0	3.7	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Hepatocytes
AGMO	FLJ16237, TMEM195	ENSG00000187546	Alkylglycerol monooxygenase	Q6ZNB7	7	15200318-15562015	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	intestine: 41.9;liver: 57.9	Cell type enriched	Detected in some	5	Hepatocytes: 79.7	Cancer enriched	Detected in many	5	liver cancer: 15.7	Low region specificity	Detected in some			Group enriched	Detected in some	5	basophil: 3.6;neutrophil: 3.1	Lineage enriched	Detected in single	5	granulocytes: 3.6	Cell line enhanced	Detected in some		HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA057900			Uncertain	Vesicles						Vesicles		HPA057900: 	unprognostic (2.82e-1)	unprognostic (9.28e-2)	unprognostic (5.60e-3)	unprognostic (1.44e-4)	unprognostic (7.52e-2)	unprognostic (1.07e-2)	unprognostic (3.61e-2)	unprognostic (6.56e-2)	unprognostic (3.31e-1)	unprognostic (3.35e-1)	unprognostic (4.18e-3)	unprognostic (3.24e-1)	unprognostic (1.64e-1)	unprognostic (2.04e-2)	unprognostic (3.45e-1)	unprognostic (1.00e-1)	unprognostic (1.93e-1)	6.8	0.2	0.8	1	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0	0.7	0.4	0.7	0.4	0.3	0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2	0	0.7	0.1	0.1	1	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0	0	2.5	0.1	2.2	0.2	3.2	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0.3	0	0	4.1	0	0	0	0	0	0	0	8.7	0	0	0	0.1	3.9	0	0	0	0	1.3	0	0.7	3.7	0	0	0	0	2.9	0	0	4.4	1.5	0.3	0.2	0	0.7	0	0	0	0	17.2	3.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0	0.2	0.1	0.1	3.1	0.6	0	0.1	0	0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2	0	0	0	0.1	0.1	0	0	15.3	0	0	3.5	0	0.1	0	0	0.7	0.1	2.6	0	0	0.1	0.7	0	0	79.7	0.1	0	1.7	1.3	1.3	0.9	0	0.1	3.3	0	0.1	0	0.6	0	0	15.2	0	6.5	0.2	0.4	2.5	0	0.1	0	0.6	0	Hepatocytes
HAPLN4	BRAL2, KIAA1926	ENSG00000187664	Hyaluronan and proteoglycan link protein 4	Q86UW8	19	19255641-19262796	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 38.5;intestine: 24.3	Cell type enriched	Detected in single	6	Hepatocytes: 4.9	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA055856	Enhanced				Secreted in brain							HPA055856: AB_2682946					unprognostic (3.36e-4)													0.5	1.9	3	0.4	7.5	0.4	0.7	8.9	38.5	2.4	0.6	1.6	0	19.6	1.6	0.5	0.4	0.7	0.6	0.5	8.9	9.4	0.5	7.5	0.6	0.4	7.8	2.7	1.4	1.3	0.4	0.2	0.7	26.4	1.1	0.6	0.4	0.5	0.8	0.4	0.4	24.3	0.6	3.8	0.4	0.8	0.5	0	0	0.4	0	0.4	0.5	0.3	0	0.6	0	0	0	0	0	0	0	0.5	0	0	0	0.1	0	0	0	0.1	0	0	0	1.7	0	0.2	0	1.7	0	0	0	0.1	0	0	0	0.6	0.6	0	0.1	0	0.1	0	0	0	0	0.2	0	0.3	0	0	5.7	14.9	0	0	0	0	0	0	0	3.2	1.5	0	0	0	0.6	0	1.1	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	3	7.5	8.9	38.5	8.9	9.4	7.8	2.7	26.4	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	0.1	0	0	0.6	0	0	0.3	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.1	0	0	0	0	0	Hepatocytes
ADH1A	ADH1	ENSG00000187758	Alcohol dehydrogenase 1A (class I), alpha polypeptide	P07327	4	99276367-99291028	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	322	liver: 250.3	Cell type enriched	Detected in some	10	Hepatocytes: 212.0	Cancer enriched	Detected in some	251	liver cancer: 165.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	ASC diff: 11.2									CAB009562, HPA047814, HPA060902	Enhanced		Approved	Plasma membrane,Cytosol					12000000	Plasma membrane, Cytosol		CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384	unprognostic (5.89e-2)	unprognostic (6.16e-2)		unprognostic (1.20e-1)	unprognostic (2.07e-1)	unprognostic (4.40e-1)	prognostic favorable (2.38e-4)	unprognostic (2.78e-3)		unprognostic (4.25e-1)	unprognostic (4.79e-3)	unprognostic (6.21e-2)	unprognostic (9.36e-2)	unprognostic (3.25e-2)	unprognostic (1.40e-1)		unprognostic (2.86e-2)	0.4	0	0	0	0	0	0.1	0	0	0	0.7	0	0	0.7	0	0	0	0	0.6	0	0	0	0	250.3	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.5	0	11.2	0	0	0.4	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.9	0	0.1	0	2.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	1.7	0	0	0	0.1	0	1.3	0	0	0.2	0	0	0	0	0.1	0	0	0.1	0	1	0	0.6	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0.2	20.4	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0.2	0	0	212	0	0	0	7.4	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	Hepatocytes
ACADSB	ACAD7, SBCAD	ENSG00000196177	Acyl-CoA dehydrogenase short/branched chain	P45954	10	123008979-123058311	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	kidney: 28.9;liver: 114.2	Cell type enriched	Detected in many	4	Hepatocytes: 481.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		Hep G2: 35.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041458, HPA063555	Enhanced		Supported	Mitochondria					63000	Mitochondria		HPA041458: AB_2677491, HPA063555: 	unprognostic (1.53e-2)	unprognostic (1.31e-1)	unprognostic (3.91e-3)	unprognostic (2.02e-1)	unprognostic (1.25e-1)	unprognostic (4.87e-2)	unprognostic (4.15e-2)	unprognostic (1.32e-3)	unprognostic (1.30e-1)	unprognostic (3.67e-1)	prognostic favorable (3.40e-4)	unprognostic (9.37e-3)	prognostic favorable (6.37e-12)	unprognostic (2.69e-1)	unprognostic (7.20e-2)	unprognostic (1.60e-3)	unprognostic (7.14e-2)	4.6	9.4	6.7	2.4	9	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5	5.3	8	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5	4.1	6.3	6.8	13.5	5	9	11.7	6	9.7	7	5.2	9.5	7.1	8.9	4.6	6	12.2	6.1	6.1	6.1	3.2	10.2	4.2	5.1	3.7	4.1	8.1	4.2	10.1	6.6	8.4	5.3	2.1	35.3	5	7.5	5.1	6.5	4.3	3.8	3.5	9	5.8	8.6	5.1	7.5	7.5	4.5	7.1	6.2	3.2	5.4	4.4	8.5	10.9	3.2	8.6	10.8	1	6	9.2	2.8	9.5	5.2	8.4	3.7	6.1	3.3	3	7.5	7.3	8.5	9.6	5.4	5.1	7.1	2.5	13.5	5	12.3	10	5	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9	3	4.1	7.6	6	6.7	9	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4	26.8	40.3	7.3	7.2	8.2	17.2	64.9	43.3	17.4	29.6	10.4	9.8	17.9	39.7	6.4	6	7.4	6.8	0	4.2	2.5	7.5	26.5	3.5	481.6	6.3	20.6	11.6	15.4	11.8	7.8	12.4	7.6	6.8	8.2	13.3	12.2	4.3	5.8	10.3	116.2	7.3	19.4	11.3	9.7	2.5	12	25.2	13.8	15.7	10.7	Hepatocytes
SLC22A25	HIMTP, MGC120420, UST6	ENSG00000196600	Solute carrier family 22 member 25	Q6T423	11	63163776-63229652	Predicted membrane proteins, Transporters	Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	165	liver: 16.5	Cell type enriched	Detected in single	9	Hepatocytes: 5.8	Cancer enriched	Detected in single	66	liver cancer: 3.2					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA039390	Uncertain											HPA039390: AB_10671996	unprognostic (3.19e-2)				unprognostic (2.38e-1)	unprognostic (4.51e-1)	prognostic favorable (7.04e-4)							unprognostic (1.01e-1)				0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	16.5	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0.6	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ADH1B	ADH2	ENSG00000196616	Alcohol dehydrogenase 1B (class I), beta polypeptide	P00325	4	99304964-99352760	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adipose tissue: 253.5;liver: 466.3	Cell type enriched	Detected in many	38	Hepatocytes: 3603.2	Cancer enriched	Detected in many	31	liver cancer: 223.1	Group enriched	Detected in some	5	midbrain: 2.3;pons and medulla: 1.6	Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	7	ASC diff: 394.3									HPA047814, HPA060902	Supported		Approved	Plasma membrane,Cytosol					16000000	Plasma membrane, Cytosol		HPA047814: AB_2680163, HPA060902: AB_2684384	unprognostic (5.13e-2)	unprognostic (9.80e-3)	unprognostic (6.59e-2)	unprognostic (5.56e-2)	unprognostic (9.49e-2)	unprognostic (5.53e-2)	unprognostic (1.54e-3)	unprognostic (1.04e-2)	unprognostic (6.51e-2)	unprognostic (2.73e-2)	unprognostic (7.47e-3)	unprognostic (7.79e-2)	prognostic unfavorable (7.87e-4)	unprognostic (4.60e-3)	unprognostic (2.33e-1)	unprognostic (2.58e-1)	unprognostic (1.60e-2)	253.5	12.3	0.2	21.8	0	0.4	78.7	0.2	0.4	18.3	60	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0	9.2	466.3	43.8	17.5	2.3	0.1	18	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18	0.2	0.2	16.1	9.7	2	42.3	76	0.6	0.2	1.2	0.3	0.8	0.4	0	0	0	0	0	394.3	57.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.1	0	12.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0	0.2	0	0.2	0	0.3	0	2.3	0.1	1.6	0.2	0	4.3	14	0.4	19.8	0	8.9	66.2	0	3.4	0	0	0	0	0	0.4	9.2	0	46.7	0	0	81	0.3	1.1	3603.2	0.1	0	0	93.9	77.5	0	51.2	1	27	0	0	0	0	0	0.4	0	0	6.5	43.7	0	0	11.4	0.1	12.5	0	0.1	Hepatocytes
SERPINA1	A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1	ENSG00000197249	Serpin family A member 1	P01009	14	94376747-94390693	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Protease inhibitor, Serine protease inhibitor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	16	liver: 3314.2	Cell type enriched	Detected in many	7	Hepatocytes: 29973.4	Cancer enriched	Detected in all	10	liver cancer: 3850.6	Low region specificity	Detected in some			Group enriched	Detected in many	5	classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0	Group enriched	Detected in many	5	granulocytes: 139.3;monocytes: 203.0	Cell line enriched	Detected in some	8	Hep G2: 326.1					Region enriched	Detected in many	6	cerebellum: 334.2	HPA000927, HPA001292, CAB013211, CAB016648, CAB073396	Enhanced		Enhanced	Vesicles	Secreted to blood			2070000000000	210000000000	Vesicles		CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762	prognostic favorable (1.61e-5)	unprognostic (3.37e-1)	prognostic favorable (5.86e-4)	unprognostic (1.38e-2)	unprognostic (1.98e-2)	unprognostic (5.50e-3)	unprognostic (3.81e-2)	unprognostic (6.78e-2)	unprognostic (2.54e-2)	unprognostic (7.96e-2)	unprognostic (1.08e-1)	unprognostic (4.54e-1)	unprognostic (1.23e-2)	unprognostic (1.89e-1)	unprognostic (1.30e-2)	unprognostic (1.17e-2)	unprognostic (1.96e-1)	0.9	0.4	0.7	4.9	1.4	3	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1	0.4	0.5	74.1	3314.2	13.6	5.3	1	0.2	0.6	7.4	0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203	0.2	0.3	100	2.3	0	0	0	0	0	0.1	0	0.1	0	0	12.9	41	0.1	1.1	0	0.1	0.1	0	0.8	0	5	0	0.2	0.1	326.1	0	1.1	0.1	0.3	0.4	0	1.4	0.1	0	0	0.2	0	0	0	0	0.8	0.1	0.3	0.5	0.1	1.1	0.1	22.1	0.2	0	0.1	0.4	0.1	0.1	0	19.4	0.2	0.1	0.1	5.1	0.1	0.6	0.2	0.1	0.5	0.3	2.8	0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203	0.7	0.2	100	0.7	1.4	0.2	0.7	0.4	0.5	1	0.2	0.8	0.8	32.8	233.5	435.3	1.1	2.1	0	2.8	4603.8	45.5	60.3	143.1	0	1.4	58	1848.5	0.1	6.6	53.3	817.7	189.3	1.7	1.6	5	1.1	29973.4	171.4	0	11.6	922.6	1276.8	0	0	188.6	1.7	107.4	659.1	0.3	1376.2	37.4	0	447	0.2	0	5.1	0	0.1	1.5	5.4	46.5	24.7	7.1	Hepatocytes
CYP2B6	CPB6, CYP2B, CYPIIB6	ENSG00000197408	Cytochrome P450 family 2 subfamily B member 6	P20813	19	40991250-41018398	Plasma proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	44	liver: 137.3	Cell type enriched	Detected in some	7	Hepatocytes: 326.3	Cancer enhanced	Detected in many		liver cancer: 28.8	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HaCaT: 7.0;OE19: 4.9					Not detected	Not detected			CAB033866, HPA048124, HPA062973	Enhanced		Approved	Nucleoplasm,Nuclear membrane,Cytosol	Intracellular and membrane					Nuclear membrane	Nucleoplasm, Cytosol	CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914	unprognostic (1.86e-1)	unprognostic (1.23e-2)	unprognostic (1.13e-2)	unprognostic (6.13e-2)		unprognostic (4.59e-2)	unprognostic (4.63e-2)	unprognostic (4.41e-2)	unprognostic (1.73e-1)		unprognostic (5.78e-2)		unprognostic (1.04e-3)	unprognostic (2.19e-1)	unprognostic (9.43e-2)		unprognostic (5.44e-1)	0.1	0	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0	0.5	0.1	0.1	0	3	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	1.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0	0.4	0.2	0.3	0	0.1	1.5	0	0.3	0.3	0.2	0.1	7	0.4	0.1	0.1	0.3	0.6	0.4	0.7	0.4	0.4	0.4	0.4	0	0.4	0.3	0.1	0.3	0.5	0.7	0.4	0.1	0.2	0.1	0.8	1.8	0.6	4.9	0.4	0.2	0.5	0.4	1.7	0.1	0.9	0.2	0.3	0.1	0.5	0.3	0.7	1.1	0.8	0.6	0.3	0.7	0.5	0.3	0.7	0.9	0.2	1.1	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.6	0	0.3	0	0	0.2	2.5	1.4	1.2	1.8	0	0	0	0	0	0	9.9	46.7	0.2	0	0	0.1	0	326.3	0	0	0	10.4	11	0	0	0	0	0	1.4	0	0	7	0	9.7	0	0	0	0	0	0	0	1.3	3.2	0.6	Hepatocytes
ADH4	ADH-2	ENSG00000198099	Alcohol dehydrogenase 4 (class II), pi polypeptide	P08319	4	99123657-99157792	Enzymes, Plasma proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 345.2	Cell type enriched	Detected in some	34	Hepatocytes: 802.6	Cancer enriched	Detected in some	60	liver cancer: 230.7	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	11	Hep G2: 22.4	Not detected	Not detected			Not detected	Not detected			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol					5300000	Nucleoplasm, Cytosol		HPA020525: AB_1844609	unprognostic (2.75e-1)	unprognostic (1.69e-2)	unprognostic (1.85e-2)	unprognostic (5.54e-3)	unprognostic (2.14e-2)	unprognostic (1.33e-2)	prognostic favorable (7.08e-6)	unprognostic (1.49e-1)		unprognostic (1.39e-2)	unprognostic (6.91e-2)	unprognostic (1.88e-1)	unprognostic (2.34e-2)	unprognostic (7.16e-3)	unprognostic (2.20e-1)		unprognostic (5.89e-3)	0.3	0.1	0	0.1	0	0	0.6	0	0.1	0.2	3.6	0	0.1	11	0	0.1	0.7	0	0	0.1	0	0	0.2	345.2	0.1	0	0.1	0	0.1	0	0	0	0	0.1	0.1	0	0	0.4	0.1	0.4	0.1	4.5	0	0	0.1	0.1	0.1	0	0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0	0	0	0.2	0.2	0.5	0.3	0	0.2	0.3	0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0	0.2	0.2	0.2	0.1	0.2	0.4	1	0.1	0.3	0.3	0.6	0.4	0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2	0.3	0	0.3	0.5	0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1	0.4	0.5	0.7	0.3	0.1	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0	2.2	0	0	0	0.2	15.3	0	0	1.8	0	0	0	0	21.9	0	0	23.3	0.5	0	0	0	0	802.6	0	0	0	13.5	20.9	2.6	0.3	0	0	0	0	0	0.1	0	0	0.8	0	0	0	0	0.1	0	0	0	0.6	0	Hepatocytes
AKR1C4	3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581	ENSG00000198610	Aldo-keto reductase family 1 member C4	P17516	10	5195462-5218949	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	17	liver: 127.0	Cell type enriched	Detected in some	10	Hepatocytes: 437.4	Cancer enriched	Detected in some	86	liver cancer: 108.4	Not detected	Not detected			Group enriched	Detected in some	4	basophil: 1.2;gdT-cell: 1.1	Group enriched	Detected in many	6	granulocytes: 1.2;T-cells: 1.1	Group enriched	Detected in some	4	HDLM-2: 11.6;OE19: 5.1									HPA044720, HPA068265	Uncertain		Approved	Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol					1800000	Nucleoplasm, Cytosol	Nucleoli fibrillar center, Endoplasmic reticulum	HPA044720: AB_2679058, HPA068265: AB_2685966	unprognostic (2.21e-1)	unprognostic (3.04e-1)	unprognostic (5.15e-2)	unprognostic (1.25e-1)		unprognostic (5.99e-2)	unprognostic (9.40e-2)	unprognostic (2.32e-1)		unprognostic (1.26e-1)	unprognostic (1.52e-2)		unprognostic (1.29e-1)	unprognostic (3.31e-1)	unprognostic (7.34e-2)		unprognostic (1.45e-2)	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0	0.3	0	0	0	0	7.4	0	0	0	0	127	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0.2	1.2	0	0	1.1	0.1	0	1.5	0.1	1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	11.6	0	0.5	0.3	1.9	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	5.1	0	0	0.7	0	0	0.2	0	0	0.2	0	0	0	0	0	0.8	0	0.1	0.4	0	0	0	0.1	0.1	0.1	0	1.2	0	0	1.1	0	0	0	0.1	0.1	0	0	0	0.1	0.2	0	0	0.2	0.1	0.1	0	0	0	0.1	0	0	0	0	0.1	0	0	0	3.9	0	0	0	0.2	45.9	2.7	1.2	0	0	0	0	0	5.8	0	0	23.3	0.6	0	0	0	0	437.4	0	0	0	14.1	11.8	0	0	0	0	0	0	0	0.2	0	0.4	0.6	0	0	0	0.5	0.2	0	0	0	0	0.1	Hepatocytes
TAT		ENSG00000198650	Tyrosine aminotransferase	P17735	16	71565660-71577130	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Phenylalanine catabolism, Tyrosine catabolism	Aminotransferase, Transferase	Disease mutation, Mental retardation, Palmoplantar keratoderma	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	44	liver: 387.0	Cell type enriched	Detected in some	42	Hepatocytes: 3069.2	Cancer enriched	Detected in some	10	liver cancer: 152.8	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	5	Daudi: 2.4;Hep G2: 7.3	Not detected	Not detected			Not detected	Not detected																unprognostic (3.66e-3)	unprognostic (1.29e-1)	unprognostic (8.17e-2)	unprognostic (2.21e-1)	unprognostic (1.67e-1)	unprognostic (1.01e-2)	prognostic favorable (6.51e-4)	unprognostic (1.69e-1)	unprognostic (9.32e-2)	unprognostic (2.27e-1)	unprognostic (3.73e-3)	unprognostic (1.88e-1)	unprognostic (1.27e-4)	unprognostic (1.19e-1)	unprognostic (1.28e-1)	unprognostic (1.09e-1)	unprognostic (1.05e-2)	0	0	0	0	0	0	8.8	0	0.1	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	387	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.2	0	0	0.1	0	0.1	0	0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0	0	0	0	0	0	0	0	2.4	0.1	0	0.2	0	0	0	0	0.2	0.4	0.5	0.2	7.3	0	0.9	0.1	0	0	0	0	0	0	0.6	0.2	0	0	0.9	0	0.2	0.4	0	0.1	0	0.7	0.9	0	0.1	0.3	0.1	0.6	0	0.2	0	0.1	0	0	0.1	0.4	0	0	0.5	0.2	0.5	0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0	0	0	0.1	0	0	0	0	0.1	0	0	0	14	0	0	0.2	0.3	73.9	0	0	0	0	0	0	0.2	0.9	0	1	23.3	0.6	0	0	0	0	3069.2	0	0	0	53.4	61.8	0.6	0.6	0	0	0	0	0	0.2	0	0	0	0.9	0	0	0.9	1.5	0	0	0	0	0	Hepatocytes
LPA	LP, Lp(a)	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid transport, Transport	Hydrolase, Protease, Serine protease	Atherosclerosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	71	liver: 43.4	Cell type enriched	Detected in some	32	Hepatocytes: 79.7	Cancer enriched	Detected in single	38	liver cancer: 3.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	RT4: 4.7									CAB016072, HPA060604	Supported				Secreted to blood			78800000000	2900000000			CAB016072: AB_2135240, HPA060604: AB_2684330		unprognostic (2.16e-1)	unprognostic (5.10e-1)	unprognostic (7.75e-3)	unprognostic (6.70e-2)	unprognostic (1.60e-1)	unprognostic (4.17e-3)	unprognostic (1.59e-1)		unprognostic (6.38e-3)	unprognostic (3.63e-2)	unprognostic (3.18e-1)	unprognostic (7.45e-3)	unprognostic (2.56e-1)	unprognostic (1.80e-1)	unprognostic (1.34e-1)	unprognostic (3.72e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.6	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.1	0.4	0	0	0.5	0.7	0	0	0.1	0	0	4.7	0	0	0.1	0	0	0.2	0	0	0	0.1	0	0	0	0.7	0.1	0	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0.4	2.5	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	79.7	0	0	0	1.3	2.1	1.5	0	0	0	0	0	0	0	0	0	1	0	0	0	0.6	0.8	0	0	0	0	0.2	Hepatocytes
LIME1	dJ583P15.4, FLJ20406, LIME	ENSG00000203896	Lck interacting transmembrane adaptor 1	Q9H400	20	63736283-63739103	Predicted intracellular proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 87.5;liver: 43.7;lymphoid tissue: 80.4	Cell type enriched	Detected in single	11	Hepatocytes: 2.6	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Group enriched	Detected in many	6	gdT-cell: 39.4;MAIT T-cell: 35.4;memory CD4 T-cell: 54.9;memory CD8 T-cell: 51.2;naive CD4 T-cell: 37.5;naive CD8 T-cell: 40.6;plasmacytoid DC: 87.5;T-reg: 77.8	Group enriched	Detected in many	9	dendritic cells: 87.5;T-cells: 77.8	Cell line enhanced	Detected in some		Karpas-707: 13.4;MOLT-4: 14.0;RPMI-8226: 51.4;U-266/70: 27.8									CAB015363	Approved				Intracellular and membrane							CAB015363: AB_629890	unprognostic (1.16e-1)	unprognostic (2.35e-1)	unprognostic (5.95e-3)	unprognostic (3.01e-1)	unprognostic (1.34e-1)	unprognostic (3.85e-3)	unprognostic (3.06e-2)	unprognostic (1.46e-1)	unprognostic (1.36e-1)	unprognostic (1.94e-1)	unprognostic (1.05e-3)	unprognostic (1.51e-3)	prognostic unfavorable (5.04e-5)	unprognostic (2.39e-2)	unprognostic (4.25e-2)	unprognostic (1.67e-1)	prognostic favorable (6.92e-6)	1.9	0.6	2.1	17.9	4.9	4	0.7	4.4	2.1	2	5.2	0.4	0.5	2.2	0.9	0.3	4.2	0.7	8.4	0.8	2	1.8	13.6	43.7	5	20.3	1.4	1.1	1.2	0.5	0.4	1.8	0.6	0.4	2.3	0.6	1.1	9.9	0.7	0.9	4.9	3.7	0.7	1.7	10	16.9	0.7	0.5	80.4	1.6	2.4	22.8	2.5	1.1	9.6	87.5	1.3	0.1	9.2	77.8	22.3	0.7	0.2	0	0.1	0	0	1.8	0.9	0	0.1	0	0.4	0.8	2.2	1.4	0	0	1.9	0	0.1	0.1	0.9	1.7	0.4	0.7	8.6	0	0.6	0.8	0.1	0.2	0	0	0	0	6.4	0.8	13.4	0	0.4	14	3.8	0.7	0.6	2.4	9.7	0.3	51.4	0.2	0.1	0.7	1.1	0.5	0.5	1	0	0.4	0.3	0.2	0.7	1	0.7	0.5	27.8	1	4.4	0.6	0.4	0.2	0.1	0.1	0.2	39.4	0.1	35.4	9.6	54.9	51.2	0.2	3.7	37.5	40.6	1.3	9.2	0.1	87.5	77.8	22.3	2.1	4.9	4.4	2.1	2	1.8	1.4	1.1	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0.1	0	Hepatocytes
LRCOL1		ENSG00000204583	Leucine rich colipase like 1	A6NCL2	12	132603150-132610543	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	epididymis: 54.8	Cell type enriched	Detected in some	13	Hepatocytes: 39.8	Cancer enhanced	Detected in some		liver cancer: 3.0					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0														Secreted in male reproductive system								unprognostic (5.09e-3)	unprognostic (7.83e-3)	unprognostic (3.26e-1)	unprognostic (6.94e-2)	unprognostic (3.15e-2)	unprognostic (2.38e-2)	prognostic favorable (7.04e-4)	unprognostic (4.54e-2)	unprognostic (6.08e-2)	unprognostic (5.29e-2)	unprognostic (4.66e-3)	unprognostic (1.52e-1)	unprognostic (6.50e-6)	unprognostic (1.46e-3)	unprognostic (9.63e-2)	unprognostic (3.31e-1)	unprognostic (4.00e-3)	0	0	0	0	0.1	0	0	0	0	0.1	0.1	0	4.4	0.1	0	54.8	0	0.2	0.4	0	0.2		0.1	0	0.5	0.6	0	0	0	0	0	0.1	0.1	0	0.1	0	0.1	0	1.9	0.1	0	0.1	0	0	0.1	0	0.6	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	1.7	0.7	0.5	1.2	0	0	0	0.4	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0											0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	39.8	0	0	0	3.1	1.3	0	1.4	0	0	0	0	0	0	0	0.7	0	0	0	0.8	0	0.2	0.1	0	0	0	0	Hepatocytes
LCAT		ENSG00000213398	Lecithin-cholesterol acyltransferase	P04180	16	67939750-67944131	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Acyltransferase, Hydrolase, Transferase	Corneal dystrophy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	11	brain: 64.4;liver: 154.2	Cell type enriched	Detected in many	16	Hepatocytes: 204.0	Low cancer specificity	Detected in all			Region enriched	Detected in all	7	cerebellum: 64.4	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 35.6;Hep G2: 27.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044767			Approved	Nucleoplasm	Secreted to blood			6470000000	9500000000	Nucleoplasm		HPA044767: AB_2756312	unprognostic (3.34e-2)	unprognostic (3.56e-2)	prognostic unfavorable (8.50e-4)	unprognostic (5.43e-3)	unprognostic (1.25e-2)	unprognostic (2.16e-1)	prognostic favorable (4.21e-8)	unprognostic (6.42e-2)	unprognostic (4.26e-1)	unprognostic (4.12e-1)	unprognostic (1.50e-2)	unprognostic (7.21e-2)	prognostic unfavorable (1.71e-4)	unprognostic (9.93e-2)	unprognostic (1.83e-1)	unprognostic (2.85e-1)	unprognostic (1.90e-3)	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5	1.1	1.3	1.4	0.1	2.5	4	6	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2	6	0	1.6	0	4.3	0	0	0.9	2.7	7.1	2.9	1.1	204	2.1	0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0	7.5	1.4	0	8.1	0	0.5	12.9	7.1	1	1.5	2.3	10.2	0	0	1.4	Hepatocytes
ANG	RAA1, RNASE5	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Differentiation, Stress response	Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor	Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	liver: 371.4	Cell type enriched	Detected in many	21	Hepatocytes: 4646.2	Cancer enriched	Detected in all	17	liver cancer: 279.2	Low region specificity	Detected in single			Cell type enhanced	Detected in many		classical monocyte: 18.1;myeloid DC: 10.4	Low lineage specificity	Detected in many			Group enriched	Detected in many	4	Hep G2: 52.5;OE19: 40.2					Low region specificity	Detected in many			HPA055896			Approved	Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments	Secreted to blood	Yes	No	308000000	230000000	Nucleoli, Nucleoli rim, Mitotic chromosome	Actin filaments	HPA055896: 	unprognostic (2.50e-2)	unprognostic (1.82e-1)	unprognostic (9.77e-2)	prognostic favorable (6.85e-4)	unprognostic (5.71e-3)	unprognostic (6.99e-2)	prognostic favorable (7.83e-5)	unprognostic (1.16e-1)	unprognostic (3.20e-3)	unprognostic (9.19e-3)	unprognostic (1.31e-1)	unprognostic (3.69e-1)	unprognostic (6.65e-2)	unprognostic (1.03e-1)	unprognostic (3.39e-1)	unprognostic (2.00e-1)	unprognostic (3.09e-1)	17	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9	0.7	6.6	3.5	10.7	10.3	8	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1	0.1	17.7	9	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0	4.2	5.5	3.6	14.3	15	4.5	10.4	0.3	18.1	0	0.9	4.8	1.3	3.4	0.8	0	8.6	10.3	0.1	1.4	3	0.4	1.4	2	1.8	0.1	0.4	4.2	2.9	1.3	0.9	1	0.4	5.8	1.3	0.3	1.9	52.5	1.8	1.3	0.1	8.3	0.8	0.5	1.8	4.3	2	1.5	0	9.6	1.2	0.2	0.2	0.4	0.2	40.2	3.8	0.2	1.3	3.9	0.8	1	0	0.1	1.5	0.6	2.3	1.9	1.4	0.2	1.7	0.5	1	0.5	0.2	2	1.6	0.2	1.1	0.6	1.6	0	18.1	0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1	0.1	0.8	0.4	26.8	12.4	18	36	24.2	0	0.6	219.1	60.2	18.2	10.4	0	1.5	10	27.6	0.7	12.2	37.1	23.3	27.7	3.3	31	52.1	0	4646.2	15.9	0	68.2	70	110.5	1.1	65.9	16	21.9	1	138.3	9.1	26.8	17.3	22.6	45.5	0.6	12.9	18.6	0.7	1	45.8	7.8	12.1	44.2	29.8	Hepatocytes
GCGR	GGR	ENSG00000215644	Glucagon receptor	P47871	17	81804132-81814013	FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Diabetes mellitus, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 68.8	Cell type enriched	Detected in some	7	Hepatocytes: 60.2	Cancer enhanced	Detected in many		liver cancer: 10.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1	Region enriched	Detected in single	5	cerebellum: 0.9	Not detected	Not detected			HPA071228			Uncertain	Golgi apparatus						Golgi apparatus		HPA071228: AB_2686368	unprognostic (3.28e-4)	unprognostic (9.30e-2)	unprognostic (2.20e-1)	unprognostic (1.53e-4)	unprognostic (1.11e-1)	unprognostic (2.30e-3)	unprognostic (4.38e-2)	unprognostic (1.79e-3)	unprognostic (2.18e-1)	unprognostic (2.77e-1)	unprognostic (3.09e-1)	unprognostic (2.61e-1)	unprognostic (6.42e-2)	unprognostic (5.99e-3)	unprognostic (1.71e-1)	unprognostic (1.17e-3)	unprognostic (8.36e-3)	0.2	3.9	0.1	0.6	0.3	0	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0	0.1	0.1	0.1	0	11.4	68.8	0.1	0.1	0.1	0.1	0.1	0.5	3.9	0.1	0.1	0.5	0.2	0	1.4	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0	0.2	0.1	0.2	0.2	0.6	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.5	0	3.9	0.2	0	0.4	0	0	0	0	0	0	0	0	0	0	0	6.1	0	0.3	0	0	0	0	0	0.2	0	0	0.3	1.6	0	5.3	0	0	0	0.6	0	0	1.3	0	0	0	0	0	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0.1	0.3	0.1	0	0.1	0.1	0.5	0.1	0	0	0	0	0.8	0.2	0.6	0	0	0	3.5	2	0	3.3	0	0	0	0	0	0	0	0	0	0	60.2	0.1	0	0	1.3	3.7	0	0	0	0	0	0	8.3	0.1	0	0	0	0.2	0	0	0.1	0.2	0.4	0	0	0	0	Hepatocytes
APOC4-APOC2		ENSG00000224916	APOC4-APOC2 readthrough (NMD candidate)		19	44942238-44949565	Predicted membrane proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in single	267	liver: 178.9	Cell type enriched	Detected in some	6	Hepatocytes: 139.4	Cancer enriched	Detected in some	17	liver cancer: 9.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	THP-1: 11.6									HPA055877	Supported											HPA055877: AB_2682953	unprognostic (1.45e-1)	unprognostic (4.00e-2)	unprognostic (1.86e-1)	unprognostic (1.33e-1)	unprognostic (1.27e-1)	unprognostic (1.42e-1)	unprognostic (1.49e-2)	unprognostic (2.07e-2)	unprognostic (1.52e-1)	unprognostic (4.73e-2)	unprognostic (1.25e-1)	unprognostic (1.85e-1)	unprognostic (2.01e-4)	unprognostic (2.28e-1)	unprognostic (2.88e-1)	unprognostic (5.95e-2)	unprognostic (1.68e-2)	0.1	0.1	0.4	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.3	0.2	0.1	178.9	0.1	0.1	0.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.6	0.5	0	0	0	0	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.2	1.7	0	1.5	2.2	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0	0	0	1.2	0	0.7	0	0	11.6	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0.1	0.1	0.3	0.2	0.6	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.3	0	0	0	0	2.3	139.4	2.2	0	0	1.3	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ORM2	AGP-B, AGP-B', AGP2	ENSG00000228278	Orosomucoid 2	P19652	9	114329869-114333252	Plasma proteins, Predicted secreted proteins	Acute phase, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 404.1	Cell type enriched	Detected in some	43	Hepatocytes: 9578.7	Cancer enriched	Detected in many	34	liver cancer: 873.1					Cell type enriched	Detected in single	35	neutrophil: 13.2	Lineage enriched	Detected in single	35	granulocytes: 13.2	Cell line enriched	Detected in single	237	Hep G2: 136.6									HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood			422000000	61000000000	Vesicles	Golgi apparatus	HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512	unprognostic (6.77e-2)	unprognostic (8.00e-2)	unprognostic (1.19e-1)	unprognostic (4.44e-3)	unprognostic (1.18e-1)	unprognostic (5.61e-2)	unprognostic (5.66e-2)	unprognostic (9.70e-2)	unprognostic (3.05e-1)	unprognostic (1.48e-1)	unprognostic (1.99e-2)	unprognostic (5.76e-2)	prognostic unfavorable (1.23e-9)	unprognostic (3.23e-1)	unprognostic (6.80e-2)	unprognostic (7.62e-2)	unprognostic (9.15e-4)	0	0.1	0	0	0	1.2	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	404.1	0.1	0	0		0	0	0	0	0		1.2	0		0	0	0	0	0	0	0	0.3	1	0			0		0	0	0	0	0	13.2	0.3	0	0.1	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	136.6	0	0.5	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	0.4	0	0	0.3	0	0	0	0	0	0.4	0.3	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0.4	0	0.1	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	13.2	0	0.1	0	0	0.1											0	8	42.8	0	0	0	0	224.2	0	0	0	0	0	0	1.2	6.5	0	0	70	5.4	0	0	2.1	0	9578.7	0	0	0	141.2	136	5	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ORM1		ENSG00000229314	Orosomucoid 1	P02763	9	114323056-114326475	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Acute phase, Transport		Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 834.6	Cell type enriched	Detected in some	35	Hepatocytes: 50531.7	Cancer enriched	Detected in many	16	liver cancer: 2506.9					Cell type enriched	Detected in some	45	neutrophil: 53.4	Lineage enriched	Detected in many	45	granulocytes: 53.4	Cell line enriched	Detected in some	11	Hep G2: 161.7									CAB006265, HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood			945000000000	120000000000	Vesicles	Golgi apparatus	CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512	unprognostic (3.85e-1)	unprognostic (2.12e-1)	unprognostic (1.09e-2)	unprognostic (2.16e-2)	unprognostic (3.22e-2)	unprognostic (1.47e-1)	unprognostic (2.29e-1)	unprognostic (2.26e-1)		unprognostic (1.16e-1)	unprognostic (4.85e-2)	unprognostic (1.74e-1)	prognostic unfavorable (2.35e-4)	unprognostic (2.10e-1)	unprognostic (4.38e-2)	unprognostic (9.32e-3)	unprognostic (4.51e-2)	0.1	0	0	0.2	0	6.7	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	834.6	0.3	0	0		0	0	0	0	0		0.6	0		0	0	0	0	0	0	0	1.3	0.4	0			0		0	0	0	0	0	53.4	1.1	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0.2	0	0	0	0	0	0	0	0	0	0.4	0	161.7	0	0.7	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0.1	1	0	0	0	0	0	0.8	0.8	0	0	0	14.3	0.1	0	0	0	0	0.1	0	0.5	0	0.6	0	0	1.1	0	0	0.1	0	0	0	0	0	0	0	0	53.4	0	0.2	0	0	0.3											3	14.9	263	0	0	0	0	1452.2	0	1.2	0	0	0	0	6.6	0	0	0	794.3	4.5	0.1	0	31.6	0	50531.7	0.1	0	0	844.6	848.5	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	2.9	0	0.3	Hepatocytes
CYP21A2	CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B	ENSG00000231852	Cytochrome P450 family 21 subfamily A member 2	P08686	6	32038265-32041670	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Steroidogenesis	Monooxygenase, Oxidoreductase	Congenital adrenal hyperplasia, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	adrenal gland: 170.9	Cell type enriched	Detected in some	6	Hepatocytes: 14.4	Cancer enhanced	Detected in some		liver cancer: 2.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 11.8;Hep G2: 1.9;Karpas-707: 3.2					Not detected	Not detected			HPA048979, HPA053371	Enhanced				Intracellular and membrane							HPA048979: AB_2680584, HPA053371: AB_2682131	unprognostic (1.03e-2)	unprognostic (1.65e-1)	unprognostic (1.02e-4)	unprognostic (2.58e-1)	unprognostic (2.97e-1)	unprognostic (2.93e-2)	unprognostic (2.76e-2)	unprognostic (8.75e-2)	unprognostic (1.39e-1)	unprognostic (1.71e-1)	unprognostic (1.41e-1)	unprognostic (1.93e-1)	unprognostic (6.67e-7)	unprognostic (7.39e-2)	unprognostic (5.24e-2)	unprognostic (1.09e-1)	unprognostic (1.82e-1)	0.1	170.9	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	6.7	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.3	7.4	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	3.6	0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	11.8	0.3	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.4	1.1	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0.1	0.3	0.3	2.5	1.4	1.2	0	0	0	0	0.2	0	0	0	0	0	0	0.5	0.3	1.1	14.4	0	0	1.7	0	0	0	0.6	0	1.7	0	0	0.2	0.5	0	0	1.7	0.4	0	0.2	0.5	0.4	0	0	0	0	0	Hepatocytes
APOC2		ENSG00000234906	Apolipoprotein C2	P02655	19	44945982-44949565	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Disease mutation, Hyperlipidemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	78	liver: 506.5	Cell type enriched	Detected in some	26	Hepatocytes: 936.4	Cancer enriched	Detected in some	17	liver cancer: 49.7	Low region specificity	Detected in many			Cell type enriched	Detected in single	21	NK-cell: 6.5	Lineage enriched	Detected in single	21	NK-cells: 6.5	Group enriched	Detected in some	4	Hep G2: 84.9;THP-1: 156.9					Not detected	Not detected			HPA055877	Supported				Secreted to blood			43000000000	110000000000			HPA055877: AB_2682953	unprognostic (4.28e-2)	unprognostic (7.73e-3)	unprognostic (1.33e-1)	unprognostic (3.66e-2)	unprognostic (8.91e-2)	unprognostic (1.90e-1)	unprognostic (2.07e-1)	unprognostic (5.41e-2)	unprognostic (2.56e-1)	unprognostic (1.96e-2)	unprognostic (2.86e-1)	unprognostic (1.15e-2)	unprognostic (5.14e-8)	unprognostic (1.32e-1)	unprognostic (1.45e-1)	unprognostic (1.77e-2)	unprognostic (9.80e-3)	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0	0.2	0	0.7	0.3	0	0.1	0.3	0	0	6.5	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0.3	0.3	0.1	0	0	0	0.3	0	0	0	0	0	14.7	0.2	84.9	0	1.8	29	0	0	0	0	0	0	0	0.2	0.3	0	0.1	0.1	14.1	0	0.4	0	0.1	0.6	0.1	0	0.1	0	0	0.2	0	0.9	0	0	156.9	0	0	0	0.1	0	0.3	0.1	0.2	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	6.5	0	0	0	0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1	0	2.9	1.5	0	0.6	0	0.1	12.7	0	0	3.5	0	0	3.3	0	0	0	0	0	0	0	0	0.1	25.4	936.4	35.6	0	0	18.4	13.7	0	0	11.1	6.8	3.6	0	0	0	0	0.7	11.2	0	0	0	0.1	0	0.4	0.2	1.3	0	0	Hepatocytes
UGT1A1	GNT1, UGT1, UGT1A	ENSG00000241635	UDP glucuronosyltransferase family 1 member A1	P22309	2	233760248-233773299	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins		Glycosyltransferase, Transferase	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	16	intestine: 48.6;liver: 120.3	Cell type enriched	Detected in some	12	Hepatocytes: 83.9	Cancer enriched	Detected in some	19	liver cancer: 16.4	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 4.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HaCaT: 8.1;OE19: 35.4;RT4: 19.3	Not detected	Not detected																						unprognostic (7.28e-2)			unprognostic (2.49e-2)	unprognostic (3.60e-1)	unprognostic (5.69e-2)			unprognostic (4.17e-3)	unprognostic (6.31e-3)	unprognostic (1.94e-5)	unprognostic (2.78e-3)			unprognostic (2.99e-4)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0	0.3	0.1	0.1	0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0	0.1	0.4	0	0	0	0	3.1	0.2	0.1	1.4	0	0	8.1	0	0.1	0	0.1	0.1	0	0.3	0.8	0	0.3	0.1	0.1	0.3	0	0	0	0	0.1	0.1	0.3	0	0.4	0	0.2	0.3	35.4	3.6	0	0.1	0.3	0	19.3	0.1	0.2	1.4	0.2	0	0.1	0.1	0	0	0.1	0	0.2	0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	1	0	0	0	0	2.7	6.8	1.8	0	0	0	0.2	2.8	0	3.5	0	0	0	0	0.9	0	83.9	0	0	0	1.3	3.3	0.8	0	0	0	0	0.6	0	0.5	1.4	0	1.4	0	0	0	0	0.1	0	0	0	0.6	6.2	Hepatocytes
CYP2A6	CPA6, CYP2A, CYP2A3	ENSG00000255974	Cytochrome P450 family 2 subfamily A member 6	P11509	19	40843538-40850447	Plasma proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	165	liver: 199.5	Cell type enriched	Detected in some	13	Hepatocytes: 161.7	Cancer enriched	Detected in some	12	liver cancer: 281.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0									HPA046713, HPA047262	Supported				Intracellular and membrane							HPA046713: AB_2679767, HPA047262: AB_2680005	unprognostic (5.40e-2)	unprognostic (2.36e-2)	unprognostic (1.21e-1)	unprognostic (4.10e-1)	unprognostic (5.05e-2)	unprognostic (2.64e-2)	prognostic favorable (5.38e-5)	unprognostic (4.98e-3)	unprognostic (4.86e-2)	unprognostic (6.23e-2)	unprognostic (5.20e-2)	unprognostic (1.95e-1)	unprognostic (2.25e-2)	unprognostic (8.83e-3)	unprognostic (2.46e-1)	unprognostic (3.07e-2)	unprognostic (2.55e-1)	0	0	0	0	0	0	1.2	0	0.1	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	199.5	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	2.9	0	0	0	0	0	0	0	0	1.4	0	0	0.8	0	0	0	0	0	0	4.4	0	0	0	0	0	2.2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	5.1	5.3	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	161.7	0	0	0	12.9	7.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	Hepatocytes
SMLR1		ENSG00000256162	Small leucine rich protein 1	H3BR10	6	130827406-130837135	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	intestine: 33.8;liver: 67.3	Cell type enriched	Detected in some	13	Hepatocytes: 193.4	Cancer enriched	Detected in some	20	liver cancer: 16.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	12	Hep G2: 42.5					Low region specificity	Detected in all			HPA066060	Uncertain											HPA066060: AB_2685607	unprognostic (1.73e-1)		unprognostic (7.37e-3)	unprognostic (1.43e-1)	unprognostic (1.32e-2)		unprognostic (2.35e-1)			unprognostic (1.31e-1)	unprognostic (1.50e-1)		unprognostic (6.43e-3)	unprognostic (2.68e-3)	unprognostic (3.29e-1)			0.1	0.3	0.1	0	0.1	0	0	0	0.1	0.1	14	0	0	7.8	0	0.2	0	0.1	0.1	0.1	0.1	0.1	2.3	67.3	0.1	0	0.1	0	0.2	1	0	0	0	0	0	0	0	0	0	0	0	33.8	0	0.1	0.1	0.1	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	42.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	10.2	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	193.4	0.1	0	0	1.8	3.2	0	0	0	0	0	0	0.3	0.5	0	0	15.3	1.3	0	0	0	0	0	0.1	0	0	0	Hepatocytes
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Immunity	Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	37	liver: 1156.9	Cell type enriched	Detected in many	51	Hepatocytes: 52541.7	Cancer enriched	Detected in many	81	liver cancer: 1297.4	Not detected	Not detected			Group enriched	Detected in some	4	classical monocyte: 20.0;eosinophil: 30.9	Group enriched	Detected in many	7	granulocytes: 30.9;monocytes: 20.0	Group enriched	Detected in some	5	Hep G2: 66.2;HSkMC: 37.9									CAB003787, HPA047750	Enhanced		Approved	Vesicles	Secreted to blood			998000000000	140000000000	Vesicles		CAB003787: , HPA047750: AB_2680146	unprognostic (6.38e-3)	unprognostic (7.73e-3)	unprognostic (1.23e-1)	unprognostic (2.41e-2)	unprognostic (2.34e-3)	unprognostic (2.07e-1)	unprognostic (7.79e-3)	unprognostic (1.37e-1)	unprognostic (2.31e-1)	unprognostic (1.84e-1)	unprognostic (6.30e-2)	unprognostic (8.18e-2)	prognostic unfavorable (6.94e-13)	unprognostic (4.34e-4)	unprognostic (1.80e-1)	unprognostic (6.61e-2)	unprognostic (2.49e-2)	9.8	0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0	0.3	0.5	0.3	1.1	0.3	3	0.3	0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0	0.5	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	0	0.3	0.3	0.3	1.4	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0	3.5	30.9	20	0	0	5	0	0	0	0	2.1	0	0.1	0	0	0	0	0	0.1	2.5	0.1	0	0	0.7	0	0	0	0	0	3.4	0	66.2	0.1	9.5	1.8	37.9	0	0	0	0	0	0	2.5	0	0	0	0.6	0.1	0.8	0	0	0.3	7.1	0	0	0	0	0	4.8	0	0	0	0	2.1	1.4	0	0.2	0	0	1.2	0	4.5	0	3.7	0	2.6	20	30.9	0	0.8	0	0	0	0	3.5	0	0	0	5.8	0	0.9	0	0	5	0.3	0.3	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	17.9	220.1	295.8	0.8	0.1	0.2	72.5	853.5	10.7	10.3	0	0	0	0	0	0.1	6.8	0	864.3	9.6	0	0.2	0.2	3.5	52541.7	2.4	0	0	971	1021.7	0	9.5	0	1.7	0	0	1.2	0	0	0	0.5	0.1	0	0.9	0	0	0.3	0.1	23	0	0	Hepatocytes
HPR		ENSG00000261701	Haptoglobin-related protein	P00739	16	72063224-72077246	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	liver: 151.4	Cell type enriched	Detected in some	18	Hepatocytes: 430.8	Cancer enriched	Detected in some	53	liver cancer: 185.1					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	14	Hep G2: 33.6									HPA047750	Supported		Approved	Vesicles	Secreted to blood			49000000000	77000000000	Vesicles		HPA047750: AB_2680146	unprognostic (2.43e-1)		unprognostic (4.69e-2)	unprognostic (5.97e-3)	unprognostic (2.42e-1)		unprognostic (2.32e-3)	unprognostic (2.36e-1)		unprognostic (1.66e-1)	unprognostic (8.21e-2)	unprognostic (2.30e-1)	unprognostic (3.44e-6)	unprognostic (2.09e-2)	unprognostic (1.45e-1)	unprognostic (1.29e-1)		0.2	0	1.3	0	1.6	0	0	0	0.6	0.1	0			0.1	0	0.1	0	0	0.1	15.2	0.7	0.8	0.1	151.4	0	0.1	2.1		0.4	0	0	0	0		0	0		0	0.1	0	0	0.1	0	0.3	0	0	0.2			0		0	0	0	1.1	2.9	1.1	1	0.4	2.3	0.3	0	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	33.6	1.6	0	0	2.4	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0.8	1.1	1.3	1	0.1	0.5	0.4	0.4	0.3	1.1	2	1.1	0.3	0.4	0.3	2.9	2.3	0.3											0	9.8	0	0	0.1	0	14.9	17.8	0	0	0	0	0	0	0	2.4	0	0	23.3	0.2	0	0.2	0	0	430.8	0	0	0	9.8	7.3	2.1	9.2	0	0	0	0	5.2	0	0	4.9	4.8	0	0	0.1	0	0	0	0	0	0	0	Hepatocytes
APOC4		ENSG00000267467	Apolipoprotein C4	P55056	19	44942238-44945496	Plasma proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	liver: 126.0	Cell type enriched	Detected in single	34	Hepatocytes: 3.4	Cancer enriched	Detected in single	15	liver cancer: 0.7	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 4.2;SK-MEL-30: 6.5;TIME: 3.1									HPA062671	Approved				Secreted to blood			1000000000	1500000000			HPA062671: AB_2684828							unprognostic (1.82e-3)											0	0.2	0.1	0	0.2	0.1	0	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0.2	0.2	0	126	0.1	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0.2	0.2	0	0.1	0	0	0.1	0	0	0	0	1.4	3.1	4.3	1.7	0.8	1.2	0.1	0.8	0	0	0.8	0	0.9	1.6	0	0	1.1	0.2	0	0.2	1.1	0.1	0	0.2	0.1	0.6	0.4	0.3	0.2	0.4	4.2	0	2.6	0	0.3	1.2	2.5	0.3	0	0.4	0.1	0	1.3	1.2	1.9	0.8	1	0.4	0	0	0.1	0.5	0	0.6	0.8	0	1.5	0.5	0.2	0.7	0.8	6.5	0.2	1.4	0	3.1	0.6	0.3	0.4	0	0.8	0.9	2	0.2	1.3	0	2.1	0.8	1.9	0.9	1.7	0.4	0.6	0.9	1.2	0.4	1.4	0.6	0.6	4.3	0.8	0.8	3.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
CCL16	CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4	ENSG00000275152	C-C motif chemokine ligand 16	O15467	17	35976493-35981496	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	127	liver: 79.1	Cell type enriched	Detected in some	14	Hepatocytes: 244.8	Cancer enriched	Detected in single	154	liver cancer: 49.0					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	23	Hep G2: 15.0					Low region specificity	Detected in many								Secreted to blood			2780000	20000000				unprognostic (3.85e-1)	unprognostic (4.71e-1)	unprognostic (1.49e-1)	unprognostic (3.75e-2)		unprognostic (2.72e-1)	unprognostic (4.58e-2)	unprognostic (2.80e-1)	unprognostic (1.09e-1)	unprognostic (1.54e-1)	unprognostic (1.91e-2)	unprognostic (3.57e-1)	unprognostic (1.40e-3)	unprognostic (1.66e-2)	unprognostic (2.32e-1)	unprognostic (1.09e-1)	unprognostic (4.08e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0		0	79.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.4	0.2	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	15	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0.1	0	0	0.1	0	0.2	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.2											0	0	0	0	0	0	0.3	5.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	244.8	0	0	0	17.8	4.1	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	Hepatocytes
